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Abstract
This work comprises studies into the application of the enzyme-linked 
immunosorbent assay for ABH grouping as it applies to forensic serology. 
The detection of groups A, B and H substance in liquid saliva and 
bloodstains on cotton cloth were studied by ELISA. Assays were developed 
to group A and B substance in 0.40 pi of liquid saliva using commercial 
polyclonal antisera in a two-stage indirect ELISA. The use of human 
immune sera to group ABH substance in extracts of bloodstains was 
confounded by reaction of anti-human Ig conjugates with immunoglobulin 
from the stain extracts co-immobilizing with extracted blood group 
substance. Several anti-ABH monoclonal antibodies were used to 
successfully type groups A, B and 0 secretor saliva and groups A,, B and 
A,B bloodstains extracted with a combination of detergents and ammonia. 
Group 0 stains were not detectable because the anti-H reagent was of 
insufficient titre. The MAb were purified on immunoadsorbents and by 
size exclusion chromatography and partially characterised. Attempts were 
made to conjugate purified MAb to alkaline phosphatase by the 
glutaraldehyde, the SPDP method (3- (2-pyridyldithio) propionic acid N- 
hydroxy succinimide ester) and using the avid in-bio tin system. The latter 
was most successful although problems were encountered with endogenous 
bio tin. The implications of these findings and suggestions for further 
study are discussed.
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1 General Introduction
1.1 Forensic Science and Blood Grouping
Forensic Science is a general term covering a number of 
scientific disciplines involved in the analysis and comparison of trace 
materials exchanged during a criminal act. The principle of this exchange 
was formulated by Edmund Locard in 1910 at the University of Lyons, 
which paraphrased said that all contact leaves a trace, however small.
Such traces may be as obvious as leaving weapons or tools at 
the scene of an assault or break-in or as subtle as the exchange of 
minute clothing fibres between victim and assailant during a rape, or 
minute paint flakes embedded on the clothes of a victim of a hit and run 
incident. The identification of the component characteristics of the 
trace material enable its comparison with the parent material thus 
relating a thief to a stolen car, or a bloodstain as having originated 
from a victim of a grievous assault or excluding an innocent suspect.
In England and Wales, six regional Forensic Science Laboratories 
administered by the Home Office carry out numerous searching and 
secondary comparisons on various evidence types. The laboratories are 
sub-divided to deal with drugs and toxicology cases, alcohol analyses, 
biology and chemistry cases. The breakdown of the responsibilities and 
the number of cases and exhibits for one such laboratory in 1984 are
shown in Table 1,
Forensic Biology is concerned with the transfer of blood, other 
body fluids such as saliva and semen, hair, textile fibres, and to a 
lesser extent wood and other vegetable matter between the the victim or 
assailant and the scene of the crime. Blood splashes on clothing and on 
furnishings provide several types of evidence (Figure 1).
The amount, position and distribution of blood stains all give
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TABLE 1
Forensic Science: Case Types and Exhibits
Case Type Number of Cases (%) Number of Exhibits (%)
Explosives, Arson 2.1 3.3
Breaking 3.3 11.5
Drugs, Alcohol 81.4 42.1
Miscellaneous 8.7 14.2
Murder, GBH 1.8 13.7
Sex crimes 2.7 15.3
Total Cases/Exhibits 9484 24.589
INTRO..;. ION
Figure 1. Blood splash patterns after a domestic murder 
incident.The smears indicate physical contact while the
1 • ü e the res.. It >f f or ref i blows on a bloo
overeu sur race.
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valuable evidence. The mere presence of blood on clothes is evidentially 
significant regardless of any further considerations [Briggs 19781. 
Minute splashes of blood may indicate the force used during an assault 
as well as the relative position of the victim and assailant. In a
multiple assault, and one in which the assailant becomes injured, a 
complex story as told by the mixture of blood splashes needs to be 
unravelled. Fine sprays of blood leave minute bloodstains on a variety of 
substrates which range from textile materials which are absorbent to 
glass and plastic surfaces.
The forensic scientist, when presented with an article of
clothing or other evidence type needs first to locate the bloodstain,
usually visually. A presumptive test follows, based on the presence of 
red cell haemoglobin-associa ted peroxidase activity CHigaki and Philip 
19763 to exclude other dark red or brown stains. The history of 
bloodstain identification started with tests made in the absence of any 
detailed knowledge of blood composition. Current techniques have found 
their origins in the 19th century and this development has been 
chronicled CGaensslen 1983 p773.
The species of origin of a bloodstain is usually the first test 
carried out on a blood stain selected for further analysis. The most 
commonly used method is crossed-over immunoelectrophoresis in agar gels 
(the precipitin test) to detect serum proteins using specific polyclonal 
antisera directed against 7-globulins as first described by Culliford 
[19643.
Having established that a particular stain is human blood, a
battery of grouping and other tests may be used to compare it to a 
sample of control blood from the putative originator of the bloodstain. 
The same principles can also be applied to saliva staining masks, semen 
staining on clothing and sheath cells from hair roots of hair 
transferred during a crime for example. Some laboratories may routinely
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use as many as 10 grouping systems although the selection of a 
particular grouping system such as the ABO system or PGM system depends 
on many factors besides operational competence in the technique. The 
condition, size and age of the bloodstain have to be considered as do 
the benefits to be gained from a particular grouping system. For example 
if both parties in an assault bled and from their control samples they 
had been grouped as group A then the value of carrying out ABO grouping 
on blood staining a suspect weapon would be questionable.
The systems in use in various laboratories are typically divided 
into serological and biochemical. The former are those used to detect 
antigens on red cell membranes and carried on molecules in serum and 
secretions detectable using antisera. The latter group are red cell 
enzyme polymorphisms and other protein polymorphisms which may be 
separated e lec t rophore t ica 1 ly. Table 2 shows the systems in use and the 
amount of bloodstain needed for a single evaluation estimated by 
comparing stains (in reasonable condition) on cotton cloth. It is not 
possible using current grouping systems to unequivocally attribute a 
bloodstain to a particular individual. Only a probability can be 
expressed that given the the known occurrence of a certain spectrum of 
blood groups in a stain, there is a certain chance that a person having 
the same spectrum was the originator of that blood. Of course in crime 
cases other evidence may be used to substantiate the results of blood 
group analyses.
If in each blood group system there was only one characteristic 
which all people possessed then blood or any other body fluid would be 
indistinguishable between individuals. It is possible to discriminate 
between the blood of individuals because when considering one grouping 
system (eg ABO) only one blood group will be inherited. This frequency 
of inheritance has been quantified so that the probability that two sam-
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TABLE 2
Current Blood Grouping Systems In English Forensic Science Labs.
System Blood Groups Stain Size* Stability*
ABO A, B, 0, AB 20 mm > 1. Year.
PGMC 1, 2, 2-1 40 mm 6 weeks
HP 1, 2, 2-1 20 mm 4 weeks
Gm/Km 1, 2, 10 etc 40 mm 2 months
EAP B, c, BA 15 mm 1 month
AK 1. 2, 2-1 40 mm 3 months
Led a±b± a 30pl 3 days
(a) Size (mm) indicates the length of bloodstained cotton thread 
for one test.
(b) The average age of stain after which a grouping result is 
difficult to obtain in a particular system.
(c) The anodal and cathodal variants of these groups can be 
distinguished eg 1+1-, 2+1- etc giving 15 sub-groups.
(d) Performed on whole blood.
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-pies of blood taken at random being the same can be estimated. The 
probability (P) of two random samples matching in eg the ABO system is:
n
P = Z pl=
1=1
where n is the number of groups in one system and pi is the frequency 
of occurence of one group eg group B in the ABO system.
The probability that two blood samples (for example a 
bloodstain at the scene of a break-in and the control blood sample from 
a suspect with an unexplained hand injury) match when grouped is given 
by the product of the square of each frequency [Jones 19723 :
Group — __ _p Frequency
A, Pi 0.340
A= P= 0.080
B P= 0.090
A1B P* 0.240
A=B Ps 0.006
0 Pe 0.460
P= <0.340)2 x (0.080)= x (0.090)= x (0.240)= x (0.006)= x (0.460)=
P= 0.399
The probability of being able to discriminate between two 
samples using the ABO system (le the converse of matching them) is 
known as Discriminating Power (DP) and is given by:
1 - P 
= 1 - 0.399
= 0.601
ie there is a 60% chance that samples grouped using the ABO system 
alone might be different.
This discrimination will be highest for a system if the many
INTRODUCTION Page 18.
components of the system (eg the ABO antigens) are present in a 
population in equal proportion. For a system with a large number of
components there will be a higher probability of discrimination between 
the blood in two bloodstains. This argument can be extended for two or
more grouping systems since the combined DP is 1 - (P, x P2 ?„)
where P, and Ps are the probabilities that for each system two
bloodstains considered at random will match each other when grouped by 
these n different, independant grouping systems.
For example if the ABO, Haptoglobin and PGM systems were used 
to group blood stains the DP would be calculated as follows:
ABO P,= 0.3990
Hp P2= 0.6753
PGM P3= 0.4742 ~
•*• the combined probability (of a match)
= 0.1278 
the DP = 1 - 0.1278 
= 0.8722
ie there is a 87% chance that two samples grouped by these three 
grouping systems will be different. If they are found to match then this 
is an uncommon event and suggests a common origin. The frequencies for 
the occurrence of the components of twelve grouping systems have been 
published CStedman 19721.
2 The ABO System
2.1 The ABO System: History and Serology
Any review of the ABO system must include the theory of the 
serology and biochemistry, current grouping techniques generally as well 
as those developed specifically for medico-legal applications. The 
discovery of the ABO system is credited to Lands te iner in 1900 who
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published a paper on the agglutination of human red cells using serum 
from other individuals [Lands te iner 19001. He later postulated that 
human blood could be divided into four groups based on data produced by 
himself and other workers. This early work has been extensively 
reviewed, much of it translated from the original German [Camp and 
Ellis 19741. A lucid account appears in Race and dangers' classic work 
•Blood Groups in Man' [Sixth Edition, 19751 and elsewhere [Gaensslen 
1983 p2611.
The theory of the ABO system was based on the presence of two 
agglutinogens (components that can be agglutinated) A and B, and two 
agglutinins (agglutinating agents) termed a and p or anti-A and anti-B. 
Despite practical exceptions the agglutinins present for each group were 
widely accepted as follows:
Blood Group Antigens on Red Cells Antibodies in Serum
A A Anti-B
B B Anti-A
0 - Anti-A and Anti-B
AB A and B
That these agglutinogens were inherited was established after
numerous family studies [Von Dungern and Hirschfeld 19111. Bernstein
proposed the basis of the mechanism of inheritance accepted today based 
on extensive statistical analyses and calculation. He concluded that the 
A and B agglutinogens were the product (individually as it transpired) 
of multiple alleles at a single genetic locus, then the first of its kind 
demonstrated in man. A and B are dominant characters.
By this time A sub-groups had been identified: group A red cells 
may be classed as A,, A2 and others. The difference is attributed to
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quantitative differences in A antigens on red cells. However, evidence 
for a qualitative difference rather than a quantitative one CMohn and 
Cunningham 19803 is indicated by different agglutinins present in the 
serum. Anti-A, and A2 agglutinins (present in normal B serum) were 
found to agglutinate group A cells as follows:
Blood Group Antigen Type Agglutinated Bv:
A, A, A, Anti-A, Anti-A,
A2 A Anti-A
The inability of A2 cells to be agglutinated by anti-A, was
attributed to a lower site density on A2 red cells compared to A, cells 
caused by an inefficient transferase enzyme (see below) converting less 
H substance to A antigen so that true agglutination does not happen 
[Schenkel-Brunner 19823 (see also page 32). Numerous other sub-types 
of group A exist which can be loosely termed A*. They are rare and 
exhibit very weak group A characteristics I Race and Sanger 1975 pl53 , 
while group B sub-types exist in an analogous way. In terms of strength 
of reaction with strong anti-A antisera (as distinct from anti-A or 
anti-A, antisera) the reaction decreases in the series A, > A,B > A2 > 
A2B. Steric hindrance in AB antigens may be responsible for decreased 
reactivity with anti-A antisera although the group A site density is 
itself important ICartron et al 19743 :
Blood Group Sites/Cell 
A, 850,000
A2 240,000
A3 30,000
A., 700
(A*i is a rare A variant)
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Antl-A and anti-B are formed in the neonate with IgM synthesis 
preceding IgG synthesis. These antibodies were postulated to arise from 
external stimulation by for example bacterial ABH-like substances 
[ Dupont 19343 with the plasma cells forming corresponding antibody (eg 
anti-A-producing cells in a group A individual) being switched off in the 
presence of A antigen.
The inheritance of the ABO genes is Mendelian. Two models were 
proposed in the 1920's to account for the observed reaction of 
agglutinins with red cells: Bernstein's model was based on three alleles, 
while Furuhata postulated a different mechanism in which two loci were 
responsible for the known inherited blood group characteristics (both 
referred to in CGaensslen 1983 p2653 ).
According to Bernstein's hypothesis either A or B or 0 (a silent 
gene) were inherited from each parent (ie AO, BO, AB or 00 to give blood 
groups A, B, AB and 0 respectively). AA and BB would also give groups A 
or B respectively. Furuhata proposed that A or not A (not A was called 
a) and B or not B (b) were two closely linked loci so that inheriting Ab 
would give group A phenotype, aB would give B and ab, 0.
Although serological evidence agreed well with the Bernstein 
model, detailed biochemical studies on transferase enzymes have shown 
that the products of alleles have different substrate specificities. This 
qualitative difference in gene products is unusual when compared to a 
system in which only quantitative differences between allelic gene 
products are seen (eg the PGM isoenzyme variants which differ in the 
kinetic properties of the enzymes). The occurrence of cis-AB individuals 
where the A and B come from the same parent favour the Furuhata model.
Although the difference in fucosyl transferase enzymes is 
unusual it is not without parallel. The enzyme systems for some plant 
species are one example CWatkins, Greenwell and Yates 19813. 
Additionally the specificity of the transferase enzymes coded for by the
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A, B and H genes is not absolute so the actual model which best fits the 
experimental data is not clear.
2.2 The ABO System: Biochemistry
The currently understood position is that at the ABO locus the
0 gene (originally 'O' was used to denote no agglutinins) is silent. 
Instead another gene, the H gene <H for heterophile) produces H activity 
in cells and secretions which is the precursor for the addition of 
sugars specifying A or B activity where appropriate. Before detailed 
biochemical studies were. possible, much work had been done on the 
extraction and characterisation of the ABH (and Lewis, which is closely 
related) antigens C Morgan 19601. The ABH antigens are polysaccharide in 
nature. The terminal sugars for each were determined by inhibition 
studies with oligosaccharides which were used to completely inhibit the 
agglutination of group A or 0 cells by animal lectins. Additionally, the 
enzymmic inactivation of blood group substance preparations by extracts 
from Trichomonas and Clostridium was itself inhibited by simple sugars.
The results of other chemical studies complemented the evidence 
described above implicating L-fucose in group H activity, N- 
acetyIgalactosamine in group A activity, and D-galactose in group B 
activity. The removal of fucose from group A, B and 0 blood group 
substances left a moiety which cross-reacted with anti-type XIV 
pneumococcal serum CWatkins and Morgan 19563 and is the basis of the 
A, B and H antigens.
The structures of the ABH immunodominant sugars are shown in 
Figure 2. These determinants are carried on two chain types (type 1 and 
2) in which p-ga lactose is joined to N- ace ty Ig lucosam ine with 1 => 3 or
1 a 4 links respectively. Conformational analyses of blood group 
structure and chemical synthesis of the blood group substances have 
indicated that type 1 and type 2 determinants differ considerably in st-
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-ructural terms and present different profiles to antibodies. The nature 
of the chain carrying the immunodominant sugars is not thought to be 
important in antibody recognition.
Blood group antigens, so called because they were first found to
be associated with erythrocytes, can occur in most secretions and
tissues [ Wiener 19433. They can also occur naturally [ Race and Sanger 
1975 p393 for example on Salmonella and Escherichia coli IKishi and 
Iseki 19753 , and have also been detected on sperms in secretors but not 
non-secretors suggesting they may originate from seminal fluid although 
this assertion is controversial.
The main ABH antigens of red cells and those expressed on 
vascular endothelia are mainly of type 2 and independant of the Lewis 
and Secretor systems COriol 19803, In secretions, both types 1 and 2 are 
present. The ABH antigens are carried on different molecules: in the 
secretions such as saliva they are carried on glycoproteins and on
erythrocytes they are carried as g ly cosph ingo 1 ip ids, glycoproteins and 
po lyg ly cosy Iceram ides CHakomori 19813. In milk and urine they are found 
as oligosaccharides and the conformation of these has been studied by 
NMR techniques CLemieux et al. 1980b3. The distribution of ABH antigens 
in red cells among various classes of molecule has been studied
COppenheim, Nachbar and Blank 19833 . The majority of ABH activity is
associated with po ly-AF-ace ty 1 lac tosam ine- type chains in the form of
glycoprotein or glycolipid with traces on Oglycosidic chains of
glycophorin and short chain glycol ip ids [ Viitala and Jërnefelt 19853. 
The expression of ABH and other blood group and tumour antigens on 
glycosphingolipids has recently been reviewed by several authors 
CHakomori 1986, Marcus 1984, Koscielak 19863. At birth the
carbohydrate structures are unbranched which may account for the low 
agglutination of neonatal red cells by class IgG anti-A or anti-B.
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The primary gene products of the A, B and H genes are
transferases which catalyse the transfer of simple sugars from activated 
donor molecules to acceptor substrates (precursor substances). At least 
four gene systems operate in sequence I Boettcher 19783 (Figure 3). The 
substrate for the action of gene-encoded transferases is a precursor 
substance (Figure 2) onto which sugars are added to form the blood
group antigens.
H type 1 is the precursor for Leb as well as the A or B
antigens although Leb may be formed by the simultaneous addition of 
fucose onto precursor substance linked l->3 and l-*4 t Watkins 1980,
Hanf land and Graham 19813 . The enzyme controlling this conversion may 
be of variable efficiency in different body compartments (eg saliva) [Le 
Pendu et al 1982b3. The synthesis of H type 2 is under the control of 
the Se gene. The distribution of both type 1 and type 2 determinants 
depends on the differentiation of two fucosyltransferases coded by the H 
and the Se genes [Mol 1 icone et al. 19853.
The analogues of the Leb and Le* (type 1) antigens are the X 
(stage specific embryonic antigen, SSEA-1) and Y antigens which are H 4  
linked type 2 antigens with the following structures:
3-Gal (1 =) 3) 3-GlcNAc -R 3-Gal (1 =» 4) 3-GlcNAc -R
Leb t 1,4 X t 1,4
oc-Fuc oc-Fuc
3-Gal (1 4 3) 3-GlcNAc -R 3-Gal (1 => 4) 3-GlcNAc -R
Le* t 1,2 t 1,4 Y t 1,2 t 1,4
oc-Fuc oc-Fuc oc-Fuc oc-Fuc
The secretor gene is a single allele (Se or se) which acts 
before the A, B, H and Lewis genes to control the action, directly or
indirectly, of the expression of A, B or H in red cells or secretions
[ Kumazaki and Yoshida 19843. Although the secretor gene was originally
postulated as having a regulatory function controlling both the
appearance of H substance and the fucosyltransferase in secretory fluid,
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Figure .3
The ABO,.. H, „Le .and Se Gene Systems
TYPE 1 ANTIGENS
These are present in secretions only under the control of the Se 
gene* ie the gene products are not present in the secretions of non- 
secretors (sese).
Se le E
PS
A TYPE 1
H TYPE 1 (Le*)
B B TYPE 1
Se Le H
PS H TYPE 1 Le*
se Le
PS Le*
Se Le H A
PS H TYPE 1 ÀLe*
Se Le H B
PS H TYPE 1 BLe*
TYPE 2 ANTIGENS
These are present on red cells (and serum) and in secretions when 
the Se gene is present.
Se H Le or le
PS -------  H TYPE 2
(In secretions)
A TYPE 2
B TYPE 2
Le or le
PS
Se
(In blood)
1/3 of H TYPE 2 is Se 
controlled
Se or se
PS
Se or se 2/3 of H TYPE 2 is Se 
independant.
X (SSEA-1)
Se or se 
PS -------► Y
(a) As an alternative to the structural role for the Se gene, a 
regulatory one has been proposed [Watkins 1980].
(b) Two H enzymes have been postulated, which appear in all 
individuals with genotype H or only in secretors [Oriol, 
Danilovs and Hawkins 1981].
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a structural role has been proposed for It by Oriol COriol 1980, Oriol, 
Danilovs and Hawkins 19813 . The Se gene is thought to code for an 
epithelial fucosyl transferase that catalyses the transfer of fucose to 
type 1 or to type 2 precursor chains thus controlling the appearance of 
ABH substances in secretions C Kumazaki and Yoshida 19843.
The transferases involved in ABH antigen synthesis have been
extensively characterised [Watkins 19803.
The H gene is a structural gene which acts before the A "and B 
genes by coding for a fucosyl transferase. This enzyme, present in 
mesodermal tissue, acts on type 2 precursor substrates to produce H- 
active structures [Kumazaki and Yoshida 19843.
The Lewis gene acts independently of the ABO, H and Se genes
and evidence has been presented for its functioning after the formation
of group H antigens [Boettcher 19783.
2.3 The ABO System; Application in Forensic Science.
The use of the ABO system in a medicolegal context began with 
paternity testing [Lattes 19323. The grouping of bloodstains using the 
ABO 'system' coincided with it's discovery [Landsteiner 19003 , and 
bloodstain grouping developed with the emphasis on detecting the 
antibodies responsible for agglutination of group A or B cells (reviewed 
in [Gaensslen 1983, p2963 ).
Current techniques, usually used in parallel in English Forensic 
Science Laboratories, are the absorption-inhibit ion (A/I) and the 
absorption-elution (A/E) techniques which detect blood group antigens on 
cells, or molecules in secretions and stains.
In the A/I technique, the reaction of anti-A or anti-B antisera 
with homologous red cell suspensions is inhibited by prior incubation of 
the antisera with an extract of the unknown stain. A stain containing 
the appropriate antigen will inhibit part or all of the reaction between
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the antiserum and the indicator cells [ Coombs and Dodd 19613.
The more sensitive A/E technique is based on the reaction of 
the antiserum (anti-A or anti-B) or H-specific lectin with blood-stained 
thread in two stages. In the first, the antiserum is absorbed onto the 
blood antigens. After washing off unbound material, the bound antibody 
is eluted by raising the temperature to 56*C and is detected by 
assessing the agglutination of added homologous red cell suspensions 
[Kind 19603.
This technique (A/E) as first described in its modern form is 
done either extractively [Nickolls and Pereira 1962, Howard and 
Martin 19693 or non-extract ively [ Kind and Cleevely 19693. These two 
methods have been compared by a manual technique [ Kind and Lang 1976b3 
and using an autoanalyser [Shaw and Bosley 19833. For the grouping of 
A and B bloodstains both approaches gave similar amounts of anti-A and 
anti-B eluting from homologous blood staining the threads tested. 
However in the non-extractive test, the amount of H-specific reagent 
[Boorman, Dodd and Lincoln 19773 eluted from 15 mm long bloodstained 
threads was up to three times the level of that from an immobilised 
ammoniacal extract of the same amount of stain.
The sensitivity of the A/I and the A/E methods has been 
compared [Outteridge 19633. The A/I technique is relatively insensitive, 
requiring at least 1 mg of dried blood [Gaensslen 1983, p3013 . The A/E 
technique needs only 10 pg of dried blood for good results [Outteridge 
19623.
The grouping of bloodstains by A/E and A/I is problemmatical 
for a number of reasons. Some of these are associated specifically with 
serology based grouping systems while others result from the widespread 
distribution of ABH substances in nature.
A serious problem during the early development of A/I 
techniques was the non-specific absorption of the antiserum to the
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substrate on which the bloodstain was present. This absorption caused 
false positive results for stains not bearing the homologous antigens. 
The absorption of test antisera has been found to be especially strong 
for plant materials such as some tree bark and paper [Gaensslen 1983, 
p304] presumably because of the cross-react ion between the antiserum 
and carbohydrate in the plant ce 11-wall matrix.
Since there is no washing step in the A/1 technique, any 
chemical treatment of the cloth will remain in the incubation mixture 
in which red cells and antiserum are reacting. This is especially a 
problem when detergent is present in the cloth on which blood has 
fallen. The worst consequence is non-specific absorption of antisera 
although lysis of indicator red cells may also occur. The use of 
appropriate controls can avoid mis-typing errors [Kijewsky and von 
Mülmann 19753.
The A/E test includes a wash step which would remove 
substances that might interfere with the interpretation of results 
including presumably soluble blood group substances. However sweat- 
contaminated cloth has been found to interfere with A/E [ Tha Aye 19783. 
In some cases it was found that the reaction from control cloth 
(supposedly unstained with blood) gave a reaction equal in strength to 
the reaction from the bloodstain itself.
Both A/I and A/E are prone to problems due to the widespread 
occurrence of ABH antigens in nature. A study into the possible sources 
of adventitious ABH substances was conducted on such commonly occurring 
materials as dust (from vacuum cleaners), wood shavings and soil [ Kind 
and Lang 1976a] . Dust samples especially cross-reacted with anti-A or 
anti-B in some of the tests.
Several other techniques have been used for ABO grouping 
besides ELISA (page 55). These include RIA [Le Pendu et al. 19833,
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fluorescence Immunoassay CLlu, Kl ink and Nicol 1980] and rocket 
affinoelectrophoresis [Lindquist 1982].
3 Immunology
3.1 Immunology; Polyclonal Antisera In Bloodgrouping
3.1.1 Properties of Antisera
Polyclonal human antisera are routinely used in forensic science 
for spéciation, ABO grouping and grouping in the Lewis, Gm/Km and MN 
blood group systems.
Polyclonal antisera for ABO grouping were originally of human 
origin. Group 0 people have both anti-A and anti-B in their serum and 
saliva [Lincoln and Dodd 19693 although the titre of each may not be 
equivalent and more seriously, the antisera are not absolutely specific 
ie antibody absorbed onto group A cells for example and then 
subsequently eluted has some reactivity against group B cells and vice 
versa.
The origin of the anti-A and anti-B in normal serum has been 
attributed to environmental factors [Springer, Horton and Forbes 
19593. The presence of the blood group substances A and B as naturally 
occurring carbohydrate antigens on plant and animal tissue (cf the 
cross-react ion of anti-A and anti-B with dust) may cause immunization 
after birth. Tolerance will be acquired to the antigen inherited, leaving 
antibodies to the other determinant in the serum. Since H substance is 
present in almost all people then a normal human anti-H is never formed.
These isoantisera are made in the neonate in the early months 
of life [ referred to in Race and Sanger 1975 p463. Anti-A and anti-B 
have been detected in saliva [Bell and Fortwengler 19713 and other 
body fluids. However- the levels of salivary anti-A and anti-B in group 0 
males did not correlate with serum levels either in the normal group or
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after stimulation with injected porcine (group A) or equine (group B) 
substance. The majority of the antibody activity (anti-A or -B) was 
found to be IgA-associated which is a typical response to 'invading 
pathogens'.
The immunoglobulin class of serum anti-A and anti-B is 
predominantly IgM although IgG and IgA can also be detected [Contreras, 
Armitage and Hewitt 19841. This is true in normal subjects and in those 
producing hyperimmune sera following injection with commercial blood 
group substances [MSkelS, Ruoslahti and Ehnholm 19693.
3.1.2 Polyclonal Antisera: Antisera in Forensic Science
The assay of hyperimmune sera is necessary before it can be 
used in agglutination tests [Lang 19763. The most common way of 
determining the activity of anti-A and anti-B is to test it in the 
actual grouping system to be used for unknown samples. This is usually 
done against a fixed antigen concentration (in the form- of red cells or 
blood stains) [Lang 19763. The antisera is titrated and the highest 
dilution giving complete agglutination is taken as the titre of that 
particular antiserum. The titre figure is not a good indicator of the 
properties of a particular antiserum since its value depends on the test 
used and the environment in which the test was carried out. However 
antisera assayed in the same system (eg red cell concentration, same 
batch and assay temperature) can be compared using haemagglutination 
titre values.
In tests used in Forensic Science Laboratories (A/E) the 
antiserum is usually used neat against a single antigen (ie bloodstain 
extract) concentration. Consequently there is a danger of a prozone 
phenomenon taking place; in the equilibrium between antibody and cells, 
the dissociation of antibody from the cell is more likely to be followed 
by reassociation with free antibody than antibody already linked to
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another cell.
Polyclonal sera in use is either commercial hyperimmune human 
anti-A and anti-B [Contreras, Armitage and Hewitt 1984] or sera from 
normal healthy donors. Plant and animal lectins with activity against 
group A and B antigens have been used. Sub-typing of A, and A^ blood is 
occasionally carried out using a plant lectin (Dolichos biflorus) which 
reacts preferentially with group A, blood. The reaction of polyclonal 
anti-A reagents with the sub-types A, and A2 has been related to the 
quantity of group A sites on erythrocytes. In one study the use of ,2eI- 
labelled IgG anti-A showed that the reaction of polyclonal anti-A, and 
plant anti-A, with group A sub-types correlated with the number of A 
antigenic sites per cell [Lopez et al. 19803. Recently a monoclonal 
antibody has been described that reacts with group A, cells but not 
group A2 cells and this difference was attributed to the presence of a 
type 3 A chain with the structure:
Ga INAccd-» 3Ga Ip l-»3Ga INAccc 1 ->3Ga ipi->4G IcNAc 
2 2
t t
Fucal Fucocl
Pl-»3Gaipi-*4Glc
The formation of this structure from the type 3 H chain is thought to 
be controlled by a transferase present in group A, but absent in group 
A2 individuals [Clausen et al. 19853.
An anti-H lectin from extracts of gorse seeds 
(Ulex europaeus) is routinely used for the detection of group 0 blood 
[Voak, Lodge and Reed 19693.
The phenomenon of agglutination, which is the basis of commonly 
used serological tests, is known to occur in two stages. In the first 
stage an equilibrium between free specific antibody and antibody bound 
to the carbohydrate antigens on red cells is achieved. Cross-linking then 
follows between such sensitized cells (agglutination).
The affinity constant for an antiserum can be calculated by
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measuring the amount of free and bound antibody in the first stage of 
agglutination. This affinity constant is a gross measure of all the 
antibody populations in a particular serum and it refers specifically to 
the interaction of a single monovalent antibody to a single antigen or 
epitope. The strengths of binding for each population of antibody in a 
serum are different [Risen and Siskind 19643. The affinity so measured
has been termed intrinsic by Karush C19833 since it refers to the
kinetic considerations of a single antibody variable region with a single
antigen:
K.
C Ab3 + C Ag3 [ AbAg3
K„
[Ab3 = antibody concentration. CAg3 = antigen concentration.
K« = association constant. Kd = dissociation constant.
For the situation in a serum composed of several antibody
populations, the term- functional affinity may be used as a replacement 
for the undefined term avidity which has no meaning in thermodynamic 
terms. Functional affinity is related to the actual situation which can 
be observed albeit indirectly ie multivalent antibodies reacting with 
cell surface antigens for example or other processes such as complement 
activation, The intrinsic affinity constant of an antibody can be defined 
as:
Kcmto - CAbAgl 
CAg3
A polyclonal serum contains different populations of antibodies 
each derived from a different B cell clone. Each population will have 
it's own affinity value and may be more or less specific for the antigen 
in question in the sense that low affinity antibodies may be 'less 
specific' than high affinity ones.
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The widely varying values for affinity constants of antibody 
populations in a serum result from differences in the rate constants for 
the dissociation reaction of the antibody-antigen complex. Antibody binds 
antigen quickly and rate association constants are of similar orders (K* 
values of approximately 107-10e M-'sec-1 for anti-dinitropheno 1 anti­
bodies C Karush 1983 Chapter 31), The consequence is that a small 
number of antibody molecules are biologically active in terms of eg 
haemagg lut ina t ion. The range of the rate constants for the dissociation 
of the antibody-antigen complex are wider and differ about one 
thousand-fold among antibody populations.
The binding between antigen and antibody is non-covalent. The 
forces holding antigen to antibody are hydrophobic and electrostatic; Van 
der Waals forces and hydrogen bonds also contribute.
Once the initial binding of antibody to antigen has taken place 
the agglutination step occurs. IgM antibodies are more effective in 
agglutinating red cells than IgG antibodies because of the higher 
valency of the former COnoue et al. 19653. This was studied with ABO 
antibodies against the cells of weak A and B variants [Lopez et al 
19791 . In samples of serum from immunized or non-immunized individuals, 
only IgM antibodies, separated by SEC, reacted with the weaker group A 
variants. The measurement of the association constants gave similar 
values for IgG and IgM antibodies (of the order of 107-10e M-1 sec-1) 
and the difference in reactivity against red cells was thus attributed 
to valency effects.
It is known however that IgG antibodies can agglutinate red 
cells of the appropriate specificity. This agglutination is dependant on 
the antigen density on the cell surface but occurs in a similar way as 
agglutination with IgM antibodies ie single antibody molecules are the 
cross-links between antigenic sites on cells adjacent in the agglutinate.
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These IgG cross-links work by joining cells of the appropriate 
specificity as found by experiment [Romano and Mollison 19733 rather 
than making the cells sticky by lowering the natural repulsive forces 
between cells. For other blood groups, eg the integral protein antigens 
of the Rhesus system, IgG antibodies cannot agglutinate appropriate red 
cells diluted in saline without other conditions being satisfied 
[Goldsmith 19743.
Red cells normally bear a net negative charge largely as a
result of sialic acid residues [Pollack et ai. 19653 present on the red 
cell surface. In a solution (eg saline) the positively charged ions form 
layers around the red cells and across these layers there exists an 
electric potential (the Zeta potential). It is known that the presence of 
high molecular weight colloids such as BSA [Goldsmith, Reckel and 
Harris 19783, dextran, gelatin etc can enhance specific agglutination of 
sensitized cells.
The enzyme treatment of cells has the same effect as high
molecular weight colloids as found for the 'incomplete' IgG anti-Rhesus D
antibodies [Casey, Dodd and Lincoln 19723. The mechanism of this 
enhanced agglutination has been attributed to changes in the Zeta
potential [Pollack et al. 19653 but a simpler explanation is that the 
esterase activity of these 'proteolytic' enzymes may lessen steric 
hindrance of surface sialic acid residues. Other workers [Van Oss, Mohn 
and Cunningham 19783 have questioned the role of the Zeta potential as 
a factor influencing agglutination.
When the antibody concentration is low then less agglutination 
takes place because there are fewer antibody molecules to link cells 
together. Lowering the antibody concentration does not increase the 
sensitivity of A/E and A/I methods since the best agglutination 
endpoints in such tests were found for high antigen levels (1.12-0.18 mg
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bloodstain) using antiserum diluted from neat to 1/16.
Agglutination is also affected by the ionic strength of the
medium in which the test takes place. The use of low ionic strength
media instead of saline has been shown to give higher titres of some
antisera [Leikola and Perkins 1980] against Rhesus D but not for some 
ABO or Lewis sera evaluated in a modified anti-globulin technique. This 
was attributed to the protrusion of ABO antigens from the cell surface. 
Thus charge interactions at the membrane surface which modulate 
intrinsic antigen (membrane protein) antibody reactions would not be as 
likely to affect ABO an t igen-an t ibody interactions.
3.2 Immunology: Monoclonal Antibodies (MAbs)
3.2.1 Monoclonal Antibodies: Introduction
The challenge of populations of B-cells with antigen causes 
some of them, which bear membrane bound IgM receptors complementary to 
the immunogen, to differentiate into antibody-secreting plasma cells. The 
cells that proliferate to produce each antibody clone each bear a unique 
receptor that is preserved in subsequent generations. Each population 
(clone) of B cells secretes only one antibody population (monoclonal 
antibody, MAb) which has arisen from the original stimulation.
The fusion of spleen cells from an animal immunized with the 
antigen of interest, with myeloma cells from a cell line which does not
secrete Ig to produce hybrid cell lines viable in vitro was achieved in
1975 [Ktihler and Milstein]. The resultant fusions are selected for 
viability and then screened for antibody secretion by RIA, ELISA 
CDouillard, Hoffman and Herberman 19803 or fluorescent antibody 
techniques CMicheel, Karsten and Fiebach 19813.
Monoclonal antibodies are grown either in continuous culture or
obtained as ascites from implanted tumour-bearing hybrids in 
histocompatible or immune-supressed mice. Although the majority of early
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studies were conducted using mice as the donors of spleen cells, the 
production of human MAb have been attempted (reviewed in [Lewin 19813) 
and rat MAb have been also made.
There are numerous reviews of the impact of MAb on clinical and 
research science. These include detailed descriptions of methods for 
fusions and cloning, highlighting the problem areas [Coding 19803, and 
the clinical applications of MAb [British Medical Bulletin, volume 40 
1984, Shuster 19843. More specifically the potential of MAb to various 
areas of research has been noted. These include the detection of cell- 
surface (differentiation) antigens CEisenbarth 19813 , lymphocyte 
antigens and antigens of the Major Histocompatibility Complex C Parham e± 
ah 19823 . Applications of MAb are given in Table 3.
3.2.2 MAbs: Advantages and Limitations
The use of monoclonal antibodies was heralded as a great 
revolution providing reagents which could be standardized, were highly 
specific and which could be raised using an impure source of antigen. 
The reality of MAb in various fields has stemmed the initial optimism 
but their advantages ensure wide-ranging applications.
The potential benefits of MAb are:
1. They can be produced from impure or unknown antigens or mixtures.
2. The cell lines from which they are derived can be cloned giving an
infinite supply of the same antibody in high yield and titre with no
contaminating immunoglobulin.
3. From (2) it follows that in vitro culture of cells is likely to be
less prob lemma tic than repeated stimulation of animals producing 
variable responses.
4. MAb are mono-specific and of one class type for each specificity.
5. Monoclonal antibodies can be radio label led in culture.
6. The use of antibodies in immunoassays is made easier since only one 
species will be labelled or attached to the solid phase.
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TABLE 3
Monoclonal Antibodies: Summary of their Applications
Histocompatibility antigens MAb are used to block certain cellular
interactions eg lymphocyte macrophage; 
showing lack of HLA antigens on eg sperm 
cells; study of HLA system III.
Lymphocyte differentiation C33. 
antigens
Cancer cells
Anti-bacterial and 
anti-viral
Red blood cell
Enzyme research
Drug targeting.
Cytotoxicity.
Immunopurification Insolubilized MAb affinity columns; immuno
precipitation; T cell purification [81
Agglutination assays
Capture and other eg RIA, ELISA etc
immunoassays.
Referencess:
C13 Parham et al 1982.[23 Trucco et al 1979.133 Eisenbarth 1981.C43 
Kennett et al 1980. [53 Porterfield and Tobin 1984. [63 Anstee and 
Edwards 1982. [73 Slaughter et al 1980. [83 Parkhouse 1984.
Location of genes for human tumour markers 
on mouse-human hybrids [43
Eg Influenza. Herpes. Streptococcus types 
rabies etc [53.
Analysis of Rhesus null phenotypes [63,
ABO, Le, Gm/Km, Mn etc blood groups.
Enzyme polymorphisms eg human alkaline 
phosphatase [73.
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The use of impure antigens as a source of immunogen in the
initial stimulation is an exciting possibility where the purification of 
the antigen is either very difficult and time consuming or not possible 
at all. One example was interferon. A preparation, where the interferon 
was only 1 % pure, was used to immunize mice [Wright et al. 19833 and 
the resultant selected MAb was used to immunopurif y crude interferon 
preparations 5000 times more than previous methods.
Although tissue culture supernatants (TCS) produce pure MAb, 
the culture medium and other contaminants necessitate purification of 
the immunoglobulin for some applications. This is also true for MAb from 
ascitic fluid, which although obtained in high yield (up to 10 mg/ml for 
specific antibody), are contaminated with natural antibodies [Gooi and 
Feizi 19823. However, if purification is necessary then the effective 
yield is lower because of losses during fractionation of the TCS 
especially for IgM antibodies.
Although animals used for the production of polyclonal sera are 
mortal and prone to disease etc, cell lines may be similarly at risk
unless extensive precautions are taken. Infection with Mycoplasma
plagued the early development of human MAb [Lewin 19813. However 
despite the problems with cell viability mentioned above, hybridomas are 
infinitely more useful in terms of storage and portability. The 
performance of fusions and the screening of clones is a technically 
demanding procedure and the facilities are not available to all research 
teams. It has been estimated that of 80-160,000 spleen cells used for a 
fusion that only three viable clones are likely [Slaughterer et ai 
19803.
Each clone produces only one type of immunoglobulin which will 
generally have the same characteristics of reactivity from 'batch-to- 
batch' all things being equal. The MAb will have the same affinity
constant in it's reaction with the same antigen. However it has been
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found that MAb can react with more than one antigenic determinant
[Wright et ai 1983, Slaughterer et al 1980, Beckman et al 19813,
as shown for the cross-reactivity of MAb with human alkaline
phosphatase isoenzymes. As a general rule there is likely to be more 
cross-reactivity with antigens that are closely related (structurally) to 
an immunogen which itself is small and does not completely fill the 
active site.
A summary of some of the advantages and disadvantages of MAb 
compared to conventional polyclonal sera is given in Table 4 although 
these are referred to in the context of results obtained from
experiment.
3.2.3 MAbs: Properties of IgM Antibodies
The majority of MAb available for ABH grouping in the early 
1980's either commercially or from researchers were of class IgM. This 
may have been in part due to selection of clones producing sera that 
were effective in haemagg lut ina t ion (the screening criterion).
Early studies on IgM were conducted using IgM from patients 
secreting large amounts of Waldenstrôm macroglobulins. A review of the 
physicochemical properties of IgM was published in 1970 [Metzger!.
Secretory IgM has a sedimentation coefficient of 19S and a 
molecular weight in normal mammals ranging from 850,000 to 1 x 10e. A 
figure for mouse IgM secreted by a plasmacytoma was 1 x 10e [Jarvis 
and Voss 19813 which was derived by SEC and sedimentation equilibrium 
ultracentrifugation.
Mammalian IgM comprises 10 heavy (p) chains and ten light (k or 
X). The heavy and light chains are paired to form five 7S monomeric sub­
units with the equivalent chain complement to an IgG molecule in each 
monomer. The monomers are arranged in a stellate shape joined by 
disulphide links. A picture of the IgM molecule is shown in Figure 4. 
There is an additional J chain which is attached to the C-terminal parts
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TABLE 4
The Advantages and Limitations of MAb compared to Polyclonal Sera 
Advantages
An impure source of antigen can be used for MAb;
MAb are homogeneous.
MAb are mono specific usually and can distinguish between slightly 
differing epitopes
Binding constants can be calculated and the effect of varying 
experimental conditions can be found more easily.
MAb can be characterised in other ways more easily than mixtures 
of antibodies in polyclonal sera even if the best MAb may be a 
cocktail.
Labelling and manipulation of MAb is easier.
MAb are easy to purify.
Limi tat ions
A polyclonal serum in containing many overlapping specificities 
can provide 1 back-up* for missing specificities; MAb may miss rare 
variants or those produced by mutation or by assay effects eg 
extraction methods [13.
MAb, being homogeneous, are more susceptible to changes in pH [23, 
temperature, ionic strength of diluent than polyclonal antibodies 
because of the back up effect.
High affinity antibodies can modulate cell membrane antigens.
In a complex antigen system (eg HLA) unless enough MAb are 
characterised to recognise all the apecif ici ties so far found (by 
polyclonal sera) then the overlap between antigens found by each 
type of antibody cannot be unravelled.
Mixtures of MAb may be necessary to cover all antigen types.
MAb have typically low affinity.
MAb are not good precipitating sera.
MAb may be IgM which have been found to be problemmatic in 
immunoassays.
References:
[13 Lansdorp and Zeij iemaker 1983. [23 Mosmann, Gallatin and
Langenecker 1980.
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Figure 4. Schematic diagram of Pentamerle IgM.
The pen tamer consists of two pairs of heavy chains (H) and light 
chains (L) arranged in monomers. The disulphide bridges ( $ ) are 
shown for one monomer. The J-chain is attached by disulphide 
bridges.
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of the p chains.
Proteolysis of mammalian IgM by trypsin in urea produced 
differing fragments from different animal species C Beale and Hop ley 
19831. Mouse IgM, from hybridoma, was more resistant than human IgM to 
trypsin digestion. Only a few F(ab) arms were removed after a 24 hour 
incubation period. A degradation pathway was proposed: once mouse Fab 
fragments were produced, they were readily degraded to smaller 
fragments and peptides.
Numerous disulphide links exist in the IgM molecule CKownatzki 
19733 . These include inter sub-unit, interchain, intrachain and links 
joining the J-chain to the pen tamer ic IgM. The susceptibility of these 
various disulphide bridges to reductive cleavage has been investigated 
CKownatzki 1973, Milstein et aL 1975, Seon and Pressman 19761. A 
DTT concentration of 0.5 mM was needed to yield 50% of pentameric IgM 
as monomeric sub-units. The most resistant disulphide links were those 
joining the J-chain to the IgM molecule. The reassociation of reduced 
IgM momomers proceeds to a 19S polymer only in the presence of some 
oligomers and when the reductant is removed C Parkhouse 19751
IgM antibodies are typically low affinity COriol and Rousset 
19741 but studies have shown that some IgM, from murine hybridoma have 
two populations of binding sites per molecule [Giles, Klapper and Clem 
19831. Only one site per monomer was found to be high affinity. This 
intramolecular heterogeneity was thought to be due to conformational 
difference between the two binding sites as revealed by trypsin 
digestion studies.
3.2.4 MAbs and Forensic Science.
MAb have been reported for many antigens of interest to the 
medicolegal profession. MAb have been used to quantitate the numbers of 
antigenic sites on erythrocytes [Merry et al. 19841 and for blood group 
systems other than the ABO system: the Rh system was studied using a
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panel of MAb against erythrocytes both normal and enzyme-treated 
[ Ans tee and Edwards 19823. Their applications include spéciation 
[Fletcher, Dolton and Harris-Smith 19843, immunoglobulin alio typing 
[Fletcher, Dorri11 and Dolton 1983, Kishda and Tamaki 1984, Newall 
19843 and differentiation of foetal and adult blood using a monoclonal 
anti-a-foetoprotein antibody [ Kurucz et al 19843.
The advantages of MAb over polyclonal sera have been outlined 
above and potential benefits of ease of quality control, reproducibility 
and specificity have been reviewed in the context of forensic science 
[Fletcher and Davie 1980, Brown and Baechtel 19843 and serology 
generally [Blann 1983, Several authors in an International Forum 
published in Vox. Sang. 45 166-179 (1983)3
3.2.5 MAb for ABO Grouping
Research which has yielded anti-A, B, H and Le MAb has taken 
two forms. In the first case, MAb were specifically raised for 
bloodgrouping purposes. In the second, anti-blood group antigens were 
the by-product of investigation into either cancer and other pathogenic 
state-associated antigens or carbohydrate antigens.
The first ABO MAb reported, which had specificity for group A 
eryth-rocytes, was produced incidentally. Mice, immunized with human 
tonsil lymphocyte preparations, presumably contaminated with membranes 
bearing erythrocyte blood group substances, were used to provide spleen 
cells for fusion [ Barnstable et al 19783. One of the MAb, W6/1, was 
found to bind only to erythrocytes as detected by an anti-mouse IgG 
antibody labelled with radio iodine. It was also found to react with group 
A, and A= erythrocytes. Another anti-erythrocyte MAb, W6/28, reacted 
with all the erythrocytes tested of groups A, B and 0.
Various MAb have been raised to human red blood cell antigens 
[Daniels 19823 in addition to the ABH ones.
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Specific MAb for ABO Grouping
Following the production of W6/1 [Barnstable et al 19783, a
deliberate attempt was made to produce a monoclonal anti-A [Voak et al
19803. Cells from a colon carcinoma from a group A person were used to 
immunize mice. The spleen cells from the mice were fused using standard 
technology with myeloma cells and cells producing antibody which bound 
the original immunogen were cultured in vitro.
Some physicochemical and serological properties of the resultant 
MAb (called 6D4) were established. The MAb was class IgM and was stable 
at -20*C or 4‘C for two months. Repeated freeze-thawing (five times) or 
heating for 50 minutes at 56eC did not destabilise the MAb, although it 
was destroyed by heating at 70*C for ten minutes.
The MAb had a titre of 1/256 against 2% group A, and A2 cells
in saline at RT. The reactivity against A* cells was poor even after
concentration of the MAb 8-fold. The MAb performed well in routine
manual grouping tests although an 8-fold concentration of the MAb was 
necessary.
The main benefit of this MAb over polyclonal equivalents was
seen as a reduction in antibody tes ting-time saving 90% in pre-grouping
validation, The clone was stable throughout at least three successive
clonings.
The Cambridge-based team of Sacks and Lennox produced three
anti-B secreting hybrid clones using spleen cells from mice immunized
with group B substance [ 19813. One clone (called NB1) produced MAb with 
a titre of between 1/1024 to 1/2048 with 2% red cells in saline at RT. 
This was tested against cells of groups B, A,B and A2B with no cross­
reaction, and comparable avidity, in terms of agglutination time, with 
commercial polyclonal reagents.
These first monoclonal reagents which were made to replace
conventional polyclonal sera, were compared alongside standard blood
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typing reagents and hyperimmune sera [Voak et al 19823. The standard 
blood-typing reagents were serum from people with the appropriate 
antibody (ie anti-A in group B people and vice versa'), while hyperimmune 
polyclonal sera resulted from boosting donors using injected blood group 
substances. The two MAb (6D4 and NB1/19) had reactivity mid-way between 
National Health Service reagents and those hyperimmune sera from 
commercial sources although the MAb were considered more cost effective. 
An additional advantage of the MAb reagents was that they could be 
mixed to produce an anti-AB reagent. This is not possible with human 
reagents since the presence of serum blood group substances tends to 
neutralize the complementary antibody. The MAb were satisfactory in 
automatic grouping tests CNordhagen et al 19833.
Several MAb to the ABH and Le antigens have been raised since 
these early studies and are summarised in Table 5.
In each of the reports referred to in Table 5, different 
immunization protocols were used to produce MAb with differing 
properties.
Unfortunately the standardization which MAb technology promises 
is not reflected in the methods used to assay anti-ABH blood group MAb. 
This is in part due to the lack of a standard assay based on standards 
of international quality. The use of synthetic human blood group 
antigens may be a partial solution to this problem.
The synthesis of oligosaccharide haptens for the ABO and Lewis 
antigens has been reported [Lemieux 1980a, Lemieux 1982b] and these 
have been coupled to silica to produce immunoadsorbents (Synsorb") 
[Boul langer et al 19783. These immunoadsorbents have been used to 
purify MAb for both type 1 and type 2 ABH antigens CDoinel et al 19833 
and H type 2 only C Knowles et al 19823. They have also been used to 
evaluate MAb to A and B blood groups [Bundle et al 1982, Barrie et al 
1983, Moore et al 19833 and in binding studies [Lemieux 19813.
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TABLE 5
Monoclonal Antibodies to ABH Blood Groups,
Antigen
Group A
A
A
A
A
A
A
A!;
Group B 
B 
B 
B
Group AB
A,B>
A=B)
B1 ) 
A,B>
Group 0
Ht2
Htl)
Ht2>
H
Ht2
Ht2
Ht2
Ht2
Immunogen No. Clones Ig Class
Soluble group A= 
substance.
Human group A 
substance + A, cells. 
Group A cells.
Group A,B cells 
Group A cells
Cancer cell line 
Glycolipid 
Glycolipids
B trisaccharide on 
BSA or 0 cells. 
Saliva glycoprotein 
extract (L e  a-b+> 
Carcinoma cells
i) Ovarian cyst fluid 
glycoproteins from 
A,, A2 and B people, 
11) Cells from A,, A2 
and A2B people, 
ill) Red cell membranes 
as ii).
I) A, red cells.
II) B cells + B
substance
3
1
13
??
12
5
Human lymphoid cell 1
line.
Lysate of group 0 1
(Le a+b-) c e l ls .
Cancer cell lines
Cancer cell line 
(b)
Colonic adenoma membranes
Studies Using MAbs from Several Sources
A, B and AB Blood group substance, 
cancer lines etc
All anti-A B lood  g ro u p  s u b s ta n c e ,
cancer cell lines etc. 
Anti-A (inc. group A3 and A4)
Anti-H (Lewis groups)
(a)
IgM
IgM
igM
10 IgG 
10 IgM 
4 IgM 
1 IgG
IgM
HioM
Hm
IgM
IgM
IgM
IgM
IgM/IgG 
IgM/IgG
Ref.
C 11
£23
£33
£43
£53
£63
£73
£83
£93
£ 103 
£113 
£ 123
£ 133
£143
£153
£163
£173
£183
£153
£193
£203
£213
£223
£233
£243
Notes (a) Comparison of three MAb produced in other work £2 25 263 
(b) Study using a commercial preparation of unknown origin.
References:
1 Moore 1984 
4 Edelman 1981 
7 Abe 1984 
10 Bundle 1982 
13 Messeter 1984 
16 Doinel 1983 
19 Barnett 1986 
22 Gooi 1985 
25 Moore 1983
2 Lowe 1984.
5 Raubitschek 1985 
8 Clausen 1985 
11 Barrie 1983 
14 Fletcher 1984 
17 Anger 1982 
20 Brown 1983 
23 Furukawa 1985b 
26 Kôhler 1976
3 Majdic 1979 
6 Clausen 1986 
9 Furukawa 1985a 
12 Hansson 1983 
15 Knowles 1982 
18 Abe 1983 
21 Chen 1985 
24 Sakamoto 1984
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The use of synthetic blood group substances has the advantage 
of producing some MAb with enhanced specificity and of simplifying the 
screening of hybrids. The actual specificity of the MAb produced can be 
determined by using inhibition studies with free artificial haptens 
[Bundle et al. 19821. This approach has been used for polyclonal anti- 
Lewis antisera C Le Pendu, Lemieux and Oriol 1982a, Spitalnik et al. 
1983] and for monoclonal Lewis antibodies [Young et al. 19833.
It is difficult to compare the MAb produced since the initial 
characterisation is by haemagg lut ina t ion and the titre values are 
dependant on the test conditions as has been pointed out above. Some 
attempts have been made to assay the MAb using a radio immune anti-
globulin test CBessos, James and McClelland 19823 and by ELISA. In the
former technique differences were found in MAb produced in ascitic fluid 
compared to TCS.
Some MAb to Lewis antigens have been reported. These have been 
used in blood grouping [ Young et al 1983, Messeter et al 1984, 
Brockhaus et al. 19813 and immunoh is to logy techniques [Daniels et al
1982, Ernst et al. 19843 as well as in an ELISA system to detect
salivary Lewis substance [ Sakamoto, Yin and Lloyd 19843 . The 
application of MAb to the investigation of structural differences in the 
products of the ABO, H, Le and Se gene systems has revealed the 
distribution of type 1 and 2 versions of these molecules [Sakamoto, Yin 
and Lloyd 19843.
The detection of tumour specific antigens with MAb raised 
following immunization with human cancer lines has been used to isolate 
and purify malignancy markers.
The immunization schedules result in unexpected specificities 
which reacted with blood group H-type structures C Lloyd et al 19833 
and other related antigens. The MAb, F-3, derived from human lung cancer
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immunization was found to react with H type 2 as assayed by ELISA. In 
an indirect ELISA technique, eight glycolipids with related specificities 
were tested with the MAb. H type 2 substance from human meconium and 
erythrocytes were not found to react but only a difucosyl H type 2 (Y 
substance) reacted. Other workers have found a MAb that reacts with type 
1 blood group chains following studies on human foetal endoderm [Gooi 
et al 19833.
A study of anti-carbohydrate antibodies [ Magnani 19843 revealed 
that of 325 MAb gathered from various sources, 97 were found to bind 
carbohydrates. Only about 15 reacted with ABH or Lewis antigens. The 
majority reacted with Lacto-N-fucopentaose III (called stage specific 
embryonal antigen, SSEA-1) [ Kannagi et a J. 19823 which has the 
structure:
Gal 3 H4 GlcNAc (H3) (3-Gal (l-*4) Glc-Ceramide 
T a H3 
Fuc.
(abbreviations, Figure 2).
4 Immunoassays
4. 1 Immunoassays: Introduction
The detection of antigenic molecules or indeed any other 
molecule of interest by a biochemical technique has requirements which 
differ from those assays which demand isolation, characterisation and 
precise quantitation. Immunoassays where the molecule of interest is 
specifically bound by an antibody is one example of a binding assay and 
are the assays of choice in blood grouping and related fields.
The use of antibodies as a specific tag allows the quantitation 
of small amounts of antigen from complex mixtures and such techniques 
can be classified as primary or secondary. In the former the interaction
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of the antigen with a specific antibody is studied. Secondary techniques 
rely on such phenomenon as complement fixation or agglutination. 
Examples of both techniques are given in Table 6.
4.2 Immunoassays: Secondary Assays.
The precipitation assay, used in forensic science tCulliford 
19643 is based on the observation of the white precipitate formed when 
soluble antigen complexes with specific antibody to form a cross-linked 
lattice, In the equivalence zone, where the precipitate forms, up to 98% 
of antigen and antibody are precipitated. The test is widely performed 
in gels where immunodiffusion is passive or actively brought about by an 
electric field applied across the gel supporting medium. Although it is a 
simple test to operate, precipitation type tests are labour-intensive and 
not easily automated. MAb are generally not good precipitating antisera 
so their use in these tests is limited.
The measurement of immune complexes can be done by 
nephelometry which determines antibody/antigen excess in continuous flow 
liquid phase systems. The use of the centrifugal fast analyser has been 
a recent development in this field. Agglutination techniques have been 
referred to in the context of ABO grouping.
4.3 Immunoassays; Primary Assays.
In many secondary assays, unreacted material is not detected 
even indirectly [Kemp, John and Woodhead 19823. However the 
development of the radioimmunoassay tEkins 19603 employed a new 
principle, namely the detection of the distribution of free and bound 
analyte (bound in the sense antibody-bound). RIA's can be extremely 
sensitive having a theoretical sensitivity of lO-17 M, and because of 
the antibody-antigen interaction, extremely specific too.
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TABLE 6
Primary and Secondary Immunoassays.
Primary; Antigen Binding. Secondary; Antibody Activation
RIA
Fluoroimmunoassay 
EIA
Luminescence immunoassay 
Red cell labelled assays
Toxin neutralization 
Precipitation 
Agglutination assays 
Complement fixation 
Bacterial/viral * clumping'
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A separation step is needed to determine the distribution of 
free and bound analyte. Usually in so lid-phase RIAs, in order to reduce
lengthy separation steps, or the use of expensive bridging reagents,
antigen or antibody is adsorbed to a supporting surface. Surfaces such 
as polystyrene (tubes, plates, spheres etc), Sepharose* and polyvinyl 
chloride etc have been used.
Two analytical approaches have been identified: these are
analyte observed and reagent observed CEkins 19813 :
Ana lyte-observed Reagent-Observed
ANALYTE ANALYTE
+ +
ANTIBODY ANTIBODY
T1 ti
ANALYTE-ANTIBODY ANALYTE-ANTIBODY
+ +
residual ANALYTE residual ANTIBODY
(Bold Type indicates labelled molecule).
In the first, radio label led antigen is added to the initial 
system and its final distribution is taken as a measure of the
distribution of un label led antigen which the test is designed to measure. 
In the reagent observed system, labelled antibody is measured to
determine how much total antibody the analyte has complexed to.
The main factors influencing analyte observed assays (eg RIA) 
are the equilibrium constant (of the antibody-analyte reaction) and the 
errors in determining the amount of bound and free analyte. In contrast, 
in reagent observed assays (eg ELISA) the main factors are the non­
specific reaction of the labelled antibody with the solid phase or cross­
reaction with the antigen mixture.
RIA's have been used widely for the detection of hormones and
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drugs in body fluids and tissues. Numerous variations of RIA have been 
developed such as the immunoradiometric assay (IRMA) [Miles and Hales 
19683 where a so lid-phase antigen is detected by labelled antibody 
residual after reaction with the antigen-containing sample. Although 
careful washing of the so lid-phase is needed, the separation is achieved 
more simply than with other methods. A two-site assay where the solid 
phase antigen is replaced by un label led antibody which binds antigen is 
the basis for some commercial RIA kits.
Numerous immunoassay methods have been developed in the last 
15 years; some common ly used labels are listed below:
Labels Used In Immunoassays.
Radioisotopes,
Enzymes.
Fluorogenic molecules.
Chemiluminescent molecules.
Bioluminescent molecules.
Red cells and other particles.
Metals.
Assays may be homogeneous ie the reaction takes place without a 
separation step or heterogeneous where a so lid-phase or other device is 
used to distinguish between reacted and unreacted molecules. The 
majority of alternative immunoassays (ie to RIA) are characterised by 
having a labelled antibody, since given adequate purification procedures 
an antibody may be labelled using a standard protocol (for class IgG for 
example) whereas an analyte may have particular features necessitating 
different labelling approaches. Labelled antigens may be unstable whereas 
immunoglobulins tend to be generally rather stable.
Enzyme immunoassays (EIA) will be discussed below.
F luoro immunoassays are assays in which the antigen or antibody 
is labelled with a fluorescent molecule (a fluorophore) which, when
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excited with light of the appropriate wavelength, finally emits
measurable radiation. Most fluorophores are synthetic. The assays are 
distinguished from EIA's which use an enzyme label acting on a substrate 
which releases a fluorescent product. Fluorescent antibody techniques 
were pioneered with immunohistochemica 1 tests and are still widely used 
to localize antigens and antibodies on cells and tissue sections.
The majority of FIA are homogenous assays where thé fluorophore 
mimics a radioisotope, A summary of the principles of FIA types with 
references is given in CChard 19823.
Whereas fluorophores need to be excited with light to emit
radiation, in luminescent systems light is produced as the substrate is 
converted by the enzyme label. Luminescent systems may be either 
biological or chemical. In the former, eg firefly lue if erase, the insect 
enzyme catalyses the oxidation of lue if er in to oxyluciferin with the 
release of water and carbon dioxide. The reaction is dependant on the 
ATP concentration and the enzyme is liable to inhibition by ATP, so 
reagent levels need to be monitored carefully. In chemi luminescent 
systems, organic compounds such as luminol are oxidised in the presence 
of activated oxygen molecules. The reactions are catalysed by numerous 
substrates eg metals ions. Acrid in ium salts, in conjunction with HRP, are 
widely used in chemi luminescent systems E Woodhead et ai 19813.
Red cells have been used as detectors in analysis of the
complement system and may be used as the solid phase for the coupling 
of soluble antigen or antibody eg anti-Hepatitis B surface antigen. Other 
particle systems are based on latex spheres coated with antibody or 
antigen. An example of the latter was an immunoassay for Toxoplasma
gondii [Remington, Elms tad and Araujo 19833 in a system similar to mixed 
agglutination in the solid phase (MASP) EFiori and Chiarotti 19813. 
Latex spheres have also been used for the grouping of saliva stains for 
A and B antigens EYamaguchi and Sugimori 19793. The spheres used were
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also suitable for the grouping of A and B bloodstains but not group 0 
stains. The technique was based on agglutination.
Metal particles have also been used in immunoassay systems. 
Colloidal gold particles were conjugated to antibodies and used in the 
detection of human chorionic gonadotrophin (hCG) using atomic absorption 
spectroscopy or visual detection CLeuvering et ai 19801. Other assays 
employ columns packed with steel wire attached to an electromagnet 
[Owen and Sykes 19843 to separate metal labelled proteins.
4.4 Immunoassays: ELISA
4.4.1 ELISA; Introduction
Many names exist to describe the various basic techniques as 
well as somewhat esoteric variations. Enzyme immunoassay (EIA) is a 
general term covering all solid phase binding assays where the label for 
antigen or antibody is an enzyme, The enzyme labelled immunosorbent 
assay (ELISA) is typically a heterogeneous assay which is usually non­
competitive. The enzyme multiplied immuno-assay technique (EMIT") is the 
most widely quoted example of a homogeneous immunoassay in which the 
binding of antigen to antibody influences, usually by inhibition, the 
reaction of the enzyme label with substrate.
Many hybrid techniques involving labelled antibodies and the 
microplate format have been developed especially for red cell serology 
and in the field of infectious diseases. These will be referred to below. 
The properties of enzyme labelled immunoglobulins will be considered 
separately.
The first ELISA was reported in 1971 CEngvall and Perlmannl 
following the successful conjugation of IgG to alkaline phosphatase by 
Avrameas in 1969 t Avrameas 19693. In the EL ISA technique the conjug­
ation reaction was studied using radioimmunosorbent techniques (RIST) 
and showed that using the one-step glutaraldehyde method, about 60% of
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enzyme activity was retained in the conjugate. After purification on a 
Sephadex” G-200 column, the conjugate was used to detect rabbit IgG in 
a competitive assay. The sample of rabbit serum was reacted with anti­
rabbit IgG alkaline phosphatase conjugate in the presence of cellulose 
reactive to rabbit IgG. The increasing levels of antigen lead to lowered 
enzyme activity on the solid phase. The assay has comparable sensitivity 
to a RIST. The conjugates were stable for at least six months and gave 
good reproducibility over the same period.
Antigen-coated polystyrene tubes were used as the solid phase 
by Eng va 11 and Perlmann C 1972] for the detection of antibodies to DNP 
and HSA. The technique was a direct heterogeneous assay detecting 
antigen bound to the tube walls.
Meanwhile another team based in the Netherlands had developed
EIA's with the same basic principle [Van Weeman and Schuurs 1971,
1972, 19743.
EIA systems can be classified as homogeneous or heterogeneous.
In heterogeneous systems the assay may be competitive or non­
competitive and based on labelled antibody or labelled antigen methods. 
These are illustrated in Figure 5. Numerous other permutations exist 
based on bridging (second antibodies) as well as intermediate reactants 
such as the avid in-bio tin system and Pro te in-A systems. In the latter, 
Pro te in-A reacts with the Fc portion of many Ig molecules.
Where separation methods have been used, these include second 
antibodies and magnetic particles. Particulate solid phases such as 
agarose have also been used but these methods do not make full use of 
the potential of heterogeneous assays; ie that a washable solid phase to 
which are bound the reactants of interest provides a convenient
separation step.
The component features of an indirect ELISA are reviewed below
INTRODUCTION Page 57.
. j - ,  I
^  ANTIBODY ^ LABELLED ANTIBODY
PURIFIED ANTIGEN ^  UNKNOWN (SAMPLE)
LABELLED ANTIGEN ------  SOLID PHASE
ANTIGEN
Figure 5. Heterogeneous Immunoassays. The detection of antigen 
(3, 4, 5 and 6) or antibody (1 and 2) may be competitive (2 and 6) 
or non-competitive (1, 3, 4, and 5).
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le antigen is coated on a solid phase. After washing, immobilized antigen 
is detected by a first antibody and an enzyme-antibody conjugate. 
Substrate solution is finally added and the absorbance measured.
4.4.2 ELISA: Solid Phase
The first solid phases used in immunoassays were particulate 
and included materials such as Sephadex-iso thiocy ana te [Wide and Porath 
19663, poly-(tetrafluoroethylene-y-isothlocyanatostyrene) CCatt, Niall 
and Tregear 19663, cellulose CEngvall and Perlmann 19713, 
polyacrylamide [Avrameas and Guilbert 1971b3 and agarose [Van Weeman 
and Schuurs 19713.
The use of plastic tubes as solid supports made the separation 
of reacted and unreacted material in an assay simpler. Polystyrene or 
polyvinyl tubes, beads, cuvettes or micro titrât ion plates are the solid 
phase format of choice for contemporary ELISA although 'dipstick* and 
syringe based tests have been devised [Feigner 1978, Chandler and
Hurrell 19823.
Solid phases may be treated to enhance antigen or antibody
binding. Covalent conjugation with cross-linking reagents such as 
d ime thy Isuber im Ida te, glutaraldehyde or treatment with HC1 or ethanol 
[Rubin, Hardtke and Carr 1980, Salonen and Vaheri 19793 have been
used with variable success. Plastic surfaces have also been treated with
poly-L-lysine to enhance binding of polysaccharide and viral antigens 
[Kelsoe and Weller 19783, Comparisons between adsorptive and covalent 
binding have not demonstrated any clear advantage of one technique over 
another [von Klitzling et al. 1982, Wood and Gadow 19833. Enhanced 
binding characteristics of a solid-phase may result in decreased 
sensitivity as a result of higher binding of undesired assay components 
such as enzyme-antibody conjugate. Irradiated polystyrene adsorbs more 
antigen than non-irradiated plastic and such plates are sold specifically 
for EIA (eg Immulon from Dynatech),
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Many immunoassays use simple physical adsorption of antigen or 
antibody to solid phases CCatt, Niall and Tregear 19663. The binding 
forces are thought to be electrokinetic, electrostatic and hydrophobic.
Several authors have reported variability in the properties of 
polystyrene plates used for ELISA CKricka et al 19803. This can either
be an effect due to plate manufacture or an artefact of the assay
especially when an incubation at 37*C is involved. The variability in 
solid phase has been attributed to ‘edge effects' [ Chessum and Denmark 
19783, thermal gradients [Burt et al. 1979, Oliver et al 19813 .
adsorption characteristics CShekarchi et al 19843 and desorption 
characteristics CLehtonen and Viljanen 19803. The use of timing
protocols and spacing of duplicates have been used to control this 
variability tWright, Gall and Kelly 1985, Wright, Kelly and Gall 
19853 . A separate approach has been to use plates coated with antibody 
to produce a 'sticky* surface for the subsequent immobilization of either 
primary antibody or antigen mixtures.
4.4.3 ELISA: Antigen Presentation.
The first application of ELISA was for immunoglobulin detection. 
Since Igs are both soluble and relatively stable they make useful test 
antigens in early ELISA evaluations [ Voiler, Bi dwell and Bartlett 
19793. Antigens may need to be purified before use in ELISA CKricka et 
al 19803 but mixtures of relatively crude antigens have been used. The 
antigens to be detected in a solid-phase ELISA have to be accessible to 
detecting antibody. Comp lex ing of antigens with natural antibody may 
prejudice their detection. Immunoassays for Hepatitis B surface antigen 
are interfered with by natural antibody CDeinhardt 19803 . To counteract 
this source of interference, plates may coated with high affinity 
competing antibody; together with increased incubation time these 
procedures effect the dissociation of natural complexes.
The treatment of antigen-antibody complexes or indeed any
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antigen matrix to dissociate them or make them more accessible to 
antibody in a solid-phase assay may take several forms. Heating, pH 
change, dénaturation, proteolytic enzymes and detergents have been used 
to 'extract* antigens. The inclusion of such methods may lengthen the 
ELISA test as well as introducing other complications such as 
dénaturation of protein antigens CTabbarath et al 19803 and increased 
variability.
Detergents (surfactants) can be used as extractants of membrane 
bound antigens. This area is reviewed in the context of results obtained 
in Chapter 3, page 195. Detergents may interfere with antigen binding 
where the sample under investigation is coated directly onto the well. 
SDS for example may prejudice passive adsorption to plate wells. One 
approach has been to covalently bind SDS-solubilized proteins to 
polystyrene micro titre plates using glutaraldehyde [Evan 19843.
It has been found by experiment that antigen or antibody for 
coating micro titre plate wells at a level of between 1 and 10 pg/ml is 
optimal. Above this range coated material may become desorbed during 
subsequent assay steps [Hendry and Herrman 1980, Salonen and Vaheri 
19793.
4.4.4 ELISA; Immobilization Conditions.
Aside from plate pre treatment or antigen presentation
considerations the conditions of immobilization and possible storage of 
coated plates prior to continuation of the assay may be critical. Coating 
of plates is typically carried out overnight at 4*C or for two hours in 
a 37*C incubator. It was found that the amount of bound IgG ranged from 
20 to 50% of the input level when varying incubation times from one 
hour to several days and temperatures from 4*C to 37'C CCantarero, 
Butler and Osbourne 19803.
4.4.5 ELISA: Solid Phase Washing and Blocking.
The use of solid phase assays has become popular because the
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separation of bound and free analyte or detecting antibody can be 
achieved by washing the plates used in such assays. Buffers containing a 
surfactant (eg Tween 20") are commonly used and may or may not contain 
protein in the form of albumin or gelatin to 'block' free 'binding sites' 
on the plastic solid phase. The use of plastic which has been treated to 
increase protein binding is often accompanied by an increase in non­
specific adsorption of reagents used in subsequent assay steps CYolken 
19823. Various attempts have been made to reduce non-specific binding of 
antibodies and enzyme conjugates by blocking plastic sites [ Kenny and 
Dunsmoor 1983, Spinola and Cannon 1985, Schonheyder and Andersen 
19843.
The reduction of non-specific binding with wetting reagents and 
protein solutions has been variably successful. Some workers report the 
ineffectiveness of BSA as a suitable protein blocker [Shi 11 itoe 1982, 
Robertson, Whybin and Cox 19853. However when used in a high salt 
concentration buffer (0.5 M NaCl, with PBS-T) CEmmrich 19843 BSA at 1% 
in diluent buffers reduced non-specific binding of human IgM to plastic 
surfaces while not affecting the positive assay reactions.
High salt concentration buffers (0.4 M NaCl) have been used 
successfully to minimize serum interference in assays for human growth 
hormone [ Hashida et al 19833. Gelatin of bovine or porcine origin has 
been used in place of BSA with high ionic strength buffers [ Kato et al 
19793. Cattle gelatin at high concentrations or at the commonly used 
incubation temperature of 4*C tends to gel and the increased viscosity 
may slow down reactions. Gelatin digested with a pro tease was used to 
lessen interference by serum factors in a solid phase assay C Kato et 
aL 19803. Other workers have used human milk CHornsleth et al. 
19843 and casein hydro lysate [ Robertson, Whybin and Cox 19853 as 
serum diluents to the same end.
Microplates may be conveniently washed by emptying the plates
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by inverting them and filling wells from a wash bottle with the 
appropriate buffer. However the microplate format lends itself to 
automatic or semi-automatic washing. Numerous commercial alternatives 
exist C eg Lane 1984] which offer variable wash cycles, aspiration steps 
and soak stages as well as the possibility of reagent (eg substrate 
solution) addition.
4.4.6 ELISA: First Antibody
The development of assays which use antibodies to detect 
immobilized or coated antigen have the advantage that a commercial 
enzyme-antibody conjugate may be used which is species-directed. This 
avoids problems with conjugating enzymes to precious supplies of first 
antibody. However the increased number of reaction and wash steps may 
result in desorption of coated material so lowering sensitivity. In non­
competitive assay systems, antibody-antigen reactions with high affinity 
constants are preferable since dissociation of antibody and hence label 
will lower the sensitivity of such systems EPesce, Ford and Gizutis 
19783.
4.4.7 ELISA; Different Reaction Formats.
Many permutations exist for heterogeneous EIA. These include 
double antibody solid-phase technique (DASP) where the second antibody 
is bound to a solid-phase, competitive EIA, antibody masking enzyme tag 
immunoassay (AMETIA), inhibition and sandwich or two-site EIA (see Fig. 
5). Homogeneous EIA in which the binding of antigen by labelled antibody 
alters the enzyme reaction have also been reported in several formats 
including EMIT" tRubenstein, Schneider and Ullman 19723, enzyme 
channeling immunoassay (ECIA), enzyme enhancement immunoassay (EEIA), 
enzyme modulator mediated immunoassay (EMMIA), prosthetic or substrate 
labelled immunoassay and enzyme inhibition immunoassay COellerich 
19843.
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4.4.8 ELISA: General Applications.
Enzyme immunoassays have been used in many areas of analysis 
and with several reaction formats as the discussion on the choice of 
solid phase has indicated. The main limitation to the application of 
immunoassays is the production of suitable antiserum.
EIA’s can be quantitative or qualitative and have been used to 
measure antigens, antibodies and cellular components. Other classes of 
molecules can be classified along with antigens since the detection 
system is usually an antibody reacting with a complementary antigen. The 
present overview will be restricted to solid-phase assays; cy tochem leal 
uses of enzyme-antibody conjugates have been reviewed elsewhere [ Farr 
and Nakane 19811.
Although the distinction between antigens and antibodies is 
arbitrary in the sense that antibodies are ’antigens' when detected by 
labelled antibodies, the detection of serum and other antibodies is often 
associated with the investigation of disease states in man, animals or 
plants.
Detection of Antigens.
In the field of endocrinology, immunoassays have been developed 
for the detection of peptide and steroid hormones. Only more recently 
have assays for steroids such as testosterone, estradiol, cortisol and 
others used enzyme labels. The small size of the steroid when compared 
to commonly used enzyme labels (eg MW of testosterone = 289; MW of HRP 
= 43,000) can lead to difficulties in competitive solid-phase systems. 
This may be attributed to the dissimilarity between the endogenous 
hormone being measured and the labelled hormone which together are 
competing for limited antibody concentrations. Such problems are less 
severe with ,SBI and virtually non-existent with 3H based labels.
The most commonly encountered problems in steroid immunoassays 
are producing specific antiserum because of the structural similarities
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between related steroids, For example antisera for testosterone commonly 
cross-reacts with 08-dihydro-testosterone. Hapten-BSA conjugates are 
prepared with the protein carrier linked to different parts of the
steroid skeleton to avoid these problems. Other approaches have included
the use of monoclonal antibodies and induction of tolerance in the host 
animals CTateishi et al 19803. Many of the recent developments in this 
field have used EIA's to provide extremely sensitive assays for steroid 
hormones.
A homogeneous f luoro immunoassay for human serum albumin (HSA) 
relies on the competition between an HSA-hexylamine conjugate (which has 
minimal fluorescence) and endogenous serum HSA for limited antibody
sites. In the presence of added (3-galactosidase, captured conjugate gave 
rise to fluorescence measurable at 400nm [Pat ink in et al. 19833 .
Enzyme immunoassays have been developed for ferritin
[Theriault and Page 19773 , lipoproteins CFruchart et al. 19783 , blood 
clotting factors eg fibrinogen C Kwan et al. 19783 and rheumatoid 
factor [Maiolini et al. 19783.
The detection of enzymes in body fluids such as acid
phosphatase and 8-amylase by EIA has been reported [ Sobiech and
Slowinska 19833. The technique relies on the capture of enzyme by 
immobilized antibody and its subsequent detection by a second antibody 
also directed against the enzyme but itself enzyme-labelled. The results 
did not correlate with commonly used colour ime trie assays due to the 
lack of a specific substrate in the latter.
Various markers of the progress of tumour growth have been
analysed using immunological techniques [Shuster et al. 19803. These 
include carcinoembryonic antigen (CEA), 8-fetoprotein, haemoglobin F and 
several enzymes (eg prostatic acid phosphatase).
EIA for therapeutic and controlled drugs have been typically 
assayed by RIA. However homogeneous assays such as EMIT™ have been
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applied to many drugs such as phénobarbital, phenytoin, the barbiturates, 
amphetamines, cannabinoids, opiates and benzodiazepines. A list of 
references for drug monitoring has been published in a review of 
EIA techniques [O'Sullivan, Bridges and Marks 19793.
The Detection of Antibodies.
The detection of antibodies in body fluids is usually associated 
with the diagnosis or measurement of disease states, Enzyme-based tests 
may be used outside of clinical laboratories where colour end-points for 
reactions are sufficient to reach conclusions. Several ingenious
modifications of a plate-based assay have been reported, among them an 
assay based on a syringe, the inside of which is coated with immobilized 
antibody reagents [Chandler and Hurrell 19823.
In the field of infectious diseases EIA's have been developed 
for malarial parasites, Trvpanosom iases. toxoplasmosis, Rubella, 
Onchocerciasis, and animal viruses such as foot and mouth disease. 
Reviews of such applications have been published [Voiler, Bi dwell and 
Bartlett 19793.
4.4.9 ELISA: Uses in Forensic Science.
The application of EIA in forensic science is a recent
development. ELISA have been reported for species determination using a 
monoclonal antibody specific for human 7-globulins with only cross­
reactivity to eel proteins which causes no problems in routine use 
[Fletcher, Dolton and Harris-Smith 19843. Human haemoglobin was used 
to coat polystyrene beads as the basis of an ELISA to detect as little 
as 1 pg of haemoglobin [Oshima and Hara 19843. ELISA have been
developed for the Gm/Km alio typing system using bloodstains [Fletcher,
Dorr ill and Dolton 1983, Newall 1984, Kishda 19843, the Lewis system 
[Lang 1986 personal communication, Cowles, Spitalnik and Blumberg 
19863 and a-fetoprotein [ Kurucz et al. 19843.
ELISA and a variation using double substrates [Makler et al.
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19813 have been used In the detection of red blood cell antigens. ELISA 
methods have been reported recently for the detection of soluble blood 
group substances [Rukavlshlkova, Potapov and Slgal 1985, Katsumata 
et al. 1985, Katsumata et al. 1984, Bolton and Thorpe 19863 using 
enzyme-antibody conjugates or antl-H lectins. The avldln-blotln system 
has been exploited for the detection of salivary ABO blood group 
substances CKltlgawa et al. 1986, Takatorl and Tsutsubuchl 19863.
The use of ELISA type methods has been made when screening 
panels of MAbs raised against different ABH immunogens [Chen and Kab&t 
1985, Furukawa et al. 1985b3.
EIA methods have also been applied to bloodstains [ Ikemoto et. 
ai,. 1984, Fowler et al. in preparation!. These reports will be 
critically reviewed in the light of my own experiences in this field.
4.4.10 ELISA; Comparison with Other Assays.
The comparison of ELISA with other assays in terms of 
sensitivity, precision, reproducibility and convenience has been made in 
several areas. These include hormone analysis (compared with RIA), 
monitoring of infectious diseases (compared with haemagg lu t ina t ion 
techniques) and antibody quantitation (compared with gel diffusion and 
electrophoretic techniques). Any comparison must take into account the 
primary antibody or binding reagent as it is this which determines the 
main assay characteristics and most comparative studies are concerned 
with whether a new method such as EIA gives comparable sensitivity, 
accuracy and specificity as the existing method.
The comparison of ELISA and haemagg lut ina t ion methods for ABO 
grouping in the forensic context has not been published. However ELISA 
type methods have been compared with haemagg lut inat ion techniques in 
the context of anti-viral antibodies [Descôteaux, Payment and Trudel 
19803. It was found that the ELISA test was more sensitive than the 
haemagg lut inat ion-inhibit ion test with which it was compared especially
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when detecting low levels of antibody early after viral infection. In 
another study little difference was found betwen ELISA and HAG methods 
for the detection of anti-mycobacterial antigen antibodies [Reggiardo 
and Vazquez 19813.
4.5 Enzyme-Antibody Conjugates
4.5.1 Conjugates: Enzymes.
Since the conjugation of enzymes to sheep and other IgG by 
Avrameas in 1969 numerous methods have been used to conjugate enzymes 
to antibodies, The methods depend on the availability of chemical groups 
on both molecules and the best methods use bifunctional reagents to 
minimize homoconjugate formation.
The choice of enzyme for labelling an antibody is affected by 
the demands of assay design (eg in homogeneous assays enzymes are 
required whose activities will be altered by ligand specific antibodies 
[Rubenstein 19783 ).
Other assays may demand enzymes which are not present in the 
samples to be measured since these could, if immobilized, contribute to 
the measured signal when substrate solution is added. It was for this 
reason that alkaline phosphatase conjugates were selected in this work 
since red cell peroxidases may have interfered with sample measurement 
of HRP-labelled antibodies.
The stability of conjugates, turnover rate of the enzyme and 
potential detection system sensitivity are also important.
The desirable features for an enzyme label are as follows:
A high turnover number (number of substrate molecules per unit 
time) at a low substrate concentration.
The enzyme preparation should be of known purity and readily
soluble.
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The sensitivity of detection of the product of the enzyme 
catalysed reaction must be considered.
The ease and speed of detection of products of the enzyme 
reaction especially in terms of hardware required to measure these 
products. The stability of the converted substrate solution (ie colour) 
may also be important.
The absence of interfering factors in the test fluid.
The reactivity of the enzyme for cross-linking with antibody and 
the stability of both native and conjugated enzyme at the working pH and 
dilution.
The availability and cost, bearing in mind conjugation 
efficiency, of the enzyme.
The suitability, where appropriate, of the enzyme for 
homogeneous assays.
The non-hazardous nature of enzyme substrates, cofactors or
products.
Numerous enzymes have been used for conjugation to immuno­
globulins. Most reviews of ELISA (see above) contain lists of enzymes 
used in assays. The most favoured are alkaline phosphatase and horse­
radish peroxidase (AP, HRP). A list of some of the common ly used enzymes 
and some of their properties are given in Table 7.
Alkaline phosphatase has been used to produce stable conjugates 
and has a high turnover number. The substrate common ly used is para- 
nitrophenyl phosphate which is non-hazardous. The cost of AP is it's 
major limitation. HRP is cheap compared to other enzymes and has a high 
carbohydrate content (= 15%) which is useful in some conjugation
reactions. The most commonly used substrates for HRP are carcinogenic. 
They include 2,2'-azinodi(3-ethylbenzothiazoline-6-sulphonate) (ABTS) and 
o-phenyIdiamine (OPD). A further drawback with HRP is it's susceptibility 
to certain bacteriostats (eg NaN3).
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TABLE 7
The Properties of Enzymes Commonly Used in Homogeneous EIA.
Enzyme Activity- Krn MW
Acetylcholinesterase. 1,400 90 pM 54,000
(Electrophorus electricus)
Adenosine deaminase • 200 60 pM
(Calf intestine)
Alkaline phosphatase 1,000 0.2 mM 140,000
(Calf intestine) (for pNPP)
Catalase 40,000 (b) 250,000
(Calf liver)
p-Galactosidase 600 1 mM 540,000
Œ  coîî)
Glucose Oxidase 200 Kr,=33 mM (c) 186,000
(.Aspergillus niger) K„,=0. 2 mM (d)
Peroxidase 4,500 (b) 43,000
(Horseradish)
Urease 10,000 10 mM 483,000
(a) Specific Activity at 37'C/units mg-1.
(b) Kr,., depends on substrate.
(c) For glucose.
(d) For H202.
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In addition enzymes such as acetylcholinesterase, {3- 
ga lac tos idase, glucose 6-phosphate dehydrogenase, lysozyme and ma la te 
dehydrogenase have been used in homogeneous EIA,
The most common detection method for ELISA is visible 
spectrophotometry of the coloured enzyme products. However thermometry, 
pH electrodes or gas sensing have been used with some of the enzymes 
listed in Table 7. The most common alternatives to visible detection are 
the use of fluorometric or chemi luminescent substrate products. The 
extinction coefficients of the products of enzyme reactions determine 
the amounts that can be detected spectrophotometrically. For coloured 
products these are in the range of 10~s to 10-e M. Fluorescent 
molecules such as umbelliferone can be detected at levels = 10-e M. The 
sensitivity of detection of immobilized enzyme is much higher with these 
molecules reducing the incubation time of substrate solution. The 
ultimate sensitivity of the assay depends on the antibody-antigen 
reaction however and not the number of detectable substrate molecules.
Umbelliferone is more fluorescent as the free ketone than 
esterlfled derivatives and it’s release has been used for the detection 
of phosphatases, galactosidases, glucosidases and others [Rotman and 
Papermaster 19663. Fluorescent systems are not without their 
disadvantages however. Poor solubility of es ter if led derivatives, 
background fluorescence of buffers and low stability of the fluorescent 
products may counter-act the advantages of sensitivity.
Chemi luminescent reactions have been developed for the detection 
of peroxidase, {3-ga lactos idase and other enzyme systems. The 
disadvantages of measuring a short burst of energy released after 
enzyme involvement has been resolved by the development of enhanced 
luminescent systems where the signal is stable for a period of 20 
minutes.
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Tritia ted phosphates offer a further possibility in detection of 
immobilized enzyme tHarris et al 19793. The sensitivity increases may 
be offset by more manipulations required to separate the label from the 
incubation mixture following substrate hydrolysis.
The direct measurement of viral and bacterial enzymes in 
micro titre wells to . identify groups of pathogens is an alternative to 
the enzyme-antibody conjugate approach. Viral neuraminadases have been 
detected in such a system CYolken et al 1980c3 but contamination with 
enzymes of bacterial origin have complicated the results.
4.5.2 Conjugates: Methods.
The glutaraldehyde method is the method first used widely to 
prepare conjugates (conjugate is taken to mean enzyme covalently linked 
to antibody) for use in enzyme immunoassays. Before this method various 
cross-linking reagents had been used such as toluene-2,4-diisocyanate, 
carbodiimides and diazonium compounds. None of these methods are 
commonly in use now.
The Glutaraldehyde Method.
The conjugation of proteins with glutaraldehyde was first 
reported in 1969 CAvrameas!. The method performed in a single step has 
been used to link HRP or alkaline phosphatase to IgG from various 
species. Although enzyme activity is present in the conjugate a reduction 
in activity is noted. More seriously, antibody activity is often lost or 
present at low levels presumably because the high molecular weight 
complexes formed mask the antigen binding sites. The alteration of 
glutaraldehyde concentration or reaction time do not improve the 
antibody yield as measured by haemagg lut inat ion etc. [Ford, Rad in and 
Peace 1978, Eng va 11 19783. Other enzymes such as p-D-ga lac tos idase, 
lactoperoxidase and glucose oxidase have been linked to IgG using this 
one-step approach with variable success.
The two step approach relies for example on the reaction of
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glutaraldehyde with alkaline phosphatase alone for one hour. IgG is then 
added to minimise homoconjugate formation. Although the yields of 
immunoglobulin activity were low the decrease in activity was less than 
with the one step method [ Boorsma and Streefkerk 19763.
Glutaraldehyde is a homobifunctional aldehyde which reacts with 
amino residues in especially lysine to form initially a Schiff's base 
although the end product is likely to be more complex:
Enzyme-NHz + C(H)0.C(H2).C(H2).C(H2),C(H)0 + N(H=)-Ant ibody
l
Enzy me-N=C (H ) ,C (H2 ) .C <H2 ) .C (H2 ) .C (H )=N-An t ibody
4-
High MW Complexes
In contrast the two stage method relies in part on the presence 
of endogenous a 1 ly 1 iso th iocyana te in horseradish to block amino groups 
in HRP after the initial stage of the reaction between glutaraldehyde 
and HRP favouring the formation of a enzyme antibody conjugate 
[O'Sullivan and Marks 19811. The mechanism for preferentially favouring 
heteroconjugates for other enzymes is unclear.
The Periodate Method.
The method, described in 1974 [Nakane and Kawaoi 19743 
procédés in four reaction steps:
1) Blockage of free amino groups on HRP by treatment with l-fluoro-2,4- 
dinitrobenzene to minimize se If-conjugation.
2) Oxidation of surface carbohydrate moieties of the enzyme (HRP) with 
NaKu to produce carbohydrate groups.
3) Schiff's base formation between the amino groups of the IgG and the 
generated aldehyde groups at pH 9.5.
4) Reduction of the Schiff's base with NaBH* to stabilise the cross­
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linkages.
Various reports have shown that a typical enzyme yield is 34% 
incorporation. As much as 70% of the antibody activity may be lost 
[Hevey, Bonacker and Sparacio 19763. However in the original report 
68% of the enzyme activity and 99% of IgG were conjugated.
The Maleimide Method.
NjN’-o-pheny lenedima le imide reacts with thiols under mild 
conditions and was first used in 1975 by Kato et al to link IgG and g- 
D-ga lac tos idase in three stages:
1) Generation of thiol groups in the hinge of IgG using 2-mercapto- 
ethylamine.
2) Introduction of maleimide groups in IgG using the dimaleimide 
compound.
3) Reaction of maleimide-IgG with native thiol groups in the enzyme.
More than 99% of the enzyme activity was retained and IgG was 
recovered in 26% yield. The reaction was carried out at pH 6.0-6.5 and 
the resulting conjugates were stable for at least one year at 4*C. The 
pH must remain at neutral or acidic to prevent loss of maleimide groups 
and added EDTA to stabilize them may inactivate the enzyme moiety.
The Pyridyl Disulphide Method.
Two approaches have been used. In the first reported in 1978 
[Carlsson, Drevin and Axénl N-succ in im idy 1-3- <2pyr idy Id i th io)prop iona te 
(SPDP) was used as the cross-linking reagent. Treatment of enzyme and 
antibody with the reagent introduced 2-pyridyl disulphide groups into 
both molecules (the reactions were carried out separately). DTT was used 
to reduce these groups present in the IgG to thiol groups which were 
reacted with the pyridyl disulphide groups by disulphide interchange 
under mild conditions:
a) IgG-NH2 +
O8-
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S-CHz-CHg-C-NH-IgG
o
b) ^  ^^S-S-CHa-CHa-C-NH- IgG (DTT, ie 2R.SH) 4
O
HS-CH2-CH2-Ü-NH- IgG + Z ")=S + R.S-S.R 
o i\ o
/ = \  il ll
c> ^rS-S-CHa-CHa-C-NH-E + HS-CH3-CH2-C-NH-IgG 4
O
Il H
IgG-NH-C-CHg-CHz-S-S-CHg-CHg-C-NH-E
* <Q;S
Œ  = Enzyme, IgG = Antibody) H
a) Introduction of 2-pyridyl disulphide into eg IgG using SPDP.
b) Thiolation of modified protein.
c) Conjugation by disulphide interchange.
In the second approach [King, Li and Kochoumanian 1978, King 
and Kochoumanian 19793 different compounds were used to introduce 
thiol and disulphide structures into the proteins to be conjugated. 
Pyridyl disulphide groups were introduced using methyl 3- (4-dithlo- 
pyr idy Dprop ion im Ida te or with either methyl 3-mercap toprop ion im Ida te, 
methyl 4-mercaptobutyrlmldate or 2-iminothilane in the presence of 4,4'- 
dithiopyridine.
Both groups claimed high yields of antibody and enzyme activity 
in the conjugates using these reagents because of minimized non-intended 
reactions.
Other Methods.
Other reagents for conjugate preparation include p-benzoquinone 
which reacts with amino and thiol groups at pH 6 in a two-stage
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conjugation CTernynck and Avrameas 19763, iodoacetamide which reacts 
with thiol groups [Rector et al 19783 and meta-maleimideobenzoy 1-N- 
hydroxysucc in im ide ester (MBS) to introduce maleimide groups into 
proteins [O'Sullivan et al 19783.
The Avidin-Biotin System.
The interaction of the glycoprotein, avid in (MW= 67,000) with 
the low-molecular weight vitamin biotin has an association constant of 
101B L/mole. The nature of this interaction has been studied using 
biotin analogues [Liu and Leonard 19793. This interaction has been 
exploited in cytochemistry and EIA [Guesdon, Ternynck and Avrameas 
19793. The most common way of introducing bio tin molecules into a
protein is to use b io t iny 1- Af-hydroxysucc in im ide ester (BNHS) which reacts
with the e-amino groups of lysine side chains. Recently a method for the 
b to tiny la t ion of proteins through carbohydrate groups on the surface of 
immunoglobulins, especially IgM has been reported [ O'Shannessy, 
Dobersen and Quarles 19843. In either case labelled Ig is detected by 
enzyme labelled avid in forming an essentially irreversible linkage.
Many reviews of EIA carry comparisons of conjugate preparation 
and the characterisation of the products [Oellerich 1984, Blake and 
Gould 1984 O'Sullivan and Marks 1981, Ishikawa 19833. It has been 
pointed out that little attention has been paid to evaluating the key
reagent in an EIA technique; the principle features of analysis should
include efficiency of conjugation, stoichometry of the enzyme and 
antibody in the conjugate and stability [Masseyeff and Ferrua 19803 . 
Enzyme conjugates are stable at 4eC for up to one year or longer in the 
presence of a bacteriostat.
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5 Introduction to Practical Work.
5.1 Limitations In Current Forensic Serology
The reliability of the most frequently used grouping system 
(the ABO system) as currently used in English Forensic Science
Laboratories is near 100% which is a necessity of a system from which 
sworn evidence is derived. The success rate where results can be 
reported may be as low as 50% with bloodstain grouping using 
agglutination methods. The use of appropriate controls in the
absorption-elution and absorption inhibition techniques used in parallel 
for bloodstains ensure that inconsistent or low activity results are
recorded as "Not Reportable".
The reasons for the failure of these red-ce 11-based grouping
tests may be the low level of the blood group substance, the
inaccessability of the blood group substance in stains, high background 
reaction with antisera (often from 'cloth controls'), contamination with 
other body fluids or lysis of indicator red cells. Additionally handling 
or transcription errors, imprecision of reagent addition especially by 
untrained operators and variations in reagents or technique may
complicate the final picture,
The throughput in terms of samples is not very high (= 150
samples in the form of bloodstains per week may be typical). This may be 
in part due to the labour intensiveness of the current procedures where 
fresh blood from laboratory volunteers must be obtained and cells
separated from serum to act as indicators. In the actual technique, 
threads from stains are stuck onto pressed plastic sheets and washing is 
done manually. The results are read by eye by two operators on separate 
occasions and given an arbitrary agglutination score.
There is a need for a qualitative antibody-based system for 
ABO blood grouping. The requirements of such a system are real and not
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merely a list of the theoretical advantages that an immunoassay such as 
ELISA can offer. These are reliability, robustness, ease of automation, 
objective endpoint measurement with the facility for data reduction, 
manipulation and storage (for use by Courts of Law) and sensitivity. 
Factors such as precision and accuracy have little meaning in the 
context of the current qualitative methods. When quantitative methods 
are generally available the quantity of eg group A substance and group 
H substance expressed as a ratio may more precisely identify the 
originator of a blood sample of groups A, and Az.
The simplicity of ELISA in terms of performing the assay as
well as the other benefits of a microtitre plate based assay lead to its
choice as the assay type for an ABO grouping method for forensic 
serology. An enzyme-based system was favoured over a radio label led one 
for reasons of low capital cost during the development phase and 
avoidance of more complex safety procedures associated with handling 
radio label led compounds. Radio labelled antigens and antibodies also 
suffer from a short sheIf-life.
For these reasons the current work was begun. The extent of the
realisation of these goals is discussed at the end of this work on the
basis of the experiences and results obtained.
5.2 Context and Overview of Practical Work
This work was commenced on a part-time basis while working as 
a scientist in an operational Forensic Science Laboratory. During this 
time I completed studies on the use of polyclonal antisera for grouping 
saliva and bloodstains (Results chapters 1 and 2). I also began 
investigations into the use of monoclonal antibodies for bloodstain 
grouping.
Around this time I transferred to the Central Research 
Establishment, Aldermaston. They had been studying ELISA methods for
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species determination, immunoglobulin alio typing and ABO grouping. I 
continued to study the use of monoclonal antisera for ELISA under the 
direction of Dr Stephen Fletcher whose group had made important 
advances in this area.
The direction of my thesis took two main thrusts, With the 
invaluable help of a sandwich student, Mr Graham Parry (Hatfield 
Polytechnic), I studied the use of MAb for ABO grouping of saliva. Mr 
Parry, under my technical supervision, also carried out analyses of TCS 
(ABO monoclonals) and worked on the PCRD system.
At a later date while I was developing conjugation methods, 
another sandwich student (Miss Stephanie Gadd, University of Surrey) 
gave me considerable support in SDS-PAGE analyses of 'purified' MAb, ABO 
ELISA of bloodstain extracts and especially in data processing on an 
Apple He micro.
Overview of Practical Work.
The development of enzyme-labelled immunoassays for forensic 
serology begun by investigating a readily available soluble source of 
ABO antigen, namely saliva.
During early work only polyclonal antisera from either the BGRL, 
Oxford or hyperimmune sera from commercial sources was available. Group 
H substance is detected in Forensic Science Laboratories using a lectin, 
Ulex europeaus. and was included in the evaluation of ELISA for salivary 
blood group substance in these investigations.
Previously work done at the Central Research Establishment, 
Aldermaston, had shown that A and B blood group substances could be 
detected by ELISA methods (unpublished results). Chapter 1, the 
application of ELISA to salivary blood group substance using polyclonal 
antisera, was to confirm these previous observations and to look at some 
of the conditions affecting the detection by ELISA.
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As a means of validating the method, an assessment trial done 
blind was carried out on 50 liquid saliva samples. Very little work was 
done on saliva stains as it was known that salivary blood group 
substance are readily soluble.
Before work was started on extracting and Immobilising blood
group activity from bloodstains, some work was done on whole blood to
provide a model for later work.
The investigation into detecting blood group substance in 
bloodstain extracts using polyclonal sera proceeded in four stages 
(Chapter 2).
Attempts were made to repeat the approaches used with liquid 
saliva. After using several sets of conditions, the main problem
associated with using polyclonal sera and hence anti-human globulin 
conjugates was identified.
The work on the use of polyclonal antisera in ELISA for 
bloodstains was concluded with a breakdown of the components of the 
non-specific binding and a short study into an alternative approach to 
using anti-A or anti-B sera namely an anti-erythrocyte membrane
antibody.
The availability of MAb to A, B and H specificities both from 
commercial and research sources enabled more work on liquid saliva ABH 
grouping by ELISA to be carried out.
The importance of choice of the anti-mouse alkaline phosphatase 
conjugates was investigated.
The application of anti-ABH MAb to bloodstain grouping was 
investigated in three main parts. Firstly the extraction conditions for 
ABH antisera were established and then the effect of both MAb-conjugate 
combination and assay configuration (mode) were looked at.
An assessment trial completed the work on an indirect ELISA for 
ABO grouping of bloodstain extracts.
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The advantages already outlined for MAb were factors in the 
choice of MAb for direct or indirect conjugation to enzymes.
It was first necessary to analyse and purify samples of TCS 
prior to further work. This was done by affinity and size-exclusion 
chromatography or a mixture of both, Estimates of specific Ig were made 
on the basis of the analyses.
The conjugation of MAb to enzymes (Chapter 5) followed four 
approaches. These were the glutaraldehyde method for MAb-alkaline 
phosphatase, the periodate method for HRP-MAb, the SPDP method for MAb- 
alkaline phosphatase and investigations into the avid in-bio tin system.
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1. ELISA
1.1 Materials.
All plastic plates used in assays are shown in Table 8. 
Untreated micro titre plates (round or flat bottom) were purchased from 
Dynatech Laboratories. Liquid saliva was donated freshly by laboratory 
volounteers and frozen and thawed before use.
Reagent suppliers are listed in Appendix A. Polyclonal blood 
grouping antisera (anti-A and anti-B) were from Lome Laboratories Ltd. 
or Biotest-Folex. Crude typing sera was obtained from the Blood Group 
Reference Laboratory (Oxford). Anti-H lectin was donated by Central 
Research Establishment, Aldermaston as a preparation from gorse seeds 
Ulex europaeus. Anti-human enzyme conjugates (polyclonal anti-human IgG 
y-chain specific A3150 and anti-human IgM .alkaline phosphatase 
conjugate, p-chain specific A3275 were from Sigma Ltd., Monoclonal 
anti-human enzyme conjugates were from Miles Biochemicals (anti-human 
IgG Monoform, code 63-270-1 and anti-human IgM Monoform, code 63-271-1, 
both alkaline phosphatase conjugates). Anti-human erythrocyte membrane 
antibody, raised in rabbits, was obtained from Mercia Brockades (code 
A104)[Bjerrum and Lundahl 19743 . Anti-rabbit IgG (H+L) affinity 
purified, alkaline phosphatase conjugate was obtained from Miles 
Biochemicals (code 61-660-1).
Alkaline phosphatase substrate tablets, pNPP (5 mg), Triton 
X-100, Tween 20 and glutaraldehyde (grade I) were bought from Sigma 
Ltd. Phosphate buffered saline (PBS) tablets were bought from Oxoid Ltd.. 
Bovine serum albumin (30% solution) was bought from Ortho Diagnostics 
Ltd. All other reagents, unless stated were obtained from BDH Ltd. 
Emulgen 911 was a gift from Dr R Hubbard, Surrey and was obtained from 
the Kao Atlas Chemical Company, Japan.
Where plates were washed semi-automatically a Nunc Immunowash
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TABLE 8 
PLATE TYPES USED IN ELISA
Supplier Code Common Name Wei1-Tvpe Material
Dynatech M29A microtitre flat-bottom polystyrene
Dynatech M29B microtitre round-bottom polystyrene
Dynatech - polycarbonate flat-bottom polycarbonate
Dynatech M129B microELISA . flat-bottom Immulon*
Dynatech M129A microELISA flat-bottom Immulon*
Nunc Plate I Immunoplate flat-bottom polystyrene*
Note:
a) Irradiated polystyrene.
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8 was used from Gibco Europe Ltd. Agglutinates were read with the aid 
of a light microscope (Vickers Instruments Ltd.). Micro titre plates were 
centrifuged in a Digifuge (Heraeus Christ) centrifuge.
Buffers
Coating buffer, CB (pH 9.6), was carbonate-bicarbonate buffer 
(1.59g Na2C03, 2.93g NaHC03 and 0.2g NaN3 in one litre of water).
Wash buffer was phosphate buffered saline (PBS) (Dulbecco 'A') 
containing 1% bovine serum albumin (BSA) (Ortho Diagnostic Systems Ltd.) 
and 0.05% Tween 20 (PBS-T).
Substrate buffer was diethano lamine buffer pH 9.8 (97 ml
diethano lamine in one litre of water with 0.2 g NaN3 and 100 mg 
MgC 12.6HZ0 titrated to pH 9.8 with 1 M HC1). Substrate solution was pNPP 
(1 mg/ml) in substrate buffer.
1.2 ELISA: Plate Washing
Plates were washed manually or semi-automat ically in one of the 
following ways:
1) Immersion Washing: Plate contents were emptied into a sink 
and then the plates were immersed in a shallow tray of wash buffer. 
Buffer was left in wells for three minutes then the wash process was 
repeated twice more.
2) Squirt washing: This was the technique most widely adopted 
in the early work. Plates were emptied as above and wells filled with 
wash buffer from a plastic wash bottle. After a three minute soak,
plates were emptied and the wash process repeated twice more.
3) Semi-automatic washing: A semi-automatic washing device, the
Nunc Immunowash 8 ( eight channel) was used.
4) Automatic Washing: Plates were washed with a Titertek
Microplate Washer 120 (Flow Laboratories Ltd). The wash sequence was
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rinse - soak for 15 minutes - rinse. The volume of wash buffer and 
frequency of rinsing could be controlled on the Microplate Washer.
1.3 ELISA: Plate Reading
The conversion of substrate by captured alkaline phosphatase 
was assessed in one of the following ways:
1. Visual Method: An arbitrary scale from 0 to 6 was applied to 
the colour intensity (yellow) of the converted substrate. A score of 0 
was given for no apparent colour difference from substrate solution 
alone. A score of 6 was given for a bright yellow colour (equivalent to 
an A405 of 1.5 to 2.0).
2. Manual plate reading: A manual single beam plate reader, the 
Dynatech Mini MicroELISA Reader MR 590 was used for ELISA using 
polyclonal antisera. The reader had an in-line filter for 405nm 
wavelength. The absorbance, in the range 0.00 to 2.00, was displayed on a 
LED display and could be corrected for blanks by using a blanking knob.
3. Automatic plate reading: Plate wells were read 
spectrophotometrically at 405nm using a model MR580 dual beam reader 
(Dynatech Laboratories Ltd.) with the reference filter set at 630nm. Any 
absorbance at the reference wavelength was subtracted automatically 
from the sample reading at 405nm to compensate for marks or scratches 
on plate wells. The plate reader, interfaced to an Apple lie 
microcomputer, was controlled under software developed specifically for 
this application. The absorbance readings were read, printed out and 
saved on floppy disc for later manipulations. This further analysis, 
including subtraction of blanks or calculation of reaction score was 
performed with the aid of a commercial spreadsheet package (Flashcalc; 
Visicorp Inc).
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1.4 ELISA: Assay Configurations.
The application of ELISA to saliva and bloodstain grouping using 
polyclonal antisera and monoclonal antibody reagents lead to the 
adoption of standard methods on which all assays were based. The 
indirect assay is shown schematically in Figure 6.
1.4.1 PoIvcIona 1 Antisera: Sal 1 va Grouping.
Numerous experiments carried out by the author and others 
(Werrett, personal communication) on the application of an indirect ELISA 
using polyclonal anti-A and anti-B for saliva grouping. These studies 
resulted in the following general method as proposed for developmental 
work [Voiler, Bidwell and Bartlett 19791:
Liquid saliva, diluted 1/200 in coating buffer (CB pH 9.6) was 
dispensed manually (250 pi per well for all stages) into microtitre 
plates (Dynatech M129AR), After an overnight incubation at 4*C, plates
were squirt-washed with wash buffer. Polyclonal anti-A and anti-B
antisera diluted 1/20 in PBS-T was dispensed and incubated in plate
wells for two hours at 4*0. After washing as above, anti-human
IgG-alkaline phosphatase conjugate diluted 1/1000 in PBS-T was incubated 
in plate wells for a further two hours at 4*0. After washing, 250 pi 
substrate solution was added to plate wells; plates were read at 405nm 
typically after a 30 minute substrate incubation at room temperature.
Numerous variations of this basic method were included in the 
work to optimise this procedure. These included alterations in reagent 
volumes, incubation times and temperatures and washing methods. The 
variances are referred to in the context of the results.
1.4.1.1 Assessment Trial for Liquid Saliva
Fifty separate liquid saliva samples, freshly donated by 
laboratory volunteers were separately coded by an assistant; the blood 
group of the donors was not revealed until after the assay and the 
results had been assessed. The liquid saliva was of types A, B, 0 and AB
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Figure 6. The Indirect ELISA for Immobilised Blood Group Substance.
1. Dilutions of bloodstain extract or saliva ( ▲ ) were coated on 
plate wells, usually overnight at 4*C.
2. After washing anti-A. anti-B or anti-H (human polyclonal or mouse 
monoclonal) antibody were incubated in plate wells for eg two hours 
at 4*C.
3. After wells were washed anti-species antibody conjugated to 
alkaline phosphatase ( *-< ) was incubated, typically for a further 
two hours at 4*C.
4. Substrate solution was incubated in washed wells and the 
absorbance at 405nm (A405) was read after one hour.
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from both secretors and non-secretors.
Each sample was frozen and thawed before analysis. The saliva 
was diluted 1/50, 1/100 and 1/200 in CB (pH 9.6) (250 pi per well) and 
processed as described above for liquid saliva (page 86). The addition of 
reagents to plates was carefully synchronized to ensure that samples 
were processed identically.
1.4.2 The Use of Polyclonal Antisera for Liquid Blood Grouping.
Whole washed cells (prepared by spinning samples of freshly 
drawn blood in anti-coagulant at 5000 rpm for 5 minutes and suspending 
and washing in 0.85% saline three times) were diluted 1/10 to 1/16 000 
in PBS and dispensed manually into wells of flat-bottom micro titre 
plates (250 pi per well). After an overnight incubation at 4*C, the 
plates were washed by immersion-wash ing three times with PBS.
Polyclonal anti-A and anti-B (250 pi of dilutions from 1/10 to 
1/2000) from the Blood Group Reference Laboratory (BGRL, Oxford) were 
dispensed into wells and a further two hour incubation at 4"C followed. 
After washing the plates as described above (immersion-wash), anti-human 
IgM alkaline phosphatase conjugate (Sigma, code number A3275), diluted
1/1000 in PBS was dispensed to wells for a two hour incubation at 4*C,
Substrate solution was added after a wash step and results assessed 
visually after one hour incubation at RT. In some tests, 'protein-binding 
sites' on the plastic were blocked with 1% BSA or 1% whole rabbit serum 
(heat inactivated) following cell attachment for two hours or overnight 
at 4"C and then washed prior to the addition of antisera.
The attachment of cell layers to plastic plates was carried out
as follows: whole washed cells, diluted in PBS, were dispensed into plate 
wells and plates were centrifuged at 1000 rpm for five minutes in a 
centrifuge. Each plate was then gently immersed in PBS containing 0.25% 
glutaraldehyde at 4*C for a further five minutes. In some tests, plates
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were pretreated by incubating PBS containing poly-L-Lyslne (50 pg/ml, 
200 pi) in plate wells for 30 minutes at RT prior to washing and 
addition of cells.
Whole washed cells were lysed either by freezing-thaw ing or by 
the addition of an equal volume of distilled water. The lysates were 
diluted, without further treatment, in PBS or coating buffer (pH 9.6) and 
processed as described above,
1.4.3 The Use of Polyclonal Antisera for Grouping Bloodstains.
Plates (Dynatech micro titre M2 9 A unless otherwise stated) were 
pre treated in some tests with dilutions of grade I glutaraldehyde (250 
pi) dispensed into plate wells manually. After a two hour incubation at 
RT the plates were washed with PBS-T using the semi-automatic plate 
washer. Samples of blood were collected from laboratory volunteers into 
heparinized tubes (Microvette CB1000, Sarstedt). Stains were made using 
30 to 100 pi fresh blood on clean, twice boiled cotton cloth and left to 
air-dry at RT for at least 24 hours before use. Stains were cut out 
whole and extracted with 300 to 3000 pi of the appropriate extractant 
in plastic tubes for one hour at RT on a vibrator (Luckham VR/4). 
Extracts were diluted in CB (pH 9.6) and incubated (250 pi per well) 
overnight at 4*C. Plates were washed using the semi-automatic plate 
washer. In some tests, 'protein-binding sites' were blocked with BSA in a 
one hour soak stage of PBS-T+1% BSA (250 pi per well).
Polyclonal antisera (250 pi of 1/10 to 1/400 dilution in PBS-T) 
was dispensed into plate wells for a two hour incubation at 4*C. After 
washing as above, anti-human IgG alkaline phosphatase conjugate (Sigma, 
code number A3150) diluted 1/1000 in PBS-T was incubated in plate wells 
for a further two hours at 4*0, After washing, substrate solution (250 
pi) was dispensed to plate wells and incubated at RT, typically for one 
hour.
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1.4.4 The Grouping of Serum Stains Using Polyclonal Antisera.
Fresh blood was collected In heparinized tubes and spun at 5000 
rpm in a microcentrifuge (Maxifuge, Whyte leaf Scientific Ltd.). The 
supernatant was removed by pipette and used to make 100 pi stains on 
clean cotton cloth. These were extracted and processed in ELISA as 
described above <1.4.3).
1.4.5 The Grouping of Liquid Saliva Using Monoclonal Antisera.
The monoclonal antibody reagents (MAb) used were tissue culture 
supernatants either obtained commercially or made available by
researchers in the laboratories named below. The complete list of MAb
used is shown in Table 9. The anti-A (4) was from Dr S Moore, S.E.
Scotland Regional Blood Transfusion Service, Royal Infirmary, Edinburgh, 
Scotland. The anti-A (6-10), anti-B (15-18) and anti-AB (20) were 
supplied by Dr H Lee of CNTS, Paris, France. The remaining MAb were 
obtained commercially from the suppliers as listed. The anti-H was a 
tenfold concentrate; the titre figure (1/128) in the appended report 
CABO grouping by ELISA I. An evaluation of Monoclonal Antisera and
Commercial Enzyme Conjugates') refers to the unconcentrated anti-H which 
in fact bears a different batch number. In addition to the list in Table 
9, several other MAb were used as indicated in Table 1 of the appended 
paper ('ABH grouping by ELISA I').
The 21 listed MAb comprised 16 separate clones. MAb 6 and 9 
were different batches of the same clone as were 7 and 10, 15 and 18, 
MAb 19 was a mixture of two different anti-A,B's. MAb 20 was an anti AB 
from an undisclosed source. Elsewhere in the text, MAb coded as eg 8a or 
10b etc. refer to to different batches of the parent material shown in 
Table 9.
The conjugates were all commercially available alkaline
phosphatase labelled anti-mouse immunoglobulins. The technical
information available on each is scanty: the immunoglobulin (anti-mouse)
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Number Common Name
TABLE 9
MONOCLONAL ABH ANTISERA USED IN 
Supplier
ELISA
Lot Number
Anti-A
1 CBM Anti-A Chembiomed Ltd, Alberta, Canada AH8 123A
2 Celltech A Celltech Ltd, Slough England A.1005X 6D4
3 Cell tech INI i -
4 Moore's IgG Moore, S, Edinburgh, Scotland E516 8.11.83
5 Seraclone A Seraclone (sample) 22.12.83
6 CNTS A283 CNTS, Paris France A6104 1983
7 CNTS A383 h A696 1983
8 CNTS A184 h A549 1984
9 CNTS A284 h A6104 1984
10 CNTS A384 h A696 1984
Anti-B
11 CBM Anti-B Chembiomed Ltd AH8 123B
12 Celltech NG1 Celltech Ltd. -
13 CNTS Cocktail CNTS 83636
14 Seraclone B Seraclone 121053
15 CNTS B183 CNTS B730 1983
16 CNTS B283 i B769 1983
17 CNTS B383 i B791 1983
18 CNTS B184 i B730 1984
Anti-AB
19 CNTS A+B CNTS 83638
20 AB184 Undisclosed
Anti-H
21 CBM Anti-H Chembiomed Ltd. A07-149H
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is IgG for the Sigma and Miles conjugates. A list of conjugates used in 
work with MAb for saliva (and bloodstain) testing is given in Table 10.
The development of ELISA methods from the simple indirect assay 
for liquid saliva using polyclonal antisera to the use of MAb in 
different reaction modes to group detergent extracted bloodstains was 
accompanied by a progression in assay design and assessment of results.
The investigations into ABO grouping by ELISA of liquid saliva 
were carried out using the standard method detailed above. However in 
several tests, including the comparison of several MAb and enzyme 
antibody conjugates three different modes were compared. These were the 
sequential mode, the simultaneous mode and a pre-mix mode which are 
shown schematically in Table 11,
The sequential mode was used for the early work on MAb for 
saliva grouping. Saliva stains were made with 100 pi of freshly donated 
liquid saliva on clean boiled cotton cloth and allowed to air-dry for at
least 24 hours. Whole stains were extracted with 5% NH* / PBS to give
extracts which were 1/25 dilutions of whole saliva. Saliva, diluted in CB 
(pH 9.6) was incubated in plate wells overnight at 4*C (100 pi per well). 
Plates were washed using the semi-automatic or the automatic washing 
machines as previously described. MAb diluted in PBS-T was incubated in 
plates (100 pi per well) for two hours at 37*C. After washing, conjugate 
dilutions (100 pi per well in PBS-T) were incubated for a further two 
hours at 37*C. After washing, substrate solution was added and the A405 
read after one hour incubation at RT using the manual or automatic
readers.
In the comparison of four anti-A MAb and all MAb in the study 
(Chapter 3) on liquid saliva, liquid saliva was diluted 1/50, 1/250 and 
1/1250 in CB pH 9.6 (except where stated otherwise). The MAb and 
conjugate were also diluted in CB pH 9.6 in error in these two
comparisons.
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TABLE 10
ANTI-MURINE ALKALINE PHOSPHATASE CONJUGATES USED IN ELISA
Number Specificity
IgG Whole Molecule
IgG
IgM
IgG Heavy chain 
Kappa chain 
IgM
Description (Host)
Non-adsorbed (rabbit) 
" (goat)
HSP-adsorbed (goat) 
Non-adsorbed (rabb it) 
(sheep) 
(sheep) 
(sheep)
Manufacturer (Code)
Sigma
Miles
Serotec
Serotec
«I
Tago Inc
(A1902)
(A5153)
(A4656)
(AAC01A)
(AAC08A)
TABLE 11
Comparison of Three Reaction Modes for Indirect ELISA
Mode Reaction Sequence
Sequential bgs - Wash - MAb - Wash - Conjugate - Wash - Substrate
Simultaneous bgs - Wash - MAb + Conjugate - Wash - Substrate
Pre-mix bgs - Wash - Mixture* of MAb + Conjugate - Wash - Substrate
a) The MAb and Conjugate were mixed in tubes for 30 minutes at RT before being 
dispensed into plates coated with bgs.
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1.4.6 The Grouping of Bloodstain Extracts Using Monoclonal Antisera.
Samples of blood were collected from laboratory volunteers into 
heparinized tubes (Microvette CB1000, Sarstedt). Stains were made using 
30 to 100 pi fresh blood on clean, twice-boiled cotton cloth and left to 
air-dry at RT for at least 24 hours before use. Stains were cut out 
whole and extracted with 300 to 3000 pi of the appropriate extractant 
in plastic tubes for one hour at RT on a vibrator (Luckham VR/4) as 
indicated in the appropriate results sections. In one comparison of MAo, 
liquid blood was extracted with 1 % octy 1-($-glucose; in all other 
experiments bloodstains were used as the test material.
Extracts were diluted in CB (pH 9.6) or PB (pH 8.0) and 
incubated (100 pi per well) overnight at 4*C or for two hours at 37*C.
Plates were washed using the semi-automatic plate washer three 
times with PBS-T including a fifteen minute soak stage. In some tests, 
•pro te in-bind ing sites' were blocked with BSA in a one hour soak stage 
of PBS-T and 1 % BSA (250 pi per well).
MAb, diluted 1/50 — 1/1000 in PBS-T was incubated for two hours 
at 37*C or 4*C either alone or in a simultaneous incubation with 
conjugate (Sigma conjugate A1902) diluted 1/1000 in PBS-T. In sequential 
assays, a wash step separated the MAb and conjugate incubations. 
Specific assay conditions are referred to in the text of the results 
section.
1.4.6.1 Assessment Trial of Bloodstain Using MAb
Stains were prepared on boiled cotton cloth, using 30 pi of 
freshly drawn blood from laboratory volunteers. The stains were then 
dried at room temperature for at least 24 hours before use. Stains were 
extracted using 400 pi of extractant (PBS containing 5 % 0.880 ammonia 
solution and 1 % octyl glucose) for 30 minutes at room temperature on a 
laboratory vibrator. Extracted cloth was removed and stain extract
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dilutions (in 0.1M phosphate buffer, pH 8.0) and controls (all 100 pi) 
were incubated in microELISA plate wells for two hours at 37*C. Each of 
the 34 microELISA plates used in the trial had group A, B and 0 
bloodstain extracts at a dilution of 1/50). Plates were washed with PBS- 
T as follows:
two rinses - 15 minute soak - two rinses.
MAb was diluted 1/25 (anti-A, No. 1; anti-B, No. 11) or 1/10 
(anti-H, No. 21) and pre-incubated with an equal volume of anti-mouse 
IgM alkaline phosphatase conjugate (conjugate H, diluted 1/500 in diluent 
buffer) for 30 minutes at room temperature. After this pre-mix stage, 
100 pi aliquots of antibody-conjugate mixtures were dispensed into plate 
wells.
The plates were covered, incubated at 37*C for two hours, and 
then washed as described above. Substrate solution (100 pi) was 
dispensed into the wells and the plates left covered at room 
temperature. They were read using the automated plate reader after one 
hour and again after an overnight incubation at 4eC.
1.4,7 Studies Using Anti-Ervthrocyte Membrane Antibody
The reaction of anti-rabbit IgG alkaline phosphatase conjugate 
with anti-erythrocyte membrane antibody raised in rabbits (AEM)[Bjerrum 
and Lundahl 19743 was tested as follows: AEM was diluted 1/1000 or 
1/5000 in CB (pH 9.6) and incubated overnight at 4*C (250 pi per well of 
a microELISA, M129B plate). '
The plate was washed three times with PBS-T (semi-automatic 
method) and anti-rabbit alkaline phosphatase conjugate diluted 1/1000 in 
PBS-T was incubated in plate wells for two hours at 4*C. After washing, 
substrate solution was added and the A405 determined using a manual 
plate reader.
The reaction between AEM and immobilised capture antibody 
(anti-A or anti-B) in the absence of bloodstain extracts was tested as
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shown in Figure 7. Anti-A or anti-B polyclonal antisera, diluted
1/20-1/160 in CB (pH 9.6) was immobilized overnight in plates at 4*C
(Stage 1). Plates were washed three times with PBS-T; PBS-T with 1 % BSA 
was dispensed into plate wells for a one hour incubation at 4*C. Plates 
were washed as above; AEM, diluted 1/1000 in PBS-T, was dispensed to 
plate wells and a two hour incubation at 4#C followed (Stage 2). Plates 
were again washed; anti-rabbit conjugate diluted 1/1000 in PBS-T was
incubated in plate wells for a further two hours (Stage 3). Plates were 
washed prior to the addition of substrate solution.
The use of AEM antisera in an absorption/elution (A/E) test was 
similar to that described for A/E on bloodstains using polyclonal
antisera (Page 100). After absorbing overnight at 4*0, the threads were 
washed. AEM was eluted at 56X  into a suspension of indicator cells 
which were 0.5 % suspension washed red cells (group 0) prepared as
described as for A/E. After a 20 minute incubation at 56X, plastic
sheets were rotated for 30 minutes before the degree of agglutination
was assessed using a light microscope.
In some tests, the extract from a bloodstain was used to make a 
second stain to determine whether blood group activity had been
extracted as indicated in Figure 22. The extracted cloth from the first 
stain, the extract and the new (second) stain were tested by ELISA and 
A/E.
1.4.8 ELISA: Assessment of Results.
Initial experiments were assessed using sample blanks set up as
follows:
Sample Blank*:
Diluent Buffer* - Wash - Antisera - Wash - Conjugate - Wash - Substrate 
a) The buffer used to dilute bgs (CB pH 9.6) was used instead of sample. 
The so lid-phase was a micro titre plate well as usual.
The strength of the reaction was measured as a signal to noise
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Immobilised Capture Antisera
1 YYYYYY
MicroELISA Plate
W  ^  ^  anti-EM Antisera (Rabbit IgG)
YYYYY
anti-Rabbit IgG. Conjugate
YYYYY
pNPP pNP
XP
Substrate Conversion
Figure 7. Ant 1-Erythrocyte Membrane Antibody Assay Design.
1. Anti-A antisera vas coated onto plate veils, To evaluate the cross-reactivity betveen anti-erythrocyte 
membrane antibody (AEM, raised in rabbits) AEM vas incubated in vashed plate veils (2), Anti-rabbit- 
alkaline phosphatase conjugate vas incubated in plate veils (3), After veils vere vashed, substrate 
solution vas dispensed to veils (4) and the A405 vas read,
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ratio, termed the Reaction Score (RS) [Fletcher, Dolton and Harris- 
Smith 19843 and calculated as follows:
(A405 Test)-(A405 Sample Blank)
R.S.= (A405 Sample Blank)
or (A405 Test) -1
(A405 Sample Blank)
In subsequent tests, where the sample blank was not a true 
measure of system noise an antibody blank to measure non-specific 
binding (NSB) was used to calculate RS: bgs - Wash - Diluent Buffer - 
Wash - Conjugate - Wash - Substrate
In tests where multiple determinations were carried out 
together with statistical tests, results were expressed as absorbance 
readings with a single determination of R.S. using a mean value for
comparison purposes; statistical tests were never performed on R.S.
2 Absorption Elution (A/E)
Cellulose acetate sheets (144mm by 96mm, A Warne and Co. Ltd.) 
were pressed so that moulded cavities were produced (40 per sheet). 
Bloodstained threads, approximately 5mm long, were stuck to the sheet 
using cellulose acetate adhesive with one thread in each cavity (Figure 
8). One drop, about 30 pi from a Pasteur pipette, of appropriately 
diluted polyclonal anti-A, anti-B and anti-H lectin (not shown) was added 
to immerse each thread (2). The dilution of antiserum or lectin was
previously determined as being the penultimate doubling dilution of 
antiserum that caused complete agglutination of added red cell
suspension (0.1 - 0.5 % in 0.85 % saline with 0.3% BSA added).
After an overnight absorption at 4*C in humid chambers (3), the 
sheets to which the threads were attached were washed with chilled 
saline (0.85 %) from a wash bottle then soaked in a saline bath.
MATERIALS AND METHODS Page 99.
<5=3>
Anti-A
Anti-B
Addition of anti sera to threads
Overnight Absorption
A Cells
Threads are washed
Absorbed Antisera Eluted at 56e C 
Indicator Cells Added
B Cells
AGGLUTINATION NO REACTION
Figure 8. Absorptlon-ElutIon Technique (A/E).
1, Bloodstained threads vere stuck to cellulose acetate sheets and anti-A or anti-B added to threads (2), 
After allowing the antisera to absorb overnight at 4'C (3) threads were washed bound antisera eluted at 
56*C, Indicator cells were added (4) and the agglutination read after 30 minutes on a score of 0 to 4 (5),
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This was circulated at 4*C for 40 minutes.
Sheets were blotted dry with adsorbent paper. One drop (30 pi)
of indicator cells was added to each cavity to completely immerse the
washed threads. The Indicator cells were prepared by washing whole 
cells, from liquid blood donated by laboratory workers, three times with 
0.85 % NaCl. Cell suspensions were centrifuged at 1000 rpm for five 
minutes and supernatants were removed by suction. Cells were then
resuspended to give 0.1 - 0.5 % suspensions in 0.85 % NaCl (pale pink 
colour) containing 0,3 % BSA. These indicator cells were added to threads 
which had previously been incubated with homologous antisera ie group A 
cells to threads which had been incubated with anti-A etc (4).
The sheets were incubated, in humid chambers at 56*C for 20 
minutes to desorb specifically bound antisera from the threads. The
sheets were gently rotated on a Rotatest (R100, Luckham Ltd.) for 30 
minutes. Agglutinates (5) were read using a light microscope (objective 
X40) and scored 0-4 with 4 for complete agglutination. Controls were 
clean cotton threads processed as described above.
3 Conventional Size Exclusion Chromatography (SEC).
A glass column of dimensions 41 x 1.5 cm (LKB Limited) was 
washed with PBS (pH 7.4) and clamped vertically with the bottom filter 
assembly in place and the outlet tubing connected to a chromatography 
pump. A slurry of Ultragel 1.5 chromatography medium or Sephacryl S-300 
was poured into the column and allowed to settle. The top fitting was 
replaced and buffer (PBS) drawn through the column at a flow rate of 1.2 
ml/min. The column was equilibrated with ten column volumes of PBS. The 
full details of column packing were taken from Pharmacia Technical 
Bulletin 'Gel Filtration, Theory and Practice'.
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In normal operation the sequence of equipment was: 
buffer reservoir -» peristaltic pump -» column -» detector fraction- 
collector. The pump was a LKB 2120 Varioperpex II peristaltic pump. The 
LKB 2138 Uvicord S flow spectrophotometer was connected to a LKB 2 
channel chart recorder. Fractions were collected on a LKB 2070 Ultrorac 
II fraction collector operated by pulsed signals from the pump. Fractions 
were 2 ml.
Samples were filtered (0.2 microns) and loaded as follows:
The pump was connected to the bottom of the column and used to draw 
sample through the column from a small beaker. Once all the sample had 
soaked into the top of the column, the pump was reattached to the top 
of the column. The fractions were monitored at 280 nm.
4 High Performance Size Exclusion Chromatography (HPSEC).
The equipment for HPSEC is described below for HPLAC. The 
columns used were either commercial (LKB TSK 3000) or packed using GPC 
100 by conventional techniques.
5 High Performance Liquid Affinity Chromatography (HPLAC).
5.1 HPLAC: Materials
Monoclonals to ABH specificities were gifts or obtained 
commercially as indicated above. Affinity immunoadsorbents (Synsorb A, 
Synsorb B and Synsorb H type 2) were from Chembiomed Ltd. All other 
reagents were of analytical grade as indicated.
HPLC 6000A solvent delivery systems (pumps) and the 660 solvent 
programmer were from Waters Associates, The detector was a Spectraflow 
773 CKratos Ltd.) and was connected to a Servogor 420 chart recorder 
(John Minister Instruments Ltd). All columns, tubing and accessories were
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obtained from HPLC Technology or Shandon Ltd. as indicated.
SDS-PAGE was carried out using a Pharmacia FBE-3000 tank and
ECPS 3000/150 power supply (Pharmacia Ltd.). The following solutions
were used for SDS-PAGE, Reagents were from BDH Chemicals. Buffer stock 
solution was 34 g imidazole and 10 g SDS in 5 L water titrated to pH
7.0 with orthophosphoric acid. Electrode buffer was a 1:1 dilution of the 
stock solution. Sample buffer was 10 ml buffer stock, 1 g dithio-threitol 
(DTT) and 1 g SDS in 100 ml water. Aery lam ide solution was 22.2 g 
electrophones is-grade aery lam ide and 0.6 g bisacrylamide in 100 nl
water. Ammonium persulphate solution was 15 mg/ml and prepared fresh on 
the day of use. Bromophenol blue (0.25% w/v) and 0.1% Triton X-100 were 
also prepared. For Coomassie blue staining gels were fixed in a solution 
containing 57 g trichloroacetic acid and 17 g sulpho-salicylic acid in 
500 ml of a 2:1 mixture of water and methanol.
Staining solution was 1.25 g Coomassie brilliant blue in 500 ml 
of methanol, water and glacial acetic acid mixture (in the ratio 5:5:1). 
Gels were destained using ethanol/acetic acid/water (in the ratio 3:1:6), 
Silver staining was carried out using a silver stain kit (Bio-Rad)
following details given in their Technical Bulletin 1089.
5.2 Affinity Chromatography: Batch Method.
Weighed amounts of the appropriate Synsorb (typically 1 mg of 
Synsorb to 2 ml of sera) were rolled overnight at 4*C with antisera in 
plastic tubes. The unbound material (termed the supernatant) was removed 
and the Synsorb washed with three 5 ml volumes of phosphate buffered 
saline pH 7.4 (PBS)(tablets from Oxoid Ltd.) for five minutes each at 4*C. 
Bound antibody was eluted by rolling the Synsorb with 5ml of 2% 0.880 
ammonia in PBS at 4*C for two hours. The eluted material was saved and 
the Synsorb washed before further use.
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5.3 Affinity Chromatography: Column Method.
Stainless steel columns <i.d.= 0.4cm, o.d.= 0.8cm. length= 20cm) 
from Shandon Ltd. were clamped vertically with the bottom end fitting 
and seals in place (seals etc from HPLC Technology). Dry Synsorb was 
poured into the column and the packing was achieved by using the 
vibrations from a glass engraver (Burgess Power Tools Ltd.) It was found 
to be advisable to use a guard column (5 cm long) which was packed in a 
similar way. The column was plumbed as indicated in Figure 9 and 
equilibrated with at least 50 ml PBS at Iml/minute.
Antisera was loaded onto the column in a cyclical manner. 
Antibody was drawn into the pump chamber from the reservoir using a 
syringe. Once the pump was started and UV absorbing material had 
reached the detector, the column output was directed back into the 
reservoir. After adsorption the supernatant was collected and the column 
washed with PBS or water until the detector indicated that there was no 
UV absorbing matter in the system.
Elution of adsorbed material was achieved using an increasing 
gradient of" ammonia with two pumps under the control of the solvent 
programmer. Once the elution conditions had been established subsequent 
runs employed discreet ammonia concentrations which were pumped through 
the column using one pump alone. Column supernatants and fractions were 
concentrated using Am icon concentration units (Am icon). Antibodies were 
tested for haemagglutination and on SDS-PAGE.
5.4 Fraction Testing: Haemagglutination
Fractions were doubling diluted in 0.15 M NaCl in wells of 
'V-bottom microtitre plates using a four channel dispenser-d i lu ter 
(Hamilton Micro lab MT4, V. A. Howe and Co. Ltd.). Aliquots (50 pi) of red 
cell suspensions (0.5 % of packed washed cells) in 0,15 M NaCl containing 
1.0% BSA were added to fraction dilutions; antibody-free wells were incl-
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F
Figure 9. HPLAC. Scheme of High Performance Liquid Affinity Chromatography.
In the loading mode (dotted lines), the MAh sample was drawn from reservoir 
(A) through the pump and into the columns packed with Synsorb. After 
passing through the UV detector (280 nm) the output was directed back into 
A to cycle through the column. In the washing and elution modes, PBS or 
ammonia dilutions were selected from B and pumped through the system. 
Fractions were collected manually (F).
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-tided as controls. After gently shaking for 30 minutes on a Rotatest 
rotary shaker (Luckhams), plates were centrifuged at lOOOrpm for three 
minutes in a Digifuge centrifuge (Heraeus Christ, V. A. Howe and Co. 
Ltd.).
Plates were sloped at an angle of 40" and titres determined 
when the central button of cells in the control had completely streaked. 
The titre was taken as being the highest dilution of the fraction which 
still held the cell button intact. The titre figures were estimates for 
internal comparison purposesj the high figures obtained possibly 
reflected carry-over between wells when diluting fractions. However the 
titre figures were consistent (within one doubling dilution) for repeat 
determinations.
5.5 Fraction Testing: SDS-PAGE
Sodium dodecyl suIphate-polyacrylam ide gel electrophoresis 
(SDS-PAGE) was carried out as detailed in LKB application note 306 (LKB) 
using the imidazole system. Gels of 7.5% composition (T=7.5 %, 0=2.6 %) 
were poured into a cassette with a 1.5 mm gasket (approximately 40 ml 
of gel solution was required) and allowed to polymerise at room 
temperature. Samples to be run were reduced with DTT at 100°C for two 
minutes; bromophenol blue was added as a marker and 5 pi or 10 pi 
samples added .to the preformed slots in the gel, which had been 
pre-electrophoresed for 30 minutes at 20mA (constant current) and a 
field strength of 10 V/cm. The run was at 50mA for approximately three 
hours. Immediately after the run the plates were fixed in the 
appropriate fixing solution for at least one hour before staining using 
either Coomassie blue or the Bio-Rad silver stain.
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6 Enzvme-Antibody Conjugation
6.1 The Glutaraldehyde Method.
Two conjugation experiments were carried out using the 
glutaraldehyde method as described [Avrameas 19693.
6.1.1 The Glutaraldehyde Method: Experiment I.
In glutaraldehyde method, Experiment I the conjugation was 
performed on an affinity adsorbent (Synsorb”). A 2.0 ml sample of 
monoclonal anti-A TCS (coded 1, Table 9, Page 91) was rolled in a plastic 
Universal tube containing 0.1 mg of Synsorb-A at 4*C for two hours. 
Unbound material was washed with four volumes of PBS, pH 7.4 and two 
volumes of water.
A one millilitre volume of 0.2 % (v/v) glutaraldehyde solution 
in PBS was added to the tube containing the bound MAb. After rolling the 
tube for two hours at 4X, the Synsorb-A was washed as described above.
A sample of alkaline phosphatase (Sigma, code P5521) which had been
previously centrifuged at high speed on a Eppendorf centrifuge, was
resuspended in 2.5 ml of PBS, pH 7.4 and purified of ammonium salts on 
Sephadex G25 (PD10 column). A four-fold molar excess of alkaline
phosphatase was added to the tube and rolled for two hours at RT. The 
Synsorb was washed and bound material eluted with 1 ml of 2 % ammonia 
solution (v/v in PBS) by rolling for one hour at 4*C. The eluate was
removed. A further 0.5 ml aliquot of ammonia solution was rolled with 
the Synsorb as before. The eluate was pooled with that obtained before 
and freeze-dried overnight.
The 'conjugate' was characterised by ELISA using immobilized 
liquid saliva diluted 1/50, 1/100, 1/200 and 1/400 in CB. The 'conjugate' 
was diluted 1/1000 in PBS-T and 250 pi volumes added to washed plate 
wells overnight at 4eC. After washing wells with PBS-T three times, 
substrate solution was added for two hours at 37X. The HAG titre of the
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'conjugate1 was determined.
6.1.2 The Glutaraldehyde Method; Experiment II.
In glutaraldehyde method, Experiment II anti-A MAb (coded 1, 
Table 9, Page 91) was purified by SEC on an Ultragel 1.5 column. A 
solution of MAb containing 2 mg/ml antibody as estimated by the A280 
value was prepared.
One milligram of this MAb was mixed with a two-fold molar 
excess of alkaline phosphatase (Sigma, code P5521) diluted to 1.0 ml with 
PBS. Two pi of Grade I glutaraldehyde solution (Sigma, G5882), equivalent 
to 0.2% was stirred gently at RT for two hours with the MAb enzyme 
mixture. The reaction mixture was made up to 2.5 ml with PBS and 
purified on Sepahadex G-25, eluting with PBS,
The product was fractionated on an Ultragel 1.5 SEC column and 
2.0 ml fractions were collected. Fractions were tested for enzyme and 
HAG activity. Several fractions were pooled and tested by ELISA. Enzyme 
activity was assessed by taking 5 pi of fraction, 120 pi of substrate 
solution (Page 84) and adding 120 pi of 0.5 M NaOH after 35 seconds. The 
A405 was measured after this time. The ELISA testing was carried out on 
microELISA plates (Dynatech M129B) coated overnight with liquid saliva 
dilutions. Pooled fractions diluted in PBS-T were incubated in washed 
wells at 37X  for 90 minutes. After washing, substrate solution was 
added to wells and incubated overnight at 37X  before reading at 405nm.
6.2 Enzyme-Antibody Conjugation; The Periodate Method.
Two conjugation experiments were carried out using the 
periodate method CNakane and Kawaoi 19743.
6.2.1 The Periodate Method: Experiment I
In HRP Conjugation, Experiment I, 5 mg HRP (Sigma code P8375) 
was dissolved in 1.0 ml of water and 0.5 ml of freshly prepared 0.1 M 
sodium periodate was added and mixed gently for 30 minutes at RT. Three
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drops of ethylene glycol delivered by narrow-bore Pasteur pipette were 
added and mixed for a further 5 minutes. Unreacted material was removed 
by passage through Sephadex G-25 (Pharmacia PD10 columns) eluting with 
0.001 M sodium acetate, pH 4.5.
Anti-B MAb (coded 11, Table 9, Page 91) was purified by SEC to 
produce a 2,5 mg/ml solution as described above. 3.5 ml of activated HRP 
prepared as above was mixed with 0.5 ml of anti-B MAb (80:1 molar ratio) 
and immediately 350 pi of 1 M sodium carbonate buffer, pH 9.0 was added. 
The mixture was agitated gently for two hours at RT. A 200 pi sample of 
freshly prepared sodium borohydride (2 mg/ml in water) was mixed in and 
the reaction mixture was left for two hours at 4eC before purification 
and characterisation.
The crude conjugate was fractionated on an Ultragel 1.5 SEC 
eluted with PBS, pH 7.4. The HAG titre of each fraction was determined 
as described above. The enzyme activity was determined as follows:
From each fraction, 20 pi . was mixed with 230 pi of HRP 
substrate solution in micro titre plate wells and the A630 read 
immediately. The substrate solution was prepared by mixing 5 mg ABTS 
(Sigma code A1888) in 10 ml of citrate-phosphate buffer, pH 5.0 and 20 
pi of 20 volume H202..The substrate solution was prepared fresh before 
each assay. The ELISA activity was prepared as described for the 
glutaraldehyde conjugation experiments.
6.2.2 The Periodate Method: Experiment II
In a second HRP conjugation Experiment (ID a similar procedure 
was followed using a molar ratio of HRP.TgM of 4:1 and 8:1. The 
conjugates were analysed as described above.
6.3 Enzyme-Antibody Conjugation: The SPDP Method.
The SPDP method of Carlsson et al. [ 1977] was used to conjugate 
samples of monoclonal anti-A and anti-H to alkaline phosphatase.
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6.3.1 Experiment I.
Preparation of MAb.
Monoclonal anti-A (coded 8, Table 9, Page 91) was purified on an 
affinity immunoadsorbent, Synsorb”, as previously described. A 18.0 ml 
sample of TCS was purified in four successive stages on an affinity
column packed with Synsorb” A. Sample loadings of 5.0 ml, 5.0 ml and 8.0 
ml were followed by the combined supernatants left from the first three 
purification runs. The antibody peaks eluted after using an ammonia (in 
PBS) concentration of 0.5% were pooled and concentrated. The product had 
less than 20 pg/ml BSA as analysed by SDS-PAGE. It had a titre of 
1/1024 and an estimated protein concentration of 0.32 mg/ml (using
e280= 1.2 M-1 cm-1 [Jarvis and Voss 19813).
Pyridylthiolation of Anti-A.
Approximately 0.16 mg of anti-A was made up to 2.5 ml with PBS, 
pH 7.2. Ammonium salts which may have been present following elution 
from the Synsorb” HPLAC column were removed by passing the purified MAb 
down a Sephadex G25 column (PD10, Pharmacia) equilibrated with PBS. The 
eluate (3.5 ml) was collected and mixed with 3 pi of a 0,1 pM solution
of SPDP in ethanol. The SPDP solution was made 100 times too weak in
error in this experiment (SPDP, Experiment I) so that the effective 
initial Molar ratio of SPDP:IgM instead of being 12:1 was only 0.18:1.
The reaction mixture was incubated in a water bath at 23"C for 
30 minutes, prior to mixing with thiolated alkaline phosphatase. 
Pyridylthiolation of Alkaline Phosphatase.
A total of 2 mg of alkaline phosphatase (Sigma, coded P0905) 
was mixed with 34 pi of 10 mM SPDP solution (in ethanol) ie an effective 
initial ratio of SPDP :alka line phosphatase of 24:1 (MW of alkaline 
phosphatase = 140,000). The reaction mixture was allowed to react at 
23"C for 30 minutes and then made up to 2,5ml with PBS, pH 7.4.
The preparation was equilibrated with 0.1M sodium acetate
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buffer, pH 4.6 using Sephadex G25. A sample was removed and the 
Incorporation of 2 pyrldyl disulphide groups was determined 
Determination of the incorporation of 2-pyridyi disulphide groups.
A 2.0 ml sample of pyr idyl thiolated alkaline phosphatase (half 
of the original amount used) had DTT added to it to a concentration of 
50 mM. After a 20 minute incubation at 20*0 the change in absorbance at 
343 nm was determined. The calculation is shown in the results, page 
246.
Thiolation of alkaline phosphatase.
The remaining 2.0 ml of pyr idyl-thiolated alkaline phosphatase 
« 1.0 mg) had DTT added to it to a final concentration of 25 mM and 
was incubated at 20*C for 20 minutes. The sample was made up to 2.5 ml 
and chromatographed on Sephadex G25 equilibrated with PBS, pH 7.4.
Enzyme-An tibody Conjuga tion.
A volume of enzyme preparation (280 pi) equivalent to at most 
0.5 nmoles alkaline phosphatase was mixed with the antibody preparation 
(0.16 nmoles) ie a Molar ratio of 3:1. The enzyme-an tibody mixture was 
incubated overnight at 4*C prior to characterisation to allow complete 
disulphide in ter-change.
Characterisation of Enzyme-An tibody ’Conjugates1.
The material from SPDP Experiment I and subsequent conjugations 
was characterised by haemagg lut ina tion (as previously described), for 
enzyme activity and in an ELISA,
The enzyme activity was assessed by mixing 5 pi of crude 
conjugate with 245 pi of pNPP substrate solution (prepared as described 
on page 84). The absorbance at 405 nm was followed. The ELISA activity 
was assessed using micro titre plates coated with liquid saliva diluted 
1/100, 1/500 and 1/1000 as described for the ELISA standard method 
(page 90).
Other alkaline phosphatase conjugates were produced using the
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SPDP method:
6.3.2 The SPDP Method: Experiment II.
Monoclonal anti-H conjugates.
Four column chromatography runs on Ultragel 1.5 size exclusion 
chromatography columns using a total of 13.0 ml of MAb TCS coded 21, 
(page 91) were performed. The excluded peaks were pooled for fractions 
having HAG titres of > 1/512 against group 0 red cells and concentrated 
using Am icon concentration units.
A 2.5 ml volume of concentrate with a titre of 1/8000 and a 
protein concentration estimated at 2,18 mg/ml (A280=2.57) was produced. 
SPDP Experiment II, Pyridylthiolation.
A molar ratio of SPDPilgM of 12:1 was used for a 0,5 mg sample 
of IgM (ie 10 pi of a SPDP solution containing 1.87 mg/ 10 ml ethanol).
In the alkaline phosphatase pyridylthiolation step, 2.8 mg of 
alkaline phosphatase (264 pi of 10.6 mg/ml) was mixed with the
equivalent of 480 nmoles of SPDP (24:1 ratio) and incubated as above. In 
all other respects SPDP Experiment II proceeded as Experiment I.
6.3.3 The SPDP Method: Experiment III.
Monoclonal anti-H (coded 21) was prepared as for SPDP, 
conjugation II. SPDP was reacted with 0.5 mg amounts of purified
antibody in the ratio 15:1, 35:1 and 70:1. The ratio of SPDP to alkaline
phosphatase was 40:1.
6.3.4 The SPDP Method: Experiment IV.
An attempt was made to react any native thiol groups on
monoclonal anti-H IgM antibody with the pyrldyl disulphide reagent. le 
the antibody was not pyr idyl thiolated before conjugation with 
dérivâtised, reduced enzyme.
6.3.5 The SPDP Method: Experiment V.
Anti-B monoclonal antibody (coded 11) was purified on a size
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exclusion column. Three runs of a sample size of 5 ml of TCS produced 
purified antibody after concentration of 2.52 mg/ml as estimated by the 
absorbance at 280 nm. One milligram amounts of the IgM were reacted 
with SPDP in the ratio of 1:12, 1:50 and 1:200. The initial ratio of 
SPDP .‘alkaline phosphatase was 40:1 and the ratio of mixing dérivât ised 
enzyme with antibody was 3:1.
A summary of the five conjugation experiments is given in the 
results section, Table 44.
6.4 Enzyme-An tibody Conjugation: The Avidin-Biotin System
6.4.1 Materials,
MicroElisa plates (M129B) were from Dynatech Laboratories 
Ltd.'V'-bottom plates were from Sterilin Ltd.
Affinity-purified anti-A, anti-B and anti-H were kindly donated 
by Dr Baker, Chembiomed Ltd. N-Hydroxysuccinimidobiotin (NHSB), biotin 
hydrazide and avid in-alkaline phosphatase conjugate were from Sigma Ltd. 
Monomer ic avid in conjugated to agarose was also from Sigma Ltd. 
Phosphate buffered saline (PBS) tablets were from Oxoid Ltd. All other 
reagents were of analytical grade from Sigma Ltd unless otherwise 
stated.
Saliva was immobilized in 0.1M phosphate buffer pH 8.0. (13.18 g 
Na2HP0A and 0.99 g NaH2P04 in 1 L H20). Diluent and wash buffers were 
PBS containing 1.0% BSA (Ortho Diagnostic Systems Ltd. and 0.05 % Tween 
20. Substrate buffer was 10% diethanolamine buffer pH 9.8. Substrate 
solution was p-nitrophenyl phosphate (1 mg/ml) in substrate buffer.
Reagents were dispensed from a Titertek Autodrop; plates were 
washed in a Titertek Microplate Washer 120, both from Flow Laboratories. 
Plate absorbances were read in a MR580 double beam plate reader at 
405nm (reference filter at 630nm), from Dynatech Ltd, under software run 
on an Apple lie micro.
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6.4.2 The NHBS Method.
Antibody (0.1-2.0 mg/ml) was transferred to 0.1M NaHC03 buffer 
(pH 4.5) by dialysis or gel filtration on Sephadex 025 (PD10 column, 
Pharmacia Ltd). Various ratios of NHSB dissolved in d ime thy If ormam ide 
©MF) were allowed to react for two hours with gentle stirring at room 
temperature.
The product was dialysed overnight against PBS and was ready 
for use after the addition of BSA (1 %) and sodium azide (0.02 %).
6.4.3 The Biotin Hydrazide Method.
Antibody (lmg/ml) was oxidised by using lOmM sodium periodate 
in 0.1M sodium acetate buffer, pH 5.5 for 20 minutes at OX. Excess 
periodate was inactivated by adding glycerol for a further 5 minutes. 
The oxidised preparations were dialysed overnight against 0.1M acetate 
buffer. Bio tin hydrazide (5.0-10.0 mM) was added and allowed to react for 
two hours at RT. Products were dialysed against PBS prior to use.
Conjugates were tested for activity in ELISA and 
haemagg lut ina tion. In most cases conjugates were concentrated following 
synthesis using Am icon concentrators (Type B15, Am icon Inc.).
6.4.4 Affinity Purification of Conjugates
Some conjugates were purified by the use of a monomeric
avid in-agarose column. Columns were prepared from short plastic tubes 
(2.5 ml Eppendorf Combitips: Anderman and Co. Ltd). The tube was plugged 
with a porous support. A slurry of avid in-agarose was poured into the 
'column' and allowed to settle. The column was equilibrated with 25 ml of 
PBS (10 column volumes).
Crude biotin antibody conjugates (0.5 ml) were loaded onto the 
column and recycled using a LKB 2120 Varioperpex II peristaltic pump
with a flow spectrophotometer (2138 Uvicord S and LKB 2-channel
recorder) in-line for one hour at 1 ml/minute. The unbound material was 
collected and the column washed with 10 ml PBS. Bound material was
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eluted with PBS containing biotin (lmg/ml) and 2ml fractions collected on 
a LKB 2070 Ultrorac II. The column was regenerated with 0.1M glycine-HCl 
buffer, pH 2.2.
6.4.5 ELISA testing of conjugates.
MicroELISA plates were rinsed once with PBS. Liquid saliva 
freshly donated by secretors of blood groups A, B and 0 was frozen 
immediately after collection. Thawed samples were diluted 1/500 in 0.1M 
phosphate buffer (pH 8.0) and immobilised at 37*0 for two hours. Plates 
were aspirated and rinsed three times, including a ten minute soak stage 
with wash buffer. Biotin conjugates were diluted in diluent buffer and 
allowed to react at 37*0 for two hours.
The following blanks were included on each plate:
Non-Specific Binding Blank 
Saliva
Diluent buffer 
Avidin-alk.phos. 
Substrate solution 
Plates were washed as above. Avid in-alkaline phosphatase
(lmg/ml) was diluted 1/1000 in diluent buffer and incubated in plate
wells for five minutes. Plates were washed as above and substrate
solution incubated for typically 20 minutes at room temperature before 
reading at 405nm. All aliquots were 100 pi.
Some ELISA tests were performed with a pre- incubation of
bio tiny la ted antibody with avid in-alkaline phosphatase conjugate for 30 
minutes at room temperature prior to addition of these mixtures to plate 
wells coated with saliva in the usual way.
Sample Blank 
Phosphate buffer 
Biotin-antibody 
Avidin-alk.phos. 
Substrate solution
6.4.6 Other Work.
Conjugates produced by Experiment IV were mixed in varying 
proportions with commercial avid in-alkaline phosphatase. Volumes of 50
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or 100 pi of crude bio tin-MAb conjugates were mixed with 5 or 10 pi of 
commercial avidin-alkaline phosphatase conjugates (lmg/ml). A 1ml volume 
of PBS (pH 7.4) and BSA to 0.1% was added to each mixture prior to 
storage at 4eC, These 'MAb-alkaline phosphatase' conjugates were tested 
by ELISA using plates coated with dilutions of liquid saliva as described 
above. The pre-mixtures were diluted 1/100 and incubated for two hours 
at 37eC. After washing as described above, substrate solution was added 
and plates read after one hour and again after an overnight incubation 
at 4°C.
Capture Assay
Monoclonal anti-A (coded 1) from Chembiomed Ltd was diluted 
1/1000 in 0.1M phosphate buffer and immobilized in microElisa plates for 
two hours at 37X. Plates were washed as described above but with BSA 
to 1.0% in the soak stage. Dilutions of bloodstain extracts (group A, B 
and 0 bloodstain, 1/100 in PBS Tween) prepared as described above, were 
incubated at 37 X  for one hour. After washing, pre-mixtures of 
biotinylated MAb and commercial avidin-alkaline phosphatase (diluted 
1/100 and 1/1000 respectively in PBS Tween) were incubated for two 
hours at 37X. Plates were washed and substrate solution added. Plates 
were read after one hour,
Haemagg lut ina tion analysis of conjugates was performed as 
described above. The titres obtained were higher than expected given the 
low values obtained by other workers for commercial MAb but may reflect 
the low protein concentrations in the fractions used. Additionally 
carry-over between wells when diluting conjugates may have also 
contributed to these figures.
6.5 Conjugate Testing By Post-Column Reaction Detector.
The majority of the apparatus including columns and pumps have 
been referred to above (HPLAC). The reaction column was a steel tube of
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dimensions 60 x 0.7 cm. It was filled with glass beads (Diameter = 10 
mm, supplied by HPLC Technology) treated to retard protein adsorption .
Substrate solution was 0.1 M 4-methylumbe 11 ifery 1 phosphate in 
100 ml glycine (7.5g/l) - NaOH (0.1M) buffer (mixed 1.27 glycine 
solution: 1 part NaOH, pH 10.3). Phosphate buffer for the sample
separation (column A) was 0.01 M PB, pH 6.8.
The configuration of the apparatus is shown in Figure 10. 
Samples of commercial or synthesised conjugate (10 - 50 pi) were
injected into the sample injection device manually. After separation by 
size exclusion in column A (LKB TSK 3000) at a flow rate of 0.5 or 1.0 
ml/min. the separated sample passed into column B where it was mixed 
with substrate solution. The in-line fluor ime ter was set at an excitation 
wavelength of 360 nm close to the published value for this substrate. 
The emission wavelength was determined, by trapping a peak of enzyme 
activity, to be 447 nm.
In some tests peak fractions were collected manually into 
plastic tubes for analysis by ELISA as follows. Liquid saliva was diluted 
1/10 to 1/4000 in coating buffer (CB, pH 9.6) in wells of microELISA 
plates. After a two hour incubation at 37X the plates were rinsed three 
times with PBS-T containing 0.1% BSA including a 15 minute soak stage. 
Monoclonal anti-H (MAb 21, Table 9) diluted 1/100 in PBS-T was mixed 
with fractions collected as above. The effective fraction dilution was 
1/2000 of the original 10.pl of conjugate. After a two hour simultaneous 
incubation at 37 X plates were washed and substrate solution added. The 
corrected A405 (for ASB) was determined after 30 minutes substrate 
incubation time.
Specific details of methods are given in the context of the 
results obtained.
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SUBSTRATE SOLUTION PBS
I
PUpP B
PUMP A
SAMPLE INJECTOR (S)
SEC COLUMN 
(TSK 3000)
FLUORESCENT DETECTOR
REACTION COLUMN
WASTE
Figure 10. Post-Column Reaction Detector.
Enzyme-antibody conjugates (50 to 200 fil) were injected through the manual 
sample injector (S) and separated by size on the TSK 3000 column in PBS 
pumped by pump B. Substrate solution (see text) was pumped by pump A and 
the conjugate fractions were mixed in the reaction column. The fluorescence 
was detected by the detector linked to a chart recorder.
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CHAPTER 1 ABO Grouping of Saliva bv ELISA Using Polyclonal Antisera
1.1 Early Work.
An initial experiment involved the detection of A and B blood 
group substances in liquid saliva. The results are presented in Table 12.
An apparent discrimination between A and B saliva is evident 
from the results. Anti-A directed against group A saliva gave a deeper 
end-point colour than anti-B against the same saliva. Two commercially 
available enzyme-an tibody conjugates were compared in this two-stage 
indirect ELISA. The anti-IgG enzyme-an tibody conjugate reacted marginally 
better than the anti-IgM one although no attempts were made to equate 
their titre.
It was not possible to draw any conclusions from a comparison 
of ’squirt-washing' and immersion-washing of plates given the subjective 
assessment of reaction endpoints in this experiment.
A 1:1 mixture of anti-IgG and anti-IgM enzyme conjugates did 
not enhance the discrimination of positive and negative reactions. Other 
work using polyclonal anti-A and anti-B sera from the Blood Group 
Reference Laboratory (BGRL) Oxford, gave similar results to those 
presented in Table 12 without any clear-cut discrimination between 
positive and negative reactions. In routine blood-grouping (A/E) these 
antisera would have been used at dilutions of 1/16 to 1/32 against 
saliva and saliva stain extracts.
Previous work in this area (Werrett unpublished results) with 
commercially available blood grouping sera (anti-A and anti-B) had met 
with some success.
The influence of the dilution saliva and commercial antisera on 
the detection of A and B bloodgroup substance in liquid saliva by ELISA 
was investigated. The results in the form of reaction scores for the 
reaction of anti-A are shown in Figures 11 and 12.
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TABLE 12
DETECTION OF SALIVARY BLOOD GROUP SUBSTANCE BY ELISA 
INFLUENCE OF WASH MODE AND CONJUGATE TYPE
Colour Score*
A SECRETOR SALIVA B SECRETOR SALIVA
Conjugate: Anti IgG Anti IgM Anti IgG Anti IgM
Plate wash 
Antibody
mode:
Dilution
S/W I/W S/W I/W S/W I/W S/W I/W
Anti-A 1/10 6 5 5 4 2 2 1 1
1/20 5 4 4 3 1 1 1 1
1/40 3 2 2 1 0 <1 <1 <1
Anti-B 1/10 3 2 2 1 5 4 4 3
1/20 2 1 1 1 4 3 3 2
1/40 <1 <1 <1 <1 2 2 2 2
Sample blank (le no saliva) Antl-A: <1
Anti-B: 0
Antibody blank 0
Conjugate blank 0
The standard method (materials and methods) was followed with the following 
modifications: -liquid saliva was diluted 1/50 in coating buffer. Plates 
were washed by either a squirt wash (S/W) or immersion washing (I/W) with 
PBS. Antibody was diluted as above; anti-human IgG or IgM alkaline 
phosphatase conjugates were compared. All reagent aliquots were 200 pi.
a) After 1 hour results were assessed visually and scored 0-6 with 6 for 
deep colouration and 0 for no apparent colour.
In each case a single donor of each saliva type was used.
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Figure 11. ELISA for Salivary Blood Group Substance.
The reaction of polyclonal anti-A with group A liquid saliva. 
The effect of saliva dilution on Reaction Score. The details of 
the method are in the text.
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Figure 12. ELISA for Salivary Blood Group Substance.
The reaction of polyclonal anti-A with group B liquid saliva. 
The effect of saliva dilution on Reaction Score. The details of 
the method are in the text.
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Sample blanks were of the order of A405= 0.08 - 0.12 with 
slight variations for antisera dilution. The liquid saliva had been 
immobilized some 30 days prior to the completion of the experiment which 
must be noted when comparing these results with subsequent experiments. 
Otherwise the method was as described in the methods section, page 86.
After 40 minutes substrate incubation, optimum discrimination 
was at a saliva dilution of 1/40 to 1/80 (for group A saliva, antibody 
diluted 1/10 to 1/20). At low saliva dilution (1/10) lowered reaction 
scores were obtained for group A saliva. This may have been due to 
overcoating of the plate with salivary protein leading to multi-layered 
protein coats; washing procedures may have destabilised the upper layers 
leading to loss of subsequently captured antibody or conjugate or both. 
Additionally prolonged storage of precoated microtitre plates may have 
destabilised salivary protein with similar consequences.
As antibody dilution increased (1/40 to 1/160) the negative 
reactions (ie anti-B against A saliva, not shown and anti-A against B 
saliva) had higher RS values (up to 2.0) presumably due to more antibody 
or conjugate attaching to empty binding sites on the so lid-phase. There 
was an inverse relation between reaction score and the antisera 
concentration in negative reactions. This may have been due to blocking 
of the so lid-phase or masking of some components of the immobilized 
saliva by high levels of antisera leaving less possibility of cross­
reaction between subsequently added conjugate with the so lid-phase or 
saliva. As the antisera was diluted (eg out to 1/160) there was more 
chance of this type of cross-reaction happening. Negative reactions also 
exhibited, to some extent, an over-coating effect suggesting that other 
reactions were happening besides the intended ones such as non-intended 
attachment of the antibody and conjugate.
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1.2 Assessment Trial.
Prior to the setting up of an assessment trial to group liquid 
saliva for A or B blood group substance, the system that was to be used 
was evaluated to determine at what levels positive-negative thresholds 
would be set. This was to ensure that group 0 saliva would not be 
incorrectly grouped.
Only group A and B saliva from secretors could be detected 
unequivocally in this system: all other ABO groups must be assessed as 
•no result' because of the uncertainty involved in grouping non-secretors 
with low blood group substance levels. On the basis of this trial and 
others (data not presented), the following acceptance limits were 
established:
1. Where only one line (in the sense of an anti-A line, for 
example) gave a reaction score which was > 5.00 and also > 10.00 at a 
dilution of liquid saliva of 1/100, the donor of that sample secreted the 
corresponding blood group substance (e.g. A substance) strongly into 
their saliva.
2. Where only one line gave a reaction score > 5.00 but < 10.00 
then the donor secreted the corresponding substance weakly, or was a 
non-secretor as defined by Lewis typing.
3. Where both lines gave reaction scores > 5.00 then the donor 
secreted both A and B blood group substance into their saliva (group AB 
secretor).
4. Reaction scores < 5.00 in both lines could not be 
unambiguously interpreted; they indicated that the donor was one of the 
following: group 0 secretor, or non-secretors of groups A, B, 0 or AB.
In the actual trial liquid saliva samples from 50 laboratory 
donors were processed as described in the methods section. The results 
expressed as reaction scores are presented in Table 13 and summarised 
in Table 14.
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TABLE 13
ASSESSMENT TRIAL FOR LIQUID SALIVA
Reaction Score*
Antisera: 
D1lution: 1/50
Antl-A
1/100 1/200 1/50
Anti-B
1/100 1/200 Result
Group A 
Secretor
Donor
1 16.43 12.43 11.07 2.63 2.25 1.88 A
2 15.93 14. 14 13.43 2. 19 3. 13 2.31 A
3 20.00 13.86 14.00 2,69 2,31 2.06 A
4 18.29 14.14 12.43 3.81 2.94 2.50 A
5 12.86 11.29 10.21 2.75 2. 13 1.50 A
6 19.86 19. 14 15.50 2.31 1.63 0.38 A
7 16.07 11.29 8.43 2.25 4.06 1.25 A
8 10.00 11.36 12.07 1.19 2.44 2.94 A
9 15.71 14.14 12.71 2.94 3.13 3.50 A
10 12.93 12.07 10.36 2.44 1.94 2.56 A
11 19.43 13.71 21. 14 4.38 3.25 2.75 A
12 15.86 15.50 12.86 2.94 2.75 2.50 A
13 18.43 17.50 16.00 1.25 1.94 1.63 A
14 21.86 17.64 12.93 1.88 2.00 1.56 A
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TABLE 13 CCONT.>
ASSESSMENT TRIAL FOR LIQUID SALIVA
Reaction Score*
Antisera: Ant i~A Ant i-B
Sample
Dilution: 1/50 1/100 1/200 1/50 1/100 1/200 Resul
Group A 
Non-secretor
Donor
15 5.43 4.14 4.14 4.69 2.81 2.50 NR
16 10.71 4.29 3.43 3.81 3.69 2.44 NR
17* 6,43 5. 50 4.64 3.75 2. 13 2.06 A
18b 5.00 7.79 6.71 3. 56 3.25 4.81 A
19 3. 14 4.29 4.29 3.25 3.50 3.44 NR
20 4.29 6. 50 4.64 3.69 3.88 2.94 A
21 2.64 2.57 2.50 1.38 1.75 1.81 NR
22 7.64 5,86 5.79 2.63 1.50 1.81 A
Group B 
Secretor
23 3.93 3.79 4.29 14. 13 10.63 9.63 B
24 1.43 1.57 2. 14 7.44 6.69 4.88 B
25 2.57 3.85 2.29 9.06 10. 13 8.44 B
26 3.14 2.36 3.00 8.44 7.88 4.44 B
27 2.79 4.71 3.71 11. 19 11.44 4.88 B
28. 3.71 3.21 3.50 12.24 12.36 6. 63 B
RESULTS: CHAPTER 1 Page 127.
TABLE 13 (CONT.>
ASSESSMENT TRIAL FOR LIQUID SALIVA
Reaction Score*
Antisera:
Sample
Dilution:
Donor
1/50
Antl-A
1/100 1/200 1/50
Ant i-B
1/100 1/200 Result
Group 0 
Secretors
29 3.86 3.64 3.29 3.94 3.56 2,88 NR
30 2. 14 1.57 2.29 3.06 0.75 1.50 NR
31 2,00 2.86 3.36 3.88 3.63 2.75 NR
32 3.79 3.57 6.93 2.25 2.88 2.00 NR
33 2.86 1.21 4.50 2,31 2.38 3.31 NR
34 1.93 1. 14 1.71 2.44 1.63 0.88 NR
35 2.65 2.43 3,00 1.31 1.50 1. 19 NR
36 1.50 4.71 5.07 1.56 1.56 1.94 NR
37 3.29 2.07 2.00 2.38 0.88 0.31 NR
38 1.50 1.14 1.50 1.44 1.00 0.44 NR
39 2.64 3.71 2.86 2.69 2.56 1.69 NR
40 2.43 2. 14 7.42 3.25 3.00 3.00 NR
41 3.50 4.21 2.71 3. 19 3.81 2.25 NR
42 2.27 2.07 2.07 2.56 3.25 5.88 NR
43 3.71 4.93 3.93 3.63 4.38 2.56 NR
44 3.79 3.50 2.29 3.69 4.56 2.25 NR
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TABLE 13 (CONT.)
ASSESSMENT TRIAL FOR LIQUID SALIVA
Reaction Score*
Antisera: Antl-A Antl-B
Sample
Dilution: 1/50 1/100 1/200 1/50 1/100 1/200 Result
Donor
Group AB 
Secretors
45 16,43 14.43 11.29 11.38 8.38 5.69 AB
46 11.71 13.07 12.00 9. 31"" 10.50 8.63 AB
47 12.43 14.29 11.14 8.31 7.88 9.63 AB
48 15.21 13.21 11.57 14.69 12.25 9.44 AB
Group AB 
Non-secretors
49* 16.29 15.21 12.29 12.44 12.75 8.12 AB
50* 9.86 10.36 9.79 10.13 10.00 4,31 AB
a) Reaction Score was calculated as (A405 test/A405 blank)-!. Each test was 
performed in duplicate. The value of the sample blank was as follows:
Anti-A Sample Blank A405 0.06
Anti-B Sample Blank A405 0.08
b) These samples were typed as Lewis a-b-. Secretors were typed a-b+ and
non-secretors as a+b-. NR= not reportable.
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TABLE 14
ASSESSMENT TRIAL FOR LIQUID SALIVA 
SUMMARY OF RESULTS
Blood Group Lewis Type* No.Samples Correct Incorrect No Result*
A a~b+ 14 14 0 0
a+b- 6 2 0 4
a-b- 2 2 0 0
B a-b+ 6 6 0 0
a+b- 0 0 0 0
0 a-b+ 9 0 0 9
a+b- 7 0 0 7
AB a-b+ 4 4 0 0
a+b- 0 0 0 0
a-b- 2 2 0 0
Totals 50 30 0 20
a) Lewis type a-b+ secrete ABH blood group substances into body fluids
a+b- do not secrete blood group substances
a-b- may or may not secrete blood group substances
b) NR = results less than acceptance limits.
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All samples were grouped correctly using the acceptance criteria 
with no false positives or negatives being recorded. A range of activity 
in positive samples can be seen from inspection of the results. For 
example sample 18 (Group A Le a+b-) with a reaction score of 7.79 was 
at the lower level of activity for a positive sample while samples 13 
and 14 with reaction scores of over 17.0 were at the higher end of the 
range. Group A substance was detected (e.g. sample 20) in samples from 
individuals who would be considered non-secretors on the basis of their 
Lewis type.
Generally the activity of group B samples, in terms of reaction 
scores, was lower than that of group A samples possibly reflecting a 
difference in the activity of the antisera when compared at the same 
dilution (1/20). Samples grouped as Lewis a-b- (e.g. sample 17) were 
found in most cases to secrete detectable levels of either A or B blood 
group substance.
No pattern was evident amongst samples which gave reaction 
scores lower than the acceptance threshold of 5.0 against one antisera 
type. Group A and B non-secretors did not react more strongly in 
homologous reactions than did group 0 secretors below the threshold 
acceptance level of 5.0.
1.3 Other Investigations
Most of the initial investigations into the detection of 
salivary A and B blood group substances have used the same format, 
notably overnight incubation of saliva dilutions at 4*C and subsequent 
incubation of antibodies under similar conditions. The influence of 
incubation temperature on both the reaction of blood grouping anti-sera 
(anti-A and ant i-B) and anti-globulin enzyme conjugate is summarised in 
Figure 13.
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Figure 13. ELISA for Salivary Blood Group Substance.
The reaction of polyclonal anti-A or anti-B with 1) group A,
2) group B or 3) group 0 liquid saliva. Incubation temperature was 
4°C <▼), ambient temperature (1) or 37*v (•).
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Antl-A reacted equally well with saliva at 4eC or room
temperature when diluted 1/50 or 1/100, Anti-B reacted best at 4'C 
(diluted 1/50) or room temperature (diluted 1/100). No obvious advantage 
was found when incubating these antisera at 37eC. High cross-reactivity 
of both anti-A and ant i-B was noted when these antisera were directed 
against group 0 saliva especially at room temperature. This may be due 
to some cross-reacting component in the polyclonal antisera but more
likely the anti-human IgG conjugate is reacting with immobilized 
immunoglobulin from the saliva. The sample blanks were not influenced by 
the incubation temperature of the antisera (Table 15) suggesting that 
the main source of cross-reaction is between salivary substance and the 
blood grouping sera or enzyme-antibody conjugate or both.
A comparison of 'U'-bottom and flat bottom plates showed an
apparent difference when processing identical saliva samples of blood 
group A (Figure 14, Table 16) or group B (Figure 15, Table 17). In
separate experiments, liquid saliva from the same donor was diluted 
1/200 in either round bottom or flat bottom plates and processed 
according to the standard method.
The discrimination between positives and negatives is better in 
flat bottom plates than round bottom ones for both group A and group B 
liquid saliva. For negative tests the two plate-well types show little 
difference; the absorbance readings for positives in flat bottom plates 
are almost double the corresponding 'U'-bottom ones. The scatter of 
results as measured by %CV or by visual inspection of the Box and 
Whisker plots was generally greater for flat bottom plate tests.
The results for both platé-well types are skewed in a positive
direction ie tending towards higher A405 values.
The scatter of results in some tests was high (%CV = 20% for
sample vii, Figure 14, Table 16). The data for the results on a round- 
bottomed plate (original data not shown) was analysed by a modified stem
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TABLE 15
THE INFLUENCE OF TEMPERATURE ON THE DETECTION OF ABH SUBSTANCE
Sample Blanks
Antibody Dilution 4'C RT 37'C
Anti-A 1/50 0.12 0.13 0. 13
1/100 0.08 0.08 0. 10
Anti-B 1/50 0.10 0.12 0.13
1/100 0.07 0.06 0.10 .
METHOD
The standard method was used except that Lorne anti-A or anti-B was diluted 
1/50 or 1/100 in PBS-T and incubated for two hours at 4'C, RT or 37*C. 
Substrate solution was incubated in plate wells and the absorbance read 
after 50 minutes at 405nm.
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Figure 14. ELISA for Salivary Blood Group Substance.
Modified Box and Whisker Plot. The reaction of polyclonal antisera 
with group A liquid saliva. The comparison of plate-well type. The 
data are presented in Table 16.
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TABLE 16
COMPARISON OF PLATE-WELL TYPES:DATA FOR FIGURE 14 
Group A Saliva 
A405 Corrected for Sample Blank
Plate-wel1 
Type:
Antisera: Anti
Flat-
-A
■bottom
Anti-B
«
Anti
U'-bottom
-A Anti-B
Mean 1.32 1.22 0.31 0.21 0.77 0.63 0. 17 0.13
S.D. 0.061 0.115 0.032 0.087 0.044 0.063 0.034 0.020
%CV 4.6 9.4 10.3 41.4 5.7 10.0 20.0 15.4
1.21 1.04 0.23 0.07 0. 66 0.52 0.08 0.08
Range 4- I 4 4- 4- 4. 4 4-
2. 11 1.59 0.66 0.55 0.86 0.84 0.22 0.18
Blank* 0.07 0.06 0.06 0.06 0.08 0.07 0.07 0.06
R.S. 17.86 19.33 4. 17 2.50 8. 63 8.00 1.43 1.17
Sample (i) (11) (ill) (iv) (v) (vi) (vii) (vi i i)
a) The blank was the sample blank. The substrate incubation time for samples
Ci>, (ill), (v) and (vii) was 50 minutes; the remaining samples were incubated 
for 35 minutes. 48 identical aliquots were run in each sample.
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Figure 15. ELISA for Salivary Blood Group Substance.
Modified Box and Whisker Plot. The reaction of polyclonal antisera 
with group B liquid saliva. The comparison of plate-well type. The 
data are presented in Table 17.
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TABLE 17
COMPARISON OF PLATE-WELL TYPES:DATA FOR FIGURE 15 
Group B Saliva 
A405 Corrected for Sample Blank
Plate-wel1 
Type:
Antisera: Anti
Flat-
-A
•bottom
Anti-B
«
Anti
U'-bottom
-A Anti-B
Mean 0.57 0.41 1.31 0.93 0.35 0.29 0.67 0.55
S.D. 0.090 0.040 0.068 0.053 0.050 0.037 0.150 0.120
%CV 15.8 9.8 5.2 5.7 14.3 12.8 22.4 21.8
0.53 0.33 1.19 0.81 0.23 0.17 0.51 0.32
Range X 4. I 4- 4- 4. 4- 4-
0.69 0.49 1.47 1. 12 0.46 0.40 0.92 0.69
Blank* 0.07 0.06 0.06 0.05 0.08 0.07 0.07 0.07
R.S. 7.14 5.83 20.83 17,60 3.38 3. 14 8,57 6. 86
Sample (1) (11) (ill) (iv) (v) (vi) (vii) (vii i)
a) The blank was the sample blank. The substrate incubation time for samples 
(i), (ill), (v) and (vii) was 50 minutes; the remaining samples were 
incubated for 35 minutes. 48 identical aliquots were run in each sample.
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and leaf plot (Figure 16). It was clear that there was considerable 
variation across a plate with A405 varying from 0.5 to 0.8. This effect 
was seen in other such plates. The CV figures, although high, were not 
unreasonable for an unoptimised manual technique.
•U'-bottomed plates cause problems in some optical systems 
because of the focussing effect of the curved plastic. Flat bottomed 
plates are the sol id-phase of choice for most assays,
1.4 Discussion
The investigations carried out confirm the findings of others 
(Werrett, unpublished results) that an indirect ELISA using polyclonal 
sera can be applied to the detection of A and B blood group substances 
in liquid saliva with moderate success.
Saliva diluted 1/640 (equivalent to 0.40 pi original liquid 
saliva) may be discriminated in terms of A and B bloodgroup substances 
using commercial reagents using the criteria developed for the 
assessment trial. It was not possible to compare the sensitivities of 
this ELISA method with haemagg lu t ina t ion since the reagents were 
inequivalent in titre although the indications are that less material is 
required for the ELISA.
For more dilute saliva, the increase in non-specific background 
reactions in negative tests prevented discrimination. This increase in 
background may have been due to increased availability of sites on the 
plastic becoming available for attachment by blood-grouping sera and/or 
enzyme-antibody conjugate.
The pro zone or overcoating effect was noted at high antigen 
levels (saliva diluted 1/10 to 1/20, Figure 11). This effect which has a 
parallel in A/E methods, where excess antigen eluted from the stain 
combines with antiserum in solution, has been noted in several instances 
in ELISA methods [Pledger and Belfield 19833. The explanation of deso-
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Figure 16. ELISA for Salivary Blood Group Substance.
Modified Box and Whisker Plot to show the variation in a * U'-bottom 
Microtitre plate. The reaction of polyclonal anti-A with group A 
liquid saliva. The data are single A405 readings, corrected for 
sample blank.
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-rption of bound reactants at high antigen excess may be influenced by 
the affinity of the antibody. It was noted that early antibodies (in the 
immune response to Salmonella minnesota injected into rabbits) were more 
prone to this phenomenon C Bruins et ah 19783.
The presence of BSA as a diluent (at 1 %) did not aid
discrimination of positives and negatives; rather a general increase in 
reactivity of the assay was seen. At this stage it was unclear whether 
BSA either as a soak stage following immobilization or as a diluent for 
antisera was effective in reducing non-specific reaction.
Currently in forensic science laboratories, a variety of 
polyclonal (and some monoclonal) antisera are used in the detection of A 
and B blood group substances in saliva. The use of unpurified polyclonal 
sera supplied by the Oxford BGRL, and as used by the Aldermaston 
Forensic Science Laboratory was found to be less successful than 
commercially available antisera in ELISA for liquid saliva. This finding 
was similar to that in a recently published paper CBolton and Thorpe 
19863 where MAb were used to eliminate non-specific reactions in 
heterologous tests.
When commercial serum was used in ELISA and diluted beyond 
1/80, the RS for positive reactions fell below 5.00, the arbitrary 
threshold level for considering saliva samples positive (at 1/100 
dilution); concommitantly there is an increase in non-specific reaction 
for negative tests. This may be attributed to increasing reaction of 
anti-human globulin enzyme conjugates with salivary immunoglobulin 
immobilized on the polystyrene. At low dilution of antisera (1/20, 1/40), 
some fraction of the antisera (eg serum albumin), may interact with 
immobilized salivary immunoglobulin preventing - its detection by 
enzyme-ant ibody conjugate. However at higher dilutions of antisera, 
salivary Ig may become accessible for reaction with enzyme-ant ibody 
conjugate.
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The level of reaction for negative tests was unacceptable high, 
with a signal to noise ratio of up to five, indicating a significant 
source of cross-react ion. This cross-reaction showed a dilution effect 
(e.g Figure 12) but not an overcoating one presumably because the 
cross-reacting component (salivary Ig reacting with enzyme-ant ibody 
conjugate) was present at a lower level than the salivary blood group 
substances.
The two plate types were made of the same polystyrene type 
(Dynatech). An estimation of the surface area wetted in each is 
calculated in Appendix B and indicates little difference in wetted 
surface area. le flat bottom wells surface area = 187 mm2, round bottom 
wells surface area= 176 mm2.
Any difference in binding capacity was unlikely to be due to the 
different area of so lid-phase available in the two plate-well types 
alone. Plates were washed manually using a wash bottle; it was possible 
that the curved internal surface of 'U'-bottomed plate wells provided a 
better flow path for wash buffer with resultant destabilisation of 
adsorbed antigen/antibody layers. Flat bottomed plate wells have 
•corners’ where adsorbed material may be protected from over-washing. In 
fact following immobilization of liquid saliva in flat bottomed plate 
wells, an opaque halo of material was seen on the edges of the bottom 
surface. This halo was not observed in ’U'-bottomed wells. When substrate 
solution was added at the final stage of the assay, the development of 
colour appeared to originate from the area of the 'halo'.
There was no indication from these studies that an incubation 
temperature higher than 4'C improved discrimination of samples nor that 
it reduced the assay time. The standard method (1.4.1) performed 
adequately using polyclonal enzyme-antibody conjugates in flat bottom 
microtitre plates.
The use of anti-human Ig conjugates was not apparently affected
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by salivary Ig co-immobilised with bgs. The levels of salivary IgG are 
about 2000 times lower than serum IgG (saliva IgG = 0.65 mg/100 ml, 
serum IgG = 1228 mg/100 ml in Group 0 subjects). Additionally the 
amount of salivary protein (170 mg/100 ml) is lower than in serum (=25 
g/100 ml)[ Waissbluth and Langman 19713. It was also found that 
salivary Ig and total protein varied with ABO type and secretor status. 
Although the A sub-group of the donors was not indicated I found a 
range of three orders of magnitude of reactivity of anti-A with group A 
saliva samples from secretors while others have found about 25 orders 
of magnitude difference between all group A saliva samples from 
secretors using an automated haemagg lut inat ion-inhibition analyser 
[Sturgeon, Bates and McQuiston 19733. Any attempt to relate quantities
of group A and B substance using the ELISA method at the present stage
of development would be thwarted by inequivalence of antibody titres and 
affinities as well as non-ABO associated differences in saliva samples.
Although saliva is an easily obtainable source of ABO blood 
group substances there are several considerations when using this 
material as a basis of assay development. Although the forensic
scientist has no control over sample collection it is important to 
recognise that the various salivary glands secrete differing amounts of 
bgs: the sublingual and minor mucous glands contribute about 70% of the 
bgs found in whole saliva [Milne and Dawes 19733. The ABH activity in 
saliva is primarily associated with glycoproteins [ Slomiany and 
Slomiany 19783 but these will compete with salivary proteins and
immunoglobulins for the so lid-phase in an ELISA.
Only a limited number of investigations were carried out on 
liquid saliva. The use of polyclonal blood grouping sera presents 
problems in an indirect assay predominantly because of the need to use 
anti-human globulin enzyme conjugates with resultant cross-react ion, A 
complete grouping system for the ABO system must be able to deal with
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bloodstains in addition to 'problem stains' such as mixtures of body 
fluids (eg blood and sweat). The reliance on polyclonal sera which 
contain a spectrum of antibodies reacting with different degrees of 
avidity and affinity, varying from batch to batch, limits the potential 
advantages offered by an ELISA system.
The lack of an anti-H reagent which could be easily used in 
parallel in this system was a limitation. The conjugation of a lectin, 
Ulex europaeus to alkaline phosphatase [ Harris-Smith and Fletcher 
19833 , presented a solution prior to the possibilities offered by 
monoclonal antibodies. A sample of this conjugate was made available 
for testing in the standard assay system. No conclusive results were 
obtained (data not shown) although the authors had considerable success.
It was not considered appropriate to devote additional time to 
developing a complete method for salivary ABH grouping using ELISA since 
the problems posed by bloodstains were likely to require intensive study. 
Salivary blood group substances are readily soluble; in the few tests 
carried out saliva stains presented no additional problems in an ELISA 
(data not presented).
In conclusion, A and B blood group substances may be 
discriminated in liquid saliva with reasonable sensitivity but several 
problems associated with the use of polyclonal typing sera remain to be 
solved,
CONCLUSIONS
Immune ABO antiserum gave poor results in an indirect ELISA 
method for immobilized salivary blood group substances.
Commercial anti-A and ant i-B gave reasonable discrimination of 
group A, B and 0 secretor saliva in ELISA. Antisera at 1/20 to 1/40 
dilution was used against saliva diluted equivalent to 0.40 pi original 
saliva.
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The reaction of human polyclonal antiserum using anti-human Ig 
enzyme conjugates was influenced by high background reactions in 
heterlogous tests.
The effect of varying several reaction parameters was studied.
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CHAPTER 2: ABO Grouping of Blood by ELISA Using Polyclonal Antisera.
2.1 Liquid Blood.
Passive adsorption of whole cells was unsuccessful: cell layers 
were uneven and became easily detached during washing steps in a 
variable way. In addition immersion washing caused contamination of 
adjacent wells by detached cells.
Despite the use of various plate types (Dynatech flat-bottommed, 
•V'-bottommed polystyrene and PVC) no improvement in cell fixation 
occurred.
The use of glutaraldehyde alone or in conjunction with poly-1- 
lysine although leading to more stable cell layers, did not lead to real 
differences between positive and negative reactions. It was also 
difficult to assess the end results. Slight apparent differences in 
favour of those expected were obscured because the substrate solution 
(pH 9.8) caused cell lysis. .
The use of varying incubation times and the inclusion of a soak 
stage with BSA or heat treated rabbit serum did not enhance any 
apparent differences.
The use of red cell lysates did not lead to successful results.
Whole cells are usually encountered in forensic casework for 
grouping as controls. The above investigation was intended to study 
whole cells as a model for later investigations into blood-stalns. It was 
apparent that whole cells presented many practical problems and as such 
were not suitable for preliminary investigations.
2.2 Bloodstains: Earlv Work.
Bloodstains were extracted with aqueous ammonia solutions or 
ammonia diluted in PBS. These extracts possessed blood group activity as 
assessed by A/E on stains made by allowing volumes of extract to dry on
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them (Table 18). No apparent differences were observed when comparing 
the two extractants. Marginally reduced agglutination scores were noted 
for the doubly extracted stains when compared with controls which had 
been extracted only once. The agglutination scores for the detection of 
group H substance by the lectin Ulex europaeus were reduced for doubly 
extracted stains when compared with controls.
The results for ELISA on ammoniacal extracts of group A2 
bloodstains in untreated micro titre plates (Type M29AR) are shown in 
Figure 17 (anti-A) and Figure 18 (anti-B). The key to all graphical daca
summaries is given in Table 19. The RS data were summed for each
antisera dilution (1/20 to 1/160) to allow comparison of the two 
extraction methods in untreated microtitre plates (Figure 19), Dynatech 
microELISA plates (Figure 20) and Nunc Immunoplates” (Figure 21).
The individual data and aggregate reaction scores demonstrated 
that the maximum reaction was for bloodstain extracts diluted 1/100 to 
1/200 for both homologous and heterologous reactions. For extracts 
diluted 1/25 or 1/50 a lowered activity was found, similar to that for 
liquid saliva (the 'over-coating* effect). Dilution of extracts beyond
1/200 lead to lowered RS values with one or two exceptions.
In this comparison, the two plate types from Dynatech gave 
similar levels of activity as measured by RS, with ammonia-extracted 
stains giving slightly higher scores than PBS-only extracts. The third
plate type (Figure 21) gave up to four times the aggregate reaction 
scores compared to these other plate types. PBS extracts showed stronger 
reactivity than ammoniacal extracts in these Nunc Immunuplates.
2.3 Method Development.
PBS or detergent extracted-bloodstains were tested for ELISA 
activity and for comparison by haemagg lut inat ion (HAG) methods.
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TABLE 18
DETECTION OF ABH ACTIVITY FROM BLOODSTAINS 
BY ABSORPTION/ELUTION TECHNIQUE.
Antibody/LeetIn:
Stain Group* Extractant
5% Aq. NH,
Haemagglut inat ion Score* 
Anti-A Anti-B H Lectin
4
4
3+
4
Result
5
6
7
8
9
10 
11 
12
13
14
15
16
17
18
19
20
Controls
5% M L /P B S
5% Aq. NH*
5% NHVPBS
5% Aq. NH,
5% NHa/PBS
4
3+
3+
4
+
0
0
0
+
1
0
+
+
+
1+
+
4
1
1+
1
2
+
0
3+
4
3+
3
3+
3
3+
0
1
+
1+
+
+
0
1
1
2
3+
2
1
2+
1
2
3 
2+ 
3+
4
3
A
NR
A
A
B
B
B
B
B
NR
B
0
NR
0
0
0
a) Haemagglutination scores: the degree of agglutination of added red cells 
was scored + to 4, 4 being for complete agglutination. NR= Not reportable.
b) The blood group of the donors of blood for stains 1-20 is shown.
The test extracts were processed as described in the methods (Page 98). The 
controls were 100 pi of liquid blood not extracted prior to A/E.
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Figure 17. ELISA for Blood Group Substances in Bloodstains.
Initial investigations with ammoniacal extracts of group A bloodstains 
using polyclonal anti-A antisera. The method is given in Table 19.
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Figure 18. ELISA for Blood Group Substances in Bloodstains.
Initial investigations with ammoniacal extracts of group A bloodstains 
using polyclonal anti-B antisera. The method is given in Table 19.
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TABLE 19
COMPARISON OF PLATE TYPES FOR ELISA ON A= BLOODSTAIN EXTRACTS.
Data for Figures 17-21
Method
Group A2 stains were extracted for two hours at RT with 5% NHVPBS or
PBS alone. Extracts were doubling diluted from 1/25 of original blood.
Anti-A and anti-B was diluted as indicated in Figure! 17. The standard
method was otherwise followed (Page 89). Sample blanks were as follows:
Plate Type: M29AR M129B Immunoplate I.
Figure: 19 20 21
Anti-A 1/20 0.09 0. 10 0.15
1/40 0. 10 0.12 0. 15
1/80 0.11 0.13 0.19
1/160 0.13 0.15 0. 19
Anti-B 1/20 0.09 0.10 0. 12
1/40 0,09 0. 12 0. 12
1/80 0. 10 0. 14 0. 16
1/160 0. 11 0. 12 0. 15
Data for ammoniacal extraction are shown for all antisera dilutions in 
Figures 17 and 18. The reaction scores were summed for each antisera 
dilution to enable a comparison of plates.
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Figure 19. ELISA for Blood Group Substances in Bloodstains.
Initial investigations with extracts of group A bloodstains using 
polyclonal antisera in Microtitre plates (M29AR). The method is given 
in Table 19.
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Figure 20. ELISA for Blood Group Substances in Bloodstains.
Initial investigations with extracts of group A bloodstains using 
polyclonal antisera in MicroELISA plates (M129B). The method is given 
in Table 19.
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Figure 21. ELISA for Blood Group Substances in Bloodstains.
Initial investigations with extracts of group A bloodstains using 
polyclonal antisera in Immunoplates Type I. The method is given 
in Table 19.
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These are indicated in Figure 22. The HAG titres and ELISA 
activities (Table 20) showed that the solubilized material, although 
retaining its antigenicity in HAG tests, was not detectable in the ELISA 
system. The ELISA was carried out as detailed above (Page 89).
The extraction of activity from cotton cloth by detergents was 
more effective than using PBS alone as determined by residual HAG 
activity. The detergent-extracted cloth was visually much cleaner (ie 
less haemoglobin) than cloth extracted by PBS alone. However PBS-ex tracts 
had more HAG activity than detergent extracted ones. All extracts showed 
markedly reduced group H activity compared with unextracted controls.
Detergent extracts had no detectable activity in ELISA: 
substrate solutions were almost colourless and sample blanks gave higher 
A405 readings than tests. PBS-extracted stains gave similar levels of 
activity against polyclonal anti-A and anti-B in agreement with findings 
made in earlier work.
2.4 Development limitations.
In previous tests the values for sample blank were as high as 
A405 = 0.50 after one hour substrate incubation time. The use of more 
dilute antisera (anti-A, anti-B) at eg 1/100 to 1/300 lead to lowered 
sample blank values. However the antibody blanks (NSB) were very high 
and accounted for as much as 100% of the test absorbance either for 
bloodstain extracts immobilized at 37"C for two hours (Table 21) or 
overnight at 4"C, This finding was confirmed in similar assays (data not 
shown). The most likely cause of this level of unwanted reaction was 
reaction of anti-human IgG enzyme-antibody conjugate with immobilized 
immunoglobulin in the bloodstain extract.
To test this explanation, ce 11-free serum stains, possessing no 
ABH activity as determined by A/E, from groups A, and B donors were pr-
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Figure 22. ELISA for Blood Group Substances in Bloodstains.
The testing of bloodstains by ELISA and absorption/elution (A/E) to 
detect extracted blood group activity. The details of the method are 
in the text.
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TABLE 20
DETECTION OF BLOOD GROUP ACTIVITY BY A/E AND ELISA ON CLOTH EXTRACTS.
HaemagglutInation* ELISA*
Material: Original Cloth Extracted Cloth Extract® Extract®
Antisera: A B H A B H A B H A B
Stain Extractant*
A Bloodstain
1 PBS 3+ 0 3 3 0 4 2+ 0 0 3.58 2.58
2 3 0 3+ 3 0 +
3 1% Emulgen - 2+ 0 0 1+ 0 0 NR
4 - 2 0 + 2 0 0
5 1% Triton - 1+ 0 1+ 2+ 0 0 NR
6 - 1 0 0 1+ 0 1+
B Bloodstain -
7 PBS 0 4 4 0 4 3 0 4 0 1.42 1.83
8 0 4 3+ 0 4 +
9 1% Emulgen - 0 3 3+ 0 4 0 NR
10 — 0 4 2 + 4 0
11 1% Triton — 0 2 1+ + 2+ + NR
12 — 0 2+ 2 0 2+ +
Notes
a) Haemagglutination titres (See Table 18); antisera and H lectin dilutions 
were established by previous testing, (methods page 98).
b) Values for ELISA were RS using sample blanks of 0.12 and 0.13 for 1/40 
dilutions of anti-A of anti-B.
c) Extracts equivalent to original liquid blood were diluted 1/25 to
1/3000 with no marked change in RS.
The results above are for 1/25 blood dilution. NR: sample blanks>test RS.
d) The extractants were PBS, Emulgen 911 or Triton X-100 in aqueous solution.
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TABLE 21
INFLUENCE OF IMMOBILIZATION TEMPERATURE ON ELISA OF BLOODSTAIN EXTRACTS.
Coating:
Antisera:
Antisera Dilution 
Group A Stains 
1/100 
1/200 
1/300 
1/400
A405
Overnight/ 4"C 2 Hours/ 37'C
Anti-A Anti-B Anti-A Anti-B
0. 85 
0.91 
0.90 
0.95
0.85
1.03
0.89
0.83
0.76
0.82
0.59
0.64
0.76
0.64
0.61
0.61
Group B Stains
1/100
1/200
1/300
1/400
1.03 
1. 13 
1. 15 
1. 15
1.23 
1.08 
1. 15 
1. 13
0.85
0.95
0,97
0.98
0.85
0.96
1. 10 
0.91
The values were the A405 for undiluted bloodstain extracts (equivalent to 1/25 
dilution of original blood) not corrected for blanks. The blanks were as follows:
NSB 0.83 (A blood/ 4"C)
1.16 (B blood/ 4'C)
0.70 (A blood/ 37'C)
0.96 (B blood/ 37'C)
Sample blank 0.19 (anti-A at 1/50)
0.16 (anti-B at 1/50)
The assay was carried out as detailed in the methods section (Page 89).
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-ocessed in the standard ELISA. Data for the reaction of anti-A (Figure 
23) and anti-B (Figure 24) is presented. Similar values were found for 
the reaction of group A serum stain extracts. It was clear that the 
presence of blood-grouping sera (anti-A, anti-B) had little effect on the 
A405 readings obtained. Even in the absence of antisera (NSB) a dilution 
effect was seen ranging from lowered reaction scores at low stain 
extract dilution ('overcoating') through a peak of activity before 
becoming diluted out at higher stain dilutions in a similar way to that 
found previously (eg Figure 21). A similar pattern was found when 
examining the reactivity of anti-A and anti-B with group 0 bloodstain 
extracts, When anti-A and anti-B were diluted in the range 1/10 to 1/640 
the A405 values obtained were 0.83 to 0.90 (anti-A) and 0.98 to 1.07 
(anti-B). These were for extract dilutions comparable to those showing 
maximal activity in the serum-only tests above.
2.5 Attempted Solutions to Problems.
It was clear that the major limitation to the use of a human 
polyclonal blood grouping reagent in an indirect ELISA was the high 
background reactions. These were attributed mainly to the specific 
reaction of anti-human globulin conjugate with Ig present in bloodstain 
extracts. It was possible however that the conjugates were incidentally 
immobilized to the so lid-phase during the incubation stage merely 
because of their protein nature.
This was tested in plates which had been previously coated with 
BSA or gelatin as blocking reagents. It was clear that the binding of 
conjugate alone to the so lid-phase or in combination with antiserum did 
not produce A405 readings high enough to account for the previously 
observed reactions (results not shown). Plates which had not been 
previously blocked (PBS-treated only) showed slightly higher A405 values 
than BSA or gelatin treated plates. Plates washed six times showed lower
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Figure 23. ELISA for Blood Group Substances in Serum Stains.
The reaction of polyclonal anti-A with group B serum stain extracts.
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Figure 24. ELISA for Blood Group Substances in Serum Stains.
The reaction of polyclonal anti-B with group B serum stain extracts.
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A405 values than those washed only three times. The same comparison 
with conjugate diluted 1/5000 showed a similar pattern of reactivities 
but at a slightly reduced level.
The pre treatment of micro titre plates with glutaraldehyde 
solutions, to provide a different and hopefully more suitable so lid-phase 
to BGS from bloodstain extracts, lead to an increased non-specific 
attachment of antisera and conjugate as indicated by the values for
sample blanks (not shown).
2.6 An Alternative Approach.
Immobilized (in the sense passively coated) anti-erythrocyte
membrane (AEM) antibody raised against human red cell stroma was 
detected using an anti-rabbit alkaline phosphatase conjugate in an 
indirect EL ISA to test the specificity of the conjugate to be used in
later tests. Dilutions of AEM antibody in PBS-T were immobilized
overnight as indicated.in the methods section (page 95). Strong reaction 
was seen after 50 minutes substrate incubation with a 1/1000 dilution 
of AEM antibody (A405 = 1.20).
The AEM antibody was tested in a capture assay in the absence 
of bloodstain extracts. The results are shown in Table 22. There was
considerable cross-reaction between the AEM antibody or the anti-rabbit 
conjugate or both with immobilized capture antisera (anti-A or anti-B).
In a similar experiment, bloodstain extracts were incubated in 
plates previously coated with anti-A or anti-B. The A405 values were not
recorded but a uniform substrate conversion took place regardless of
bloodstain extract type. The AEM antibody was found to agglutinate 1%
suspensions of whole washed human red cells of groups A,, A2, B or 0 
when used diluted 1/10 in 0.85% saline. The agglutination of cells was 
complete within 20 seconds compared to 15 minutes with anti-A or anti-B 
(commercial, Lorne used neat) for homologous red cell suspensions ie the
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TABLE 22
THE REACTION OF ANTI-ERYTHROCYTE MEMBRANE ANTISERA 
WITH POLYCLONAL CAPTURE SERA IN THE ABSENCE OF BLOODSTAIN EXTRACT.
Antisera Dilution: NSB* 1/20
A405
1/40 1/80 1/160
Ant i-A 0.16 0.73 0.80 0.83 0.84
0.18 0.69 0.77 0.77 0.74
Anti-B 0.16 0.74 0.77 0.80 0. 66
0.17 0.69 0.74 0.75 0.69
a) NSB ie coating buffer instead of capture antisera (anti-A or 
anti-B. The method is given on Page 95.
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AEM antibody was very avid.
Bloodstain extracts made on cotton cloth were tested by A/E 
using anti-A, anti-B or AEM antibody. The results, shown in Table 23, 
indicated that at the dilutions used, AEM antibody was apparently not 
capable of detecting haemolysed erythrocyte membrane fragments, or at 
least those fragments which had retained associated ABH activity such as 
found in bloodstain extracts.
No further experiments were carried out using this approach
2.7 Discussion.
The use of intact cells as a source of antigen in so lid-phase 
immunoassay has been reported by several workers [Epstein and Lunney 
1985, Absolom et al. 1985] . The cells in such assays are used in
suspension or attached to a solid phase such as a microtitre plate well 
using eg glutaraldehyde and poly-1-lysine or copolymers of amino acids. 
The quality of the antisera and the inability to form stable mono-layers 
of cells were the main factors in the failure of this 'model approach' in 
my hands.
The use of bloodstains which contain a mixture of ABH antigenic 
structures necessitated a different approach to that which was
successful for liquid saliva. The ABH determinants in red cell membranes 
are present as glycol ip ids, g ly cosph ingo 1 ip ids and glycoproteins and have 
been classified as water soluble and insoluble. The two grouping tests 
carried out in parallel in English Forensic Science Laboratories are
directed against these two classes of molecules. The A/I technique relies 
on essentially soluble bgs in bloodstain extracts inhibiting the
agglutination of added test cells by homologous antisera. In the A/E 
technique it is the membrane bound material attached to bloodstained 
threads which retain the added homologous antisera.
The requirements of an ELISA for insoluble, lipid-based erythr-
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TABLE 23
REACTION OF AEM ANTISERA AND ANTI-A/ANTI-B 
WITH GROUP A BLOODSTAINS AND EXTRACTS IN ABSORPTION/ELUTION TESTS.
HaemagglutinatIon Titre*
Stain Type*: 
Antisera Dilution 
Anti-A Neat
Anti-B Neat
H lectin Neat
AEMC 1/10
1/20 
1/50 
1/100
Original Stain Extracted Cloth Extract
3+
0
1+
0
0
0
0
4
0
0
0
0
+
+
a) The haemagglutination titre is scored from + to 4 (See Page 100).
b) Stains were extracted as indicated on Page 95.
c) Anti-erythrocyte membrane antibody.
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-ocyte blood group substance for detection by ELISA are two-fold. The 
substance first must be extracted from the stain containing presumably 
erythrocyte membrane fragments and then the bgs in this extract must be 
immobilized on the so lid-phase so that the blood-typing antibodies can 
recognize and bind them. Extracts of bloodstains are typically made 
using saline for convenience. The use of ammoniacal extracts has been 
shown to be more effective in solubilizing blood group substances from 
stains [Kind and Cleevely 19691. The mechanism for this increased 
solubility is unclear but the pH of the extractant is an important
factor in its action.
The effectiveness of an ELISA for blood group substance in 
bloodstains depends on effective solubilization of blood group activity 
from stains and the presentation of antigens in an appropriate way for 
immobilization onto plastic. They must also be accessible by antibody.
The initial ELISA method was compared with A/E to ensure that 
under the extraction conditions used, antigenic material was present in 
the extract. The finding of others C Bosley and Rutter, personal
communication] that group H activity is decreased compared to controls 
for ammonia extracts was confirmed. However these extracts were not 
discriminated using anti-A or anti-B commercial polyclonal antisera 
(Figures 19 to 21) in an ELISA.
The reasons for this lack of discrimination may have been that 
the extracts did not have ABH activity in a form that could be coated
onto plastic or that any bound material was conformâtiona 1 ly or charge
foreign to 'homologous* antisera. Since the extraction was non-specific, 
serum proteins of various types would have also been extracted. It is 
known that there is unequal competition for 'binding sites' on plastic 
surfaces by mixtures of antigens in EIA techniques [Kenny and Dunsmoor 
19831. It was conceivable that the immobilized antigens were not in a 
form that could be detected by the antisera used. However the
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polysaccharide chains bearing the ABH determinants are highly branched 
and the antigen conformation problem is more commonly associated with 
MAb with single epitope specificity.
The use of two detergents (Emulgen 911, [ Hernandez and Kohl i 
19833 and Triton X-100) to increase the breakdown of the membrane 
bearing the ABH bgs was tested by A/E to determine where the blood 
group activity was localized. Although the detergent extraction resulted 
in HAG activity in the extracts, blood group activity was still present 
on the extracted cloth. The results for ELISA on the detergent-ex tracts 
indicated that no specific material was immobilized on the so lid-phase 
or that it was present in undetectable amounts or form.
The amount of detergent used was not optimised and it may have 
been that extracted material was integrated into micelles and was not 
coated onto the wells. The critical micelle concentration (CMC), a 
measure of the concentration at which pure detergent will form micelles 
has been quoted as 0.085 mM for Triton N-101, a polyoxyethylene nonyl 
phenol surfactant similar to Emulgen 911 £ Helenius and Simons 19751 
and 0.240 mM for Triton X-100, However the presence of other molecules 
affects the CMC and thus these figures are dependant on the amount of 
membrane and other matter being solubilized. At the high levels used in 
this work (1% is equivalent to 12 mM for Triton X-100, MW=849, and 10.7 
mM for Triton N-101, MW=927) it is very likely that micelles were formed 
which results in lower solubilization of membrane proteins since the 
pure detergent micelles reduce the available detergent in solution. The 
use of detergents in solubilizing membrane proteins etc will be 
discussed in greater depth in Chapter 3.
In an evaluation of the influence of immobilization temperature 
on the discrimination of bloodstain extracts using polyclonal antisera 
(Table 21) it was clear that the major contribution to the A405 readings 
was from the NSB (e diluent buffer instead of antisera). This was
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highlighted by the use of cell-free serum stains in which no ABH 
activity is likely to be present, or at low levels. The increased washing 
and blocking of plates failed to reduce the 'NSB' effect seen in Figures 
23 and 24.
The treatment of plate wells with glutaraldehyde has been used 
to modify the surface of plastic to increase the binding of especially 
basic proteins £ Habeeb and Hiramoto 1968, European Patent 
011568119843 . This approach lead in my hands to increased binding of 
conjugates (data not shown). The use of glutaraldehyde has been 
questioned by some workers £Klitzing et al. 19823.
It is clear that the ELISA for blood-stain ABH antigens was 
thwarted by immobilization of serum immunoglobulin. During the 
development of ELISA for salivary blood group substance where anti­
human Ig conjugates are also used it was evident that salivary Ig was 
either at too low a level to interfere in the test or that its detection 
was masked in some way. I concluded that the high background reactions
when testing immobilized bloodstain extracts were attributable to the
increased level of immunoglobulin in serum compared with saliva and the 
lower level of bgs in the latter as a percentage of the whole. Salivary 
IgG has been determined as 0.65 mg/100 ml while serum IgG was 1.23
g/lOOml in group 0 subjects £Waissbluth and Langman 19713.
The problem of using anti-human enzyme conjugates in a system 
where significant amounts of human serum proteins are likely to become 
immobilized to the solid phase is open to a number of potential 
solutions.
These include the raising of anti-ABH antisera in species other 
than man providing the use of anti-species antisera conjugates with 
markedly reduced affinity for immobilized serum proteins. Alternatively a 
direct conjugate of the primary antisera to an enzyme would obviate the 
use of second antibody conjugates. Since the ABH structures are
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polymeric a double antibody approach is feasible: primary antibody would 
be bound to the solid-phase. After incubating the bloodstain extract 
with any specific material being captured by the solid-phase antibody 
(serum proteins washed away), a second primary antibody would be added 
and detected either directly (1* antibody-enzyme conjugates) or in­
directly through an anti-species antibody which had low cross-reactivity 
to the solid-phase antibody.
An initial attempt to solve this problem was the use of anti-
erythrocyte membrane antibody (AEM) raised in rabbits. This antibody is
raised using red cell stroma of group 0 erythrocytes CBjerrum and 
Lundahl 19743. It was demonstrated that under the limited conditions 
used, the AEM was not bound (or was bound and not eluted) from 
bloodstains on cloth which had A and B bloodgroup activity as 
demonstrated by conventional A/E techniques. The high background when 
immobilized AEM was tested in the absence of bloodstain extracts and 
lack of apparent reactivity between AEM and bloodstained threads were 
factors in the decision not to pursue this approach.
As mentioned above, an alternative to the use of human (immune 
or natural) anti-A, B antibodies was to use antisera raised in another
species. At the end of the 1970's research reports began to appear
detailing the raising of MAb to A, B, H and related specificities (see 
introduction). The first commercial MAb (anti-A and anti-B from Celltech, 
Slough) became available at this point in the research work and thus MAb 
were selected for further investigations.
Conclusions.
Immobilized whole red cells or lysates were not successful as 
sources of erythrocyte ABH antigens in an indirect ELISA.
Extracts of bloodstains (using PBS, ammonia or detergent
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solutions) apparently contained high levels of human immunoglobulins 
which prejudiced the use of anti-human Ig conjugates in an indirect 
ELISA system.
This cross-react ion was not eliminated by glutaraldehyde 
treatment of the solid phase or the adoption of alternative reaction 
strategies.
A short investigation into the use of anti-erythrocyte membrane 
antibodies as an alternative to using anti-human Ig conjugates did not 
give promising results.
RESULTS; CHAPTER 3 Page 171.
RESULTS: CHAPTER 3
RESULTS: CHAPTER 3 Page 172.
CHAPTER 3. ABO Grouping by ELISA Using Monoclonal Antisera.
3.1 Reaction of Monoclonal Antisera with Saliva Stains.
Three monoclonal antisera (MAb) (anti-A, B and H coded 1, 11 and 
21, Table 9, Page 91) when diluted 1/2000 reacted strongly with extracts 
of saliva stains in an indirect two-stage ELISA (Figures 25 to 27). Each 
point was the mean of two observations after an overnight substrate
incubation. The sample blanks were 0.33, 0.31 and 0.32 for anti-A, anti-B 
and anti-H respectively. When the saliva stain extracts were diluted 
(from 1/25 to 1/2000 equivalent to between 10 pi and 0.13 pi of whole 
saliva) the strength of the reaction did not appear to decrease. There 
was almost no cross-reaction in heterologous tests and sample blanks 
were low. The anti-H reacted strongly with the three saliva types
tested. The anti-B reacted less strongly than the anti-A at the same 
dilution although this may have reflected a difference in the levels of 
blood-group substance in the saliva samples tested, or differences in 
titre of the MAb.
Four monoclonal anti-A (coded 1,3,4 and 7) were compared in 
an ELISA for liquid saliva using three different reaction modes as
detailed in the methods section, page 93. After 30 minutes substrate 
incubation, the A405 values were determined and corrected for NSB. The 
data are too numerous to present in full.
As indicated in Table 24 for MAb coded 1 (from Chembiomed Ltd.) 
as an example, the mode of reaction for all four MAb influenced the
absorbance values obtained. At the lower dilutions of antisera and 
conjugate (1/100 and 1/1000 respectively), the pre-mix mode was best for 
MAb coded 1 while the simultaneous assay, although being the easiest to 
perform, gave the weakest reaction. However, when MAb 1 was diluted 
1/500 (with conjugate 1/1000), only the pre-mix mode showed strong rea-
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Figure 25. ELISA for Blood Group Substances In Saliva.
The reaction of monoclonal antisera with group A saliva stain extracts
* The corrected A405 > the plotted value.
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Figure 27. ELISA for Blood Group Substances In Saliva.
The reaction of monoclonal antisera with group 0 saliva stain extracts
* The corrected A405 > the plotted value.
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TABLE 24
REACTION OF MONOCLONAL ANTI-A* WITH LIQUID SALIVA IN THREE MODES.
A405 Corrected for Antisera Blank.
Antisera Dilution: 1/100 1/500 1/1000
Conjugate Dilution: 1/IK 1/5K 1/IK 1/5K 1/IK 1/5K
Pre-mix Mode
A saliva 1.037 0.170 1.149 0.144 0.621 0.099
B saliva — — - - — —
0 saliva — — 0.004 - 0.003
Simultaneous Mode.
A saliva 0.380 0.115 0.287 0.156 0.183 0.159
B saliva — — - - ~ —
0 saliva — — - - — —
Sequential Mode
A saliva 0.974 0.262 0. 157 0.052 0.069 0.037
B saliva 0.005 0.003 - 0.002
0 saliva 0.012 0.001 0.001 0.006 0.004
a) MAb coded 1, Table 9, was used.
Each A405 is the mean of three determinations corrected for 
(NSB). The method used is described on Page 90 using liquid 
indicated groups diluted 1/100. A405 < 0 indicated as 
were as follows:
antisera blank 
I saliva of the 
The NSB values
Mode: Pre-mix Simultaneous Sequential
Conjugate Dlln. 1/IK 1/5K 1/IK 1/5K 1/IK 1/5K
Saliva
A 0.028 0.027 0.024 0.024 0.023 0.023
B 0.024 0.028 0.023 0.020 0.021 0.019
0 0.022 0.032 0.018 0.018 0.016 0.016
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-ctlon. The dilution of MAb 1 to 1/1000 gave a stronger homologous 
reaction with saliva diluted 1/100 (A405 = 0.621) in the pre-mix mode 
than it did in the simultaneous assay at a dilution of 1/100.
These findings were a consequence of the strength of the test 
reaction rather than differences in blanks which were at a similar low 
level (Table 24) as was the strength of the heterologous reaction. For 
MAb 1 the strongest reaction was for a saliva dilution of 1/200 (le a 
high dose hook or overcoating effect) so for subsequent tests, saliva 
was diluted 1/50, 1/250 and 1/1250. The three other anti-A MAb reacted 
in different ways in different reaction modes. None of the reaction 
modes tested gave consistently highest results with the MAb tested. The 
reaction of 10 monoclonal anti-A, 8 anti-B, two anti-AB and one anti-H 
with liquid saliva in ELISA and subsequent detection by a panel of 7 
anti-mouse conjugates is summarised in Table 25. The reactions were 
assessed after approximately one hour substrate incubation in a 
simultaneous-mode ELISA.
The reaction of any particular MAb depended in part on the 
anti-mouse conjugate used to detect it although overall the anti-A 
tested reacted most strongly,
Anti-A.
MAb 1 reacted most strongly in homologous reaction with MAb 2 
to 5 reacting to various degrees but less strongly. The other MAb, or 
the conjugates detecting them, reacted very weakly or not at all in 
homologous reaction. There was considerable cross-react ion between these 
MAb and group 0 saliva although this could be attributed to 
conjugate/saliva cross-reaction alone. After an overnight incubation of 
substrate all the anti-A MAb reacted to some extent in a specific way 
with, conjugate D (Table 10, page 93) giving the highest reaction in this 
comparison.
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Anti-B,
In contrast to other findings, anti-B MAb 11 failed to react
with liquid saliva in this comparison. This may have been due to the pH
of the diluent buffer as discussed below. None of the other anti-B MAb
reacted specifically with liquid saliva.
Anti-AB, Anti-H,
The two anti-AB MAb failed to react to any extent in this
comparison. The MAb anti-H, (21), failed to react in contrast to other 
findings.
In a separate comparison of anti-ABH MAb against dilutions of 
liquid saliva [Fowler et al, 1986, appended] a similar pattern of 
differential results between MAb and conjugates was noted.
The inclusion of additional conjugates, which were found to be 
specific for mouse IgM (Tago Inc., conjugate H) lead to a drammatic 
increase in the ability to detect immobilized salivary blood group 
substances. This work is further discussed in the following section on 
the use of MAb to group bloodstains,
3,2 ABO Grouping by ELISA: The Use of MAb for Bloodstains.
3.2.1 Method Development.
Two monoclonal antisera were tested against bloodstain extracts 
in untreated microtitre (Dynatech M29A) or microELISA (Dynatech M129B) 
plates. A number of parameters were compared: stains were extracted with 
PBS, 5% NH* (in PBS) or PBS containing 1% Emulgen 911. Diluted extracts 
were tested against monoclonal antisera diluted 1/50, 1/100, 1/500 and 
1/1000. The anti-mouse enzyme conjugate was diluted 1/1000 or 1/5000. 
Both the monoclonal antisera and the conjugate were incubated at 4eC, RT 
or 37 *C,
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The following controls were included on each plate
1 2 3 4 5
Bloodstain Extract NO NO NO YES YES
Monoclonal antisera NO YES NO NO YES
Anti-mouse conjugate NO YES YES YES NO
Substrate YES YES YES YES YES
The appropriate diluent buffer was substituted for extracts or reagents.
The monoclonal anti-A (coded 3, table 9), when diluted 1/50 
reacted with group A stain extracts preferentially although there was 
appreciable cross-reaction with group B stain extracts. These reactions 
are shown at room temperature only (Figure 28). The highest specific 
reaction was found when the monoclonal antisera and conjugate were 
incubated at RT. The PBS and ammonia extracted stains gave the highest 
absorbance readings in homologous reactions with anti-A. Generally it 
was found that extracts diluted 1/50 (equivalent to 0.17 pi original 
blood) gave higher positive reactions than those diluted 1/20.
The anti-B (coded 12) failed to react with group B bloodstain 
extracts and the absorbance values were consistently lower than antisera 
blank values under any of the conditions compared. Conjugates diluted 
1/5000 gave positive reactions although at lowered absorbance values. 
Even when antisera was diluted 1/1000 (conjugate diluted 1/5000) group 
A stain extracts were discriminated. However antisera blanks were not 
included in the test for conjugate diluted 1/5000 so this conclusion is 
an extrapolation based on blanks for conjugate at 1/1000.
Four plate types were compared as carriers for extracted blood
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Figure 28. ELISA for Blood Group Substances in Bloodstains.
The influence of MAb incubation temperature (RT) on the reaction of 
monoclonal antisera with bloodstain extracts coated in MicroELISA 
plates.
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group activity. There was a clear difference between plates designed 
specifically for ELISA and Microtitre plates. Plate types M129B and Type 
I had a much higher capacity to adsorb extracted blood group activity 
than untreated polystyrene plates (M29A). The polycarbonate plate had 
only 100 pi of bloodstain extract and other reagents compared to 250 pi 
for the three other plate types which may explain its performance in 
this test.
The extraction of bloodstains with various extractants was 
compared in two separate experiments. The reaction of monoclonal anti-A 
and anti-B (coded 2 and 12 respectively) was tested against extracts 
immobilized with phosphate buffer, pH 8.0 or carbonate-bicarbonate 
buffer, pH 9.6 as diluent (Table 26).
It was found that immobilization and dilution of extracts in
phosphate buffer lead to more blood group activity being detected by
ELISA. The most efficient extractants were 0.5 % OBG/ 5 % ammonia, 0.5 % 
0BG/ 1 % ammonia, 0.5 % Emulgen 911/ 1 % ammonia and 0.5 % Emulgen 
911/ 5 % ammonia in that order. However the NSB blanks were high; the 
use of such blanks is discussed below. The experiment was repeated with 
a smaller number of extractants and including group B bloodstain 
extracts. The results, after a fifteen minute substrate incubation, 
showed that OBG at 0.5 % (or Emulgen) in combination with ammonia were 
efficient as extractants of blood group activity and confirmed the 
finding [Fletcher and Harris-Smith 19833 that pH 8.0 gave higher 
immobilization of extracted blood group activity than at pH 9.6. There 
was only slight activity for the anti-B against group B bloodstain 
extracted with 0.1 % Emulgen/ 5 % ammonia.
Three anti-A MAb and five anti-B MAb were tested against
bloodstains extracted with 1.0 % OBG/PBS in an indirect simultaneous
ELISA and substrate was incubated overnight at 4‘C. The results (Table 
27) using conjugate G, indicated that there was cross-reaction of both
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TABLE 26
COMPARISON OF EXTRACTANTS AND IMMOBILIZATION pH (GROUP A BLOODSTAINS)
A405“
Diluent13:
Antisera:
Extractant
1 5% NHVPBS
2 1% NHVPBS
3 0.1% OBG/5% NH4
4 0.5% OBG/5% NH^
5 0.1% OBG/1% NH4
6 0.5% OBG/1% NHa
7 0.1% Emulgen/1% NH4
8 0.5% Emulgen/1% NH4
9 0.1% Emu1gen/5% NHA
10 0.5% Emulgen/5% NH4
PB (pH 8.0) CB (pH 9.6)
Ant i-A Anti-B Anti-A Anti-B NSB
1.28
0.53
>1.49
0.14
>1.43
0.79
>1.48
0.41
>1.48
0.27
0 . 10
0.03
0.31
0.07
0.03
0.03
0.05
0. 12 0.03
0.43 
0. 55 
0.48 
0.51 
0. 53 
0.57 
0.82 
0.52 
0.48 
0.52
a) Values are absorbance values corrected for blank (NSB) for
single determinations after an overnight substrate incubation.
Where A405 C 0.00, a ’ is reported,
b) Stains (10 pi) were extracted in 100 pi of the appropriate
extractant for 30 minutes at RT on a shaker. The dilution of
extract used was equivalent to 1.5 pi original blood. OBG is 
octyl-p-glucose. Emulgen is Emulgen 911. The assay followed 
the standard method.
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TABLE 27
REACTION OF MONOCLONAL ANTISERA WITH BLOODSTAIN EXTRACTS 
A405 Corrected for NSB 
Blood Type: A B
Bloodstain Extract
lut ion: 
tisera* Dilution
1/100 1/500 1/1000 1/100 1/500 1/1000
ti-A
1 1/200 NT NT NT NT NT NT
1/1000 0,757 0. 174 0.213 0.005 - -
4 1/200 0.797 0.699 - - - -
1/1000 0.488 0.294 0.266 0.369 0. 119 0.209
7 1/200 1.057 0.486 0.337 0.312 0. 182 0. 114
1/1000 0.350 0.031 - - - -
iti-B
11 1/200 0.682 0.078 0.096 0.112 0.037 0.041
1/1000 0.377 0.068 0. 124 0. 109 0.050 0.022
12 1/200 0.096 0 . 079 0.011 0.012 0.019 -
1/1000 0.032 0.033 - - - -
15 1/200 - - - - - -
1/1000 0.035 - - - - -
16 1/200 0.044 0.127 - - - -
1/1000 0.072 0.026 - - - -
17 1/200 - 0.007 0.050 0.048 - 0. 139
1/1000 0.072 - 0.046 0.182 - -
NSB — 0. 152 0. 156 0.169 0. 169 0. 164 0.289
Bloodstains were extracted in 1% OfJG/PBS and diluted as indicated. The A405 were 
read after a 15 minute substrate incubation and corrected for antisera blank (NSB 
Conjugate G, diluted 1/1000 was used in a simultaneous assay in all cases.
A405 t indicated by
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the MAb ant i-A number 4 and 7 in heterologous tests. Only MAb 1 reacted 
strongly and specifically and with negligible cross-reaction. The anti-B 
MAb, with the exception of number 17, cross-reacted with immobilized 
bloodstain extracts. The NSB in these tests were of the order of 0.1-0.2 
which is high after so short a substrate incubation.
3.2.2 Assessment Trial of MAb for ELISA grouping of Bloodstains.
A full screen of 19 monoclonal antisera with 10 alkaline 
phosphatase anti-mouse immunoglobulin conjugates clarified the 
relationships between MAb in the detection of immobilized bloodstain 
extracts as separately reported t Fowler et al. 1985, appended! .
In a separate experiment, using an optimised system, 100 
bloodstains were typed using an ELISA as indicated in the methods, page 
94. The results are shown in full as an appended paper, I Sheehan et aL 
19853.
The reaction of an ti-A, anti-B and anti-H diluted 1/25, 1/25 and 
1/10 respectively in a pre-mix system using conjugate H (Table 10, page 
93) diluted 1/500 with bloodstain extracts at 1/50 is summarised in 
Table 28.
The data for a total of 100 stains indicates strong reaction of 
the an ti-A and anti-B in homologous reactions with group A, stain 
extracts.
The monoclonal ant i-A (at a dilution of 1/50) reacted strongly 
with A, bloodstain extracts diluted from 1/20 to 1/100, but weakly with 
A2 (stain 18, 19) and A2B (stain 25, 26). The anti-B (1/50) antibody 
reacted well with group B bloodstain extracts but not as strongly as the 
ant i-A in homologous reactions. However duplicate or quadruplicate 
extracts from the same donor processed separately were in better 
agreement in homologous B reactions than in homologous A reactions. The 
anti-B also reacted well with A2B bloodstain extracts. The anti-H monoc-
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TABLE 28
BLOODSTAIN TYPING BY ELISA: SUMMARY OF RESULTS
Antibody Stain Type Mean
Anti-A Ai 0.984
A= 0.106
B 0.038
A,B 0.702
A=B 0.070
0 0.034
Anti-B A, 0.009
A= 0.000
B 0.432
A,B 0.206
A2B 0.348
0 0.007
0b 0.019
Anti-H A, 0.031
A2 0.041
B 0.041
AiB 0.020
A2B* 0.057
0 0.083
a) A405nm corrected by subtraction for 
indicates a %CV not calculated.
Corrected A405*
SD Range %CV Samp]
0.373 0.09041.387 37.9 40
0.031 0.06240.148 29.2 4
0.024 0.00740.109 63.1 12
0.028 0.67440.730 4.0 2
0.028 0.02840.099 40.0 4
0.021 0.00340.080 61.8 38
0.011 0.00040.039 - 40
0.001 0.00040.003 - 4
0.152 0.19840,674 35.2 12
0.001 0.20540.206 0.5 2
0. 161 0.14040.571 46.3 4
0.009 0.00040.042 - 37
0.073 0.00040.462 — 38
0.015 0.00040.078 48.4 40
0,018 0.02140.069 43.9 4
0.016 0.00840.070 39.0 12
0.001 0.01940.020 5.0 2
0.016 0.04640.085 28.0 4
0.039 0.02140.162 47.0 38
NSB for extracts diluted 1/50.
b) An outlier (0.462) is included in the data summary.
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-lonal antibody (diluted 1/20) reacted weakly with all group 0 
bloodstain extracts even at an extract dilution of 1/20. The degree of 
cross-reaction of all A, and B bloodstain extracts with heterologous 
reactions was very low; the A405 of 0.109 (reaction of ant i-A with group 
B bloodstain extracts) in Table 28 was an outlier.
In the majority of cases, increasing the dilution of bloodstain 
extract gave a lower A405 reading. This decrease in absorbance values 
from a bloodstain extract dilution of 1/20 to one of 1/100 was greatest 
for anti-B homologous reactions (approximately 50%), However, even at 
the highest dilution (equivalent to 0.08 pi of original liquid blood) the 
discrimination between positives and negatives was good.
In a similar way to the setting of criteria to adjudge samples 
positive or negative (assessment trial for ELISA of liquid saliva, page 
124) threshold limits were set at an arbitrary level of 0.05 AU for all 
the three specificities at a bloodstain extract dilution of 1/50. The 
results of this exercise (Table 29) indicated that 20 samples would have 
been mis-typed or adjudged 'no result'. Of these, 18 were group 0 stains 
and attributable to the weakness of the anti-H MAb with only two 
(donors 24 and 25) not readily explicable failures. In each case for the 
latter the corresponding repeat gave the correct result.
The design of the experiment included a positive control on 
each of the 34 plates used in this assay. The controls were extracts 
(diluted 1/50) from strongly positive donors of groups A,, B and 0. The 
results (Table 30) show an appreciable variation in the plate-to-plate 
data with overlap in the ranges for the reaction of the MAb with group 
0 bloodstain extracts. The results are presented in full in the appended 
paper [Sheehan et al, 19851.
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TABLE 29
GROUPING RESULTS INTERPRETED BY ABSORBANCE VALUE THRESHOLD
Result of Grouping
Group Number of Samples Correct Incorrect No Result
A, 40 40 0
A= 4 4 0
B 12 11 1
0 38 20 9
AB 6 5 1
TOTAL 100 80 11 9
TABLE 30
SUMMARY OF POSITIVE CONTROL RESULTS
Corrected A405*
Group Antibody Mean SD Range %CV
A Anti-A 0.560 0.123 0.35040.915 22.0
Anti-B 0.059 0.021 0.03040.119 35. 6
Anti-H 0.076 0.013 0.05340.104 52.7
B Anti-A 0.083 0.022 0.05040.138 26.5
Anti-B 0.304 0.072 0.19040.530 23.7
Anti-H 0.099 0.016 0.06440.136 16.2
0 Anti-A 0.074 0.020 0.02640.029 27.0
Anti-B 0.064 0.027 0.03040.149 42.2
Anti-H 0.130 0.015 0.09140.157 11.5
a) A405 corrected for NSB.
0
 
0
 
0
 
0
)
0
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3.3 Discussion.
Saliva.
In contrast to findings for the reaction of polyclonal antisera 
with immobilized liquid saliva (eg Figure 11) there was no apparent 
overcoating phenomenon with the monoclonal sera at the dilution used 
(Figures 25 to 27). This was attributed to the MAb only recognising
single epitopes and thus a lower weight of antibody (although more
specific than the diverse specificities and hence affinities exhibited bv 
a polyclonal serum) would be attached to the so lid-phase through the 
immobilised bgs. It was noted above (Chapter 1) that the over-coating 
effect may have been due to immobilized antigen leaking from the plate 
or low affinity antibodies being washed from the plate or a combination 
of both effects. It would seem that the affinity and specificity of the 
antibody population is the key component of the over-coating effect and 
that the leakage of immobilized salivary bgs although tightly packed on 
the so lid-phase is not a prime cause. In cases where there is a low
epitope density on the so lid-phase (eg blood group substance from
bloodstains) then the A405 readings will be influenced both by the 
affinity of the MAb and epitope density [Lew 19843. This effect has
important consequences on how and when an ELISA endpoint is determined 
CNimmo et al. 19843 as discussed below.
The differential reaction of anti-H with group A and B saliva
may have been due to differences in titre between the an ti-A and anti-H
(Figure 25) and the anti-B and anti-H (Figure 26) respectively.
However there is potential for discriminating group A sub-types 
using MAb. As mentioned above (introduction, page 32) the differences 
between groups A, and Az has been proposed as being quantitative. Group 
Az individuals have less H substance converted to group A than do A,
individuals. The A: H ratio may, if the differences between A, and Az are
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reproducibly different (eg see Table 28), provide a further 
discrimination of ABO blood groups. The DP (introduction) would be 
increased from 54.6% to 60,1% (ie the probability of being able to 
distinguish between two blood or saliva samples taken at random) if A, 
and Az were distinguishable from each other. The A,-As controversy has 
been further examined with MAb where a MAb specific for A, has been 
identified based on the presence of a specific sugar sequence as noted 
in the introduction.
The reaction of an an ti-A MAb (coded 1) was clearly influenced 
by the reaction mode (Table 24). The conditions chosen for each mode 
were not optimised; they were adaptations of an optimised two step assay 
(ie first step: add 1st antibody to antigen coated wells, after
incubating and washing, second step: add enzyme conjugate). The reaction 
mode will influence the extent of recognition of the antigen by the
antibody. The use of different reaction formats will alter the
sensitivity of the assay eg capture assays (antibody on the so lid-phase) 
are more sensitive than immobilized antigen assays CA1 Moudallal et al. 
1984, Yolken and Stopa 1980b] . In most of the assays performed in this 
work the antigen is immobilized on the solid-phase and thus the 
presentation of the antigenic determinants may differ from the native 
state. Thus MAb must be carefully screened against antigen as
encountered in the assay. Other workers have found differences in the 
recognition of solid-phase as contrasted with free antigen by MAb, in 
this case oc-mannosidase from Dictvostelium discoideum [Mierendorf and 
Dimond 19831 or other proteins CVaidya, Dietzler and Ladenson 1985, 
Dierks, Butler and Richierson 19861. Once assay-dependant
conformational differences in antigen are recognised the assay can be 
manipulated to screen different forms of antigen. The attempts to alter 
reaction mode in this work certainly changed the assay characteristics 
presumably by altering the working affinities of the MAb and hence
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influencing the rate at which equilibrium was obtained.
For the sequential assay the consequences of not reaching 
equilibrium at each stage would be lowered signal when the plates were 
finally read. The affinity of antibodies for the corresponding 
immobilized blood group substance material would be higher than their 
affinity for non-blood group substances or the plastic plate, hence these 
contributions to background signal should not be proportionally higher 
than test signal in a non-equilibrium situation. Antibody affinity is 
important in a sequential assay where two wash steps take place. Low 
affinity antibody will leak from the plate or being weakly bound will 
wash off leading to a reduction in sensitivity.
In the simultaneous mode two concurrent reactions were taking 
place. These were the reaction of anti-mouse conjugate with the 
monoclonal (1°) antibody and the reaction of primary antibody with the 
immobilized blood group substance. It is likely that in a simultaneous 
assay the first reaction, taking place in the liquid phase for the most 
part, will reach equilibrium more rapidly. Since the antigen is coated 
onto the solid phase then differing amounts of antigen (in excess and 
not desorbed) will not influence the final result when the progress of 
the antibody reactions towards equilibrium is concerned. In competitive 
EIA high antigen (analyte) levels tend to bring antibody reactions to 
equilibrium more rapidly than low levels.
In the pre-mix mode, the attainment of the equilibrium between 
first antibody and anti-mouse conjugate is favoured. Since none of the 
complex is separated then the equilibrium, if at completion, should 
quickly reform when the mixture is added to the wells coated with saliva 
dilutions. The conformation of the first antibody may be changed when it 
is bound by the anti-mouse conjugate which may also sterically hinder 
the antigen binding sites. Hence the first antibody may not fully 
recognise (ie lowered K*) the immobilized blood group substance.
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It was clear that this latter event was not important for the 
an ti-A (coded 1, Table 24) since the pre-mix mode gave the highest 
absorbance values compared with the simultaneous and sequential modes 
at the lowest dilutions of conjugate and first antibody. A five-fold 
dilution in conjugate for MAb 1 at 1/100 (Table 24) produced 
differential results for the three reaction modes. In the pre-mix mode 
the conjugate dilution produced a corresponding drop in absorbance 
values. For the other modes the drop in A405 when using conjugate at 
1/5000 instead of 1/1000 was less dramatic. This may have been due to 
the failure to equilibrate (first antibody and conjugate) or approach 
equilibrium when the conjugate was stronger so that dilution to 1/5000 
gave a less pronounced affect.
In the above discussion the equilibrium model of reactants is 
used without an equilibrium being demonstrated. It has been shown that 
the binding of antibody to solid-phase antigen is limited by diffusion 
up a certain antibody concentration (0.2 pg/cm2) and above this by the 
rate of the antibody-antigen reaction, presumably related to antibody 
affinity CNygren and Stenberg 19853. The dissociation of antibody once 
bound was too slow to be measured after 43 hours. Thus the size and 
shape of reactants, including preformed immune complexes (cf pre-mix 
mode) and the reaction conditions will greatly influence the rate of 
reaction.
The reaction of the 10 MAb in Table 25 with seven anti-mouse 
conjugates showed a wide variation in reaction. Such a screen is 
necessary at least to select for suitable conjugates, the majority of 
which, being anti-mouse IgG recognised the primary antibody on the basis 
of species-common L chains. Only the Tago anti-mouse IgM conjugate gave 
a specific reaction. A variation in conjugates was found when measuring 
free and conjugated alkaline phosphatase by a PCRD system (Chapter 4, 
page 228).
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In this study the pH of the diluent buffer was 9.6 (carbonate- 
bicarbonate) in contrast to pH 7.4 used in other assays. The MAb being 
derived from a single clone may have been susceptible to pH changes in 
terms of altered specificity as found for other MAb [ Underwood and Bean 
1985, Matikainen 19841.
The affinity and concentration of antibody will determine how 
much enzyme-conjugate is eventually bound to the solid-phase which will 
in turn determine the rate of substrate conversion. The amount of 
substrate was limited in these wells; only the enzyme concentration will 
vary and hence the rate of colour change. The determination of suitable 
endpoints must take into account the kinetics of the enzyme-substrate 
reactions which may be modified by immobilized enzyme. It is conceivable 
that enzyme was detached from the solid phase by the addition of pNPP 
in pH 9.8 buffer. This may not alter the total amount of enzyme in the 
well but may influence the rate of substrate conversion.
Bloodstains.
The early work with the reaction of Ce 11 tech MAb indicated that 
the anti-A (coded 2) gave some specific reaction with extracts of group 
A bloodstains although cross-reacting with group B bloodstain extracts. 
This MAb was raised against cells from a colon carcinoma from a group A 
person EVoak et al. 19803 . This MAb was not characterised by HPLAC 
(Chapter 4) but similar experiences were found in a screen of MAb 
against bloodstain extracts (appended paper).
The specificity of MAB's generally means that their use in EIA 
must be validated" using many different conditions and sources of antigen 
since there is no back-up effect as in polyclonal sera. No clear effect 
of temperature on their reaction was found although such assay 
parameters can be very influential in EIA's which are dependant on 
antibody affinity ENygren and Stenberg 19853.
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The use of blanks throughout this work needs to be examined 
critically. A more valid alternative to the use of NSB (ie diluent 
buffer) might be. the use of heterologous antisera ie the difference 
between test and blank sera would be the presence or absence of 
specific antibody. Alternatively an artificial serum containing 10% PCS 
to mimic TCS might be used.
Similarly the use of a sample blank (coating buffer instead of
bloodstain extract) is also of limited use favouring the attachment of
immune reactants to the plate. Bloodstains contain many different 
proteins which may co-immobilize with blood group substance. Whole blood 
contains 60-70 mg/ml of protein of which about 40 mg/ml is albumin ie a
very efficient blocking solution wheras coating buffer pH 9.6 (the
sample blank) contains no protein at all. Thus the correction of A405 is 
likely to give a biased view of the assay performance.
It was clear that the reaction of the MAb anti-B was generally 
worse than the anti-A with ; immobilized bloodstain extracts. This may 
have been due to differences in titre although estimates of specific Ig 
concentration (Table 38) or HAG titre with homologous red cells showed 
no general differences from anti-A.
It has been noted that murine lam in in glycoprotein may contain 
a-D-galactopyranosy 1 groups which do bind human anti-B antisera [McCoy 
et aL 19831 . This may reduce the immunogenicity of group B substance
injected into mice to elicit MAb. It is also known that mice ascites
fluid contain natural antibodies to carbohydrate antigens EGooi and 
Feizi 19821 and anti-A antibody was found in mice serum before 
stimulation of ascites tumours E Shaw 19861. These findings have
important consequences when using unpurif led and especially
uncharacterised MAb in ELISA for ABH substance.
The level of the A405 values was further influenced by the 
plate type. The microELISA plates bound more activity as measured by
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A405 than micro titre plates ie a similar finding to that in Chapters 1 
and 2. The so-called edge-effect CChessum and Denmark 19781 was noted 
in this work and lead at one point to the use of only inside wells (ie 
column 1 and 12 and rows A and H left empty). No temperature effect 
(results not shown) could explain the edge-effect in this work. The 
spacing of duplicates to control within-plate variation is one approach 
that has been successfully used CStemshorn et aL 19831.
The extraction of bgs from bloodstains for traditional A/E has 
been found to be more efficient using ammonia solutions instead of 
saline [Kind and Cleevely 19691. In a similar study 5% (v/v) ammonia and 
water alone were compared in their efficiency as extractants of serum 
proteins from bloodstains for spéciation. It was concluded that ammonia 
was a better extractant of proteins than water [Dorrill and Whitehead, 
personal communication 19781.
In early studies with MAb against bloodstains (and with 
polyclonal sera against bloodstain extracts, Chapter 2) the use of 
ammonia solutions alone did not give clear advantages as an extractant 
over PBS. Only when ammonia and detergent mixtures were used was the 
extraction and immobilization of blood group substance clearly more 
efficient than either component alone (eg Table 26). The pH of the 
diluent was also important in this respect with pH around 8 being more 
efficient than the carbonate-bicarbonate buffer pH 9.6.
Detergents have been used to solubilize membrane proteins and 
hundreds of examples of their action have been published. Detergents are 
lipids with hydrophilic heads (polar groups such as phosphates, amino 
groups etc) and hydrophobic (hydrocarbon) tails and can be characterised 
as ionic or non-ionic. The latter group is most commonly associated with 
membrane component solubilization whilst retaining biological activity of 
extracted material.
Two terms can be used to quantify the properties of detergents.
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The hy droph i le-1 ipoph i le balance (HLB) is a measure of the hydroph il icity 
(or hydrophobicity) with the most hydrophobic materials having a low HLB 
(1-10).
The critical micelle concentration (CMC) describes the 
concentration range above which detergents spontaneously form 
thermodynamically stable colloidal aggregates (micelles). The most 
effective detergents have high CMC values ie at concentrations less than 
the CMC the free detergent is more efficient at solubilizing proteins
since free detergent molecules bind and solubilize membrane proteins
better than miceliar detergent. The CMC is affected by several physical 
parameters including temperature and the presence of other materials in 
solution [Helenius and Simons 19751.
Several general papers on detergent action in the biological
context have been published eg [ Helenius and Simons 1975, Tzagolof f 
and Penefsky 1971, Helenius and Simons 1972, Umbreit and Strominger 
1973, Helenius et al. 1979, Hjelmeland and Chrambach 19841.
The mechanism of action of solubilization of membrane proteins 
from membrane fragments present in a bloodstain will take place in a 
number of stages. The detergent molecules will insert into the lipid 
membrane fragments with polar heads associated with the polar portions 
of membrane proteins or the solution. The most energetically favourable 
outcome is the collapse of what ordered structure remains leading to 
more easily accessible proteins for solubilization [Haydon and Taylor 
19631.
Thus the detergent will solubilize membrane proteins by a 
combination of membrane disruption and protein extraction.
Since the majority of red cell-associated bgs are based on
g ly cosph ingo 1 ip ids it is conceivable that the disruption of the membrane 
into detergent complexed proteins in solution leaves free or small 
aggregates of glycosphingolipids bearing blood-group activity. It may be
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that these bind to the solid-phase and not the detergent solubilized 
proteins which are washed away during the assay since detergent 
solubilized proteins do not bind well to polystyrene CPalfree and 
Elliot 19823.
The CMC of octyl glucoside is 25 mM [ Helenius e£ al. 19793. 
At the level used (0.5%) in these studies this is equivalent to 17 mM 
(MW = 292, Hjelmeland and Chrambach 1984) ie close to but below the CMC 
which is an appropriate concentration to use. At lower levels (0.1%) 
there was presumably insufficient detergent to completely solubilize the 
membrane fragments. No steps were taken to enhance the binding of 
detergent solubilized bgs although this approach has been found useful 
in other cases CGoldring 19863.
The enhancing effect of ammonia was presumably due to a pH 
effect. It has been shown that at high pH detergent action is more 
efficient CHosaka 1968, Helenius and Simons 19753. Only the use of 
radio-label led bgs could determine the real distribution of the bgs in 
the extract and in the ELISA.
General Discussion.
The most suitable methods of endpoint detection for 
quantitative assays are based on the use of internal standards and 
controls. These include the use of standard curves, ratios of the values 
of normal samples to negative ones expressed as multiples (MONA) and 
reading off standard curves or end-point titres where the last positive 
serially diluted sample is the titre. For qualitative assays samples 
showing ratios of test to control negative ones above a certain 
threshold are considered positive cf assessment trials in Chapter 1 and 
the work with bloodstains in this Chapter. It has been stated that the 
ELISA should only be used as a qualitative test since the antibody 
affinity (see below) so influences the assay result [Lew 19863 . In the
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context of forensic blood-grouping only a semi-quantitative approach is 
possible since the actual concentration of blood group substance of 
whatever molecular origin is difficult to relate to an extremely variable 
amount of sample. For example the formation of a bloodstain on cotton 
will have different characteristics to one on nylon. A unit area of
bloodstain used in a grouping test will contain differing amounts of bgs
depending on at least how much the blood has soaked into the cloth. The 
use of ratios of eg A: H substance might be more informative in this
context and the use of an internal marker (eg haemoglobin or peroxidase
concentration) might be appropriate.
As has been noted the available MAb for ABH grouping are 
directed against type 1 or type 2 chains or both. The failure of some 
MAb to react when screened against bloodstain extracts (see appended 
paper: Fowler et al. 1985) while still giving HAG titres against
homologous red cells may be the result of conformational changes when 
the bgs is immobilized on plastic. This has been noted above CVaidya, 
Dietz 1er and Ladenson 1985, Dierks, Butler and Richierson 19863.
The majority of MAb in the screen of MAb and conjugates reacted 
with both blood and salivary bgs suggesting no discrimination between 
type 1 and type 2 chain types. However MAb coded 2 reacted only with 
saliva suggesting a preferred affinity for type 1 chains (the specificity 
was not absolute since homologous red cells were agglutinated by this 
antibody). Such MAb and others which show such differential activity
[Sakamoto, Yin and LLoyd 19843 have the potential to determine the 
origin of bgs in mixed stains (eg blood/semen or blood/sweat where
mixed stains are a problem CTha Aye 19783.
It is clear that any quantitative assay must take into account
the affinities of the antibodies used since ELISA is primarily a measure
of antibody affinity not concentration [ But 1er et aL 19783,
The sensitivity of detection in an ELISA is based on the Molar
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extinction coefficient of the product of the enzyme catalysed reaction ie 
how much product needs to accumulated to be detected by the detection 
system. This is influenced by the amount of background reaction and the 
rate at which this develops. The rate for background reaction should be 
slower than for test reactions because less enzyme should turnover less 
substrate. The performance of the enzyme-substrate reaction will 
influence the speed of detection. It has been pointed out [Tijssen 
19851 that residual phosphate buffer left after plate washing (in the 
form of P0A ions) will inhibit the alkaline phosphatase reaction. It has 
also been noted that Mg2+ ions do not enhance the substrate conversion 
in diethanolamine buffer. Fluorogenic substrates such as 4- 
methy lumbe 11 if er y 1 phosphate would lead to increased sensitivity of 
detection.
The lack of appropriate standards has prevented the development 
of a reproducible endpoint measurement. The ELISA for salivary bgs is at 
the stage of field trials to validate any choice of conditions especially 
with problem samples. For bloodstain grouping the low reaction of the 
anti-H with immobilized bgs precludes a full assay at this stage. This 
lack of reaction may have been due to the loss of group H activity after 
ammoniacal extraction as found by Rutter and Bosley (personal
communication).
Other work in this area will be commented on in the general
discussion.
CONCLUSIONS
Monoclonal ABO antisera reacted strongly and specifically with 
immobilized salivary bgs in an indirect ELISA.
The choice of anti-mouse Ig conjugate and the reaction mode
were very influential in determining the level of signal in such ELISA.
A combination of ammonia and detergent extractant and
immobilization at pH 8.0 of erythrocyte ABH antigens was necessary to
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give optimal discrimination of stain bloodgroup substances.
These conditions were verified in a trial of 100 stains and 
enabled detection of group A,, B and A,B bloodstains.
The lack of a strong anti-H reagent precluded accurate typing 
of group 0 stains.
RESULTS: CHAPTER 4
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CHAPTER 4 The Analysis and Purification of Monoclonal Antibodies.
4.1 Affinity Chromatography
4.1.1 Batch Method
Three MAb were purified on Synsorb in a batch mode, the 
specific details of the method and the results are shown in Table 31.
All three antisera were purified successfully on the homologous 
Synsorb using the batch method. The haemagglutination (HAG) titre of the 
anti-A was reduced by rolling it overnight on Synsorb and HAG activity 
was retained in the ammonia eluate. The mass of product formed was not 
accurately determined because of inaccuracies caused by incomplete 
transfer of the powdery MAb to weighing vials. Additionally it was 
difficult to remove supernatants (le residual TCS after affinity 
adsorption) completely and without including grains of Synsorb. The 
anti-B HAG activity was not completely removed from the TCS reflecting a 
possible difference in the amount or properties of this MAb.
This batch approach was applied to the purification of six TCS 
from CNTS, Paris. Samples of TCS were adsorbed on Synsorb in three 
successive adsorptions. The basic reaction scheme is summarised in 
Figure 29. This sequence was repeated twice more using the supernatant, 
as defined above, removed at stage 2 so that as much MAb activity would 
be removed as possible.
The results of the weighing of freeze dried eluates and HAG 
titre determinations are shown in Table 32 for each of the derived 
fractions. The actual weight of freeze dried material is shown in Table 
33. For four of the six TCS, the Synsorb was not able to completely 
reduce the HAG activity after only one adsorption. The activity of MAb 
B283 and B383 were effectively removed after this first adsorption 
dropping from about 1/4,000 to almost zero. As expected a reciprocal re-
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TABLE 31
Batch Affinity Chromatography of MAb
Antibody
Mass of 
Synsorb
Mass of 
Product
HAG Titre 
Original S/N Produc
la Cell tech anti-A (3) 0.1 mg
b " 0.1 mg
c " 0.1 mg
ND
0.07 mg * 
0.30 mg b
> 4000 > 4000 
ND 
ND
2a Celltech anti-B (12) 0.1 mg
b " 0.1 mg
c " 0,1 mg
ND
0.08 mg * 
0.22 mg
1000
> 4000
128
128
0
128 
ND 
> 4000
3 CBM anti-H (21) 1.0 mg a)
b)
c)
d)
e)
ND 
0.35 mg 
0.31 mg 
0.47 mg 
0.28 mg
> 4000 > 4000
2ml samples of MAb (codes in parentheses refer to Table 9, page 91) were shaken 
overnight in plastic universels containing weighed amounts of homologous Synsorb. 
The unadsorbed material (supernatant, S/N) was removed and the Synsorb washed 
with 20ml water or until frothing stopped (on a Buchner funnel).
A 1ml volume of 2 % (v/v) aqueous ammonia was shaken with each portion of 
Synsorb A and B (4.0 ml for Synsorb H) for one hour at 4*C, The eluate was 
removed and half volumes of 2 % ammonia were added to each Synsorb sample for a 
further incubation at 4*C (rolled for one hour).
The eluates (from both elutions) were pooled. The eluate from the Synsorb H was 
divided into five aliquots (a-e). One ml of each eluate (la, 1c and 3a) was 
retained for testing; the remaining eluates were freeze dried and weighed. The 
original MAb, the supernatant and eluate were tested for HAG activity; the 
reciprocal titres are shown.
ND Not done.
a) In some cases not all the freeze dried material was weighed
b) Some Synsorb grains were present in the sample to be weighed.
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Figure 29. Analysis and Purification of Monoclonal Antisera.
Batch Affinity Chromatography Method.
1. Affinity beads eg Synsorb A ( A > were shaken with anti-A TCS 
containing MAb ( Y ) and other components ( « ).
2. After adsorbing, the Synsorb was washed to remove unbound materia
3. The bound material was eluted using 2% ammonia solutions.
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TABLE 32
PURIFICATION OF MAb BY BATCH AFFINITY CHROMATOGRAPHY 
Successive Adsorptions 
Reciprocal Haemagglutination Titre (Weight of Eluate in mg)
Anti-A
MAb Code* 8a 6 7
Fraction
Original > 4,000 (ND) 4,000 (ND) 4,000(ND)
Supernatant I >4,000 4,000 1000
Eluate I 512 (1.35) 256 (1.68) 1,000(1.48)
Supernatant II 512 4 16
Eluate II 2,000 (0.59) 1024 (1.15) 1,000(1.03)
Supernatant III 16 0 0
Eluate III 256 (0,67) 32 (0.81) 64 (0.52)
Total Weight (mg) 2.61 3.64 3.03
Anti-B
MAb Code* : 15 16 17
Fraction
Original > 4,000 (ND) 4,000 (ND) 4,000 (ND)
Supernatant I > 4,000 4 64
Eluate I 32 (0.38) > 4,000 (0.54) > 4,000(0.59)
Supernatant II > 4,000 4 64
Eluate II 256 (1.01) 128 (0.98) 128 (0.64)
Supernatant III > 2,000 2 64
Eluate III 128 (0.37) 64 (0.52) 64 (0.31)
Total Weight (mg) 1.76 1.94 1.54
The details of the assay are given in the text. The HAG titre were tested 
as detailed on page 103. The figures for weight were for freeze-dried eluate. 
Each eluate was divided into four 1ml aliquots. One of these was retained; 
the other three were separately freeze dried and weighed. The weight for each 
eluate was an estimate assuming the fourth aliquot to contain a similar weight 
of material. The full data are shown in Table 33.
a) MAb codes are listed in Table 9.
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TABLE 33
BATCH AFFINITY CHROMATOGRAPHY: MASS OF EACH ELUATE FRACTION
Weight of freeze-dried eluate (mg)
MAb Code' 8a 6 7 15 16 17
Eluate Fraction
I a 0.31 0.01* 0.26 0.10 0.14 0.14
b 0.22 0.01* 0.61 0.14 0.14 0.18
c 0.47 0.48 0.31 0.04 0.13 0.13
II a 0.18 0.23 0.29 0.38 0.29 0.19
b 0.14 0.38 0.28 0.25 0.23 0.13
c 0.12 0.24 0.21 0.18 0.23 0.17
III a 0. 19 0.20 0.14 0.06 0. 11 0.08
b 0.16 0.18 0.08 0.19 0.11 0.06
c . 0.16 0.23 0.15 0.06 0.19 0.09
a) The MAb codes are listed in Table 9.
b) Not all material was transferred and weighed.
The weight of material eluted from the Synsorb purifications 
was measured for three <1-1II) of the four aliquots recovered.
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-lationship between the titres for the first supernatant and eluate was 
seen; le if the supernatant contained high HAG • activity then the
subsequent eluate would contain little and vice versa. There was no 
evidence of loss of HAG activity for MAb eluted from the affinity 
support.
The second adsorption, using supernatant from adsorption 1, 
resulted in partial removal of HAG activity for MAb 8a, 6 and 7. However, 
MAb 15 had little affinity for the Synsorb even after a further 
adsorption/elution step. After three adsorptions, five out of the six TCS 
were effectively exhausted as measured by HAG activity.
The mass of recovered material (Table 32 and Table 33) from
anti-A MAb decreased after each adsorption-elution. However, for the
anti-B MAb, the second elution contained the most material as measured 
by weighing the freeze-dried product. The total estimated recovery from 
each elution did not correlate with the HAG titre determined for each
eluate. The mass at each stage was of the same order of magnitude,
regardless of MAb, and with few exceptions, quite similar.
The concentration of MAb in the TCS can be estimated using data 
obtained for total mass of recovered material (Table 34). These values 
are high CBussard 19843 and suggest that contaminating material was 
present in the eluates in addition to specific antibody.
The purity of the eluted material was analysed in a SDS-PAGE
system as described in the methods section (page 105).
The results are shown in Figure 30 and Table 35. They indicate 
that appreciable BSA was present in the eluted material. If the intensity 
of staining with Coomassie blue was proportional to the number of
amino-acid residues, occurring with equal frequency in BSA and IgM, then 
the molar amounts of BSA in the eluates exceeded those of antibody. On 
the same basis, there was more BSA in the stage 1 eluate (track 9) than
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TABLE 34
ESTIMATION OF SPECIFIC MAb CONCENTRATION IN TCS BASED ON 
BATCH AFFINITY CHROMATOGRAPHY RESULTS
MAb Code: 8a 6 7 15 16
Estimated total
protein recovered* 2.61 3.64 3.03 1.76 1.94
(mg)
>
Ig Concentration~ 130 180 152 88 97
(pg/ml)
17
1.54
77
a) The total weight of material from 20 ml TCS (mg) is shown. This was an estimate 
based on three weighings as detailed in Table 33.
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TABLE 35 
SDS-PAGE (FIGURE 30)
Analysis of Batch Affinity Chromatography Eluates
Lane Number Sample (MW) Rf*
Standards
1 Cytochrome C (12,500) 0.91
2 Carbonic anhydrase (29,000) 0.64
3 Ovalbumin (45,000) 0.53
4 BSA (66,000) 0.38
5 Phosphorylase b (97,400) 0.21
6 p-galactosldase (116,000) 0.18
7 Mixture of 1-6 NR
Samples*
8 8a E II c 0.28, 0.38, 0.72
9 6 E I b As Lane 8.
10 7 E II b As Lane 8.
11 15 E II b As Lane 8.
12 16 E II b As Lane 8.
13 17 E II b 0.38
a) The Rf was calculated as: Distance travelled by protein
Distance travelled by dye front (5.3 cm)
b) The MAb codes are listed In Table 9.
The eluates (labelled E) are referred to In Table 33. A standard curve
was plotted using the Rf values from the standards (Figure 31). An Rf of
0.38 corresponded to a MW of 66,000 (le BSA). Rf values of 0.28 and 0.72 
corresponded to MW's of 80,000 and 25,000 (le heavy and light chains 
respectively).
LO
G 
MW
 
(x 
10
0)
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200 -,
beta Galactosidase
100 - 
90 - 
80 - 
70 -
Phosphorylase b
BSA
60
50
Ovalbumin
40
30 Carbonic Anhydrase
20
• Cytochrome C
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
Rf
Figure 31. Analysis and Purification of Monoclonal Antisera. 
Standard curve for SDS-PAGE analysis of proteins. The data for the 
curve were taken from Figure 30. Details are given in the text.
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the stage 2 eluates amongst those analysed by SDS-PAGE.
4.1.2 HPLAC: Gradient Elution
A chromatography column packed with Synsorb H was the core of 
a High Performance Liquid Affinity Chromatography (HPLAC) system. The 
column was packed as described in the Methods section (page 103). The 
early investigations were to determine the optimum conditions for the
elution of bound MAb using an ammonia gradient.
A 2.5 ml sample of anti-H MAb (MAb No. 21) was circulated 
through the column overnight at RT. The column was washed with water 
and a linear gradient of aqueous ammonia (0 - 1.0 %, v/v) was pumped 
through the column at 0.1 ml/minute over one hour le a total volume of
6.0 ml). The changes in A280 with volume were recorded in and indicated 
that over 6.0 ml the change in gradient may have been too rapid to allow 
the column packing to equilibria te with the successive ammonia 
concentrations. Only after the 1.0 % ammonia concentration had been
achieved was there an elution of adsorbed material. This ’peak' of
activity was collected and analysed by SDS-PAGE and for HAG activity. 
BSA was detected in the eluate although apparently much reduced from 
the original TCS. The titre of the peak was 1/480 after concentration to
1.0 ml; this compared with a titre of 1/4,000 for the original material.
4.1.3 Stepped Elution
A previously adsorbed supernatant (anti-H, MAb 21, with a 
residual titre of 1/2000) was loaded onto the affinity column for one 
hour at 1 ml/minute at RT. The column was washed with water, and aqueous 
ammonia solutions were pumped through the column to elute the bound 
material. Ammonia solutions of 0.05 % (v/v) and 0.5 % (v/v) were pumped 
at 1 ml/minute. Material with HAG activity was only eluted after 0.5 % 
ammonia was used. Neither BSA nor immunoglobulin were detected by 
SDS-PAGE in this fraction. Either the level of both was lower than the 
sensitivity of the stain or BSA was absent in this fraction eluted with
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0.5 % NH*. In fractions produced by 0.05 % NHVwater wash, BSA was 
detected with most BSA in fraction 1 (produced by a water wash of the 
column). However no HAG activity accompanied it.
Fifteen MAb were analysed using the HPLAC system. The results 
for this survey are presented in Table 36.
Anti-A
Anti-A MAb 1 was a times ten concentrate of the MAb referred
to in Table 10 (also coded number 1). MAb 8a was from the same clone as
MAb 8 but from an earlier batch. MAb 10b was a commercial preparation 
of three MAb obtained from CNTS; during the loading of this MAb the
pump stalled so MAb was not circulating for the whole of the 90 minute
loading time.
The HAG titres were adjusted to be equivalent to the sample 
loading volume. The relative proportion of HAG activity in the 
supernatant (as defined on page 102) and in eluted fractions gave an 
indication of whether MAb were pur if lab le on affinity columns. The 
fractions eluted with 0.5 % ammonia solution for MAb 5 and 6 had strong 
HAG activity. MAb 1 had similar levels of activity in the supernatant and 
in the aluted fractions; this finding was expected since MAb 1 was a 
concentrate. MAb 4 had some HAG activity in the eluted fraction, but 
both this fraction and the supernatant had low titre compared to the 
original TCS. MAb 8a had an acceptable level of HAG activity in the
eluted fraction but no firm conclusions can be drawn in the absence of 
data for the supernatant.
Generally the 0.05 % elution did not produce fractions with HAG 
activity although the small peak (A280 = 0.050) for MAb 5 was not
analysed. The HAG activity for the eluted fractions was low compared to
the original TCS for all MAb analysed. These fractions eluted after 0.5
% ammonia were concentrated however from as much as 20 ml before 
analysis.
RESULTS: CHAPTER 4 Page 214.
TABLE 36 
HPLAC OF MONOCLONAL ANTIBODIES
I —— SAMPLE 1 I LOADING 1 I-——  ELUTION-------------- — I
HaemagglutInat1on Titre*
Antibody Titre» Volume (ml) Time® S/N* 0,06% 0.5% 2.0%
Anti-A
1* 2000K 2.5 O/N 130 NP 425 NP
4 4096 2.5 5 hr 2 NP 20 NP
5 4096 2.5 0/N 13 ND 400, 400 NP
6 4096 5.0 0/N 2 0 400 NP
7 8K 5.0 0/N ND NP 20 NPP
8a 4096 5.0 0/N RA NP 128 NP
10b 
Anti-B
ND 5.0 1. 5hr ND NP 80 NP
11* 64K 1.0 1, 5hr 128 8 2048 NU
12 256 5.0 0/N 80 NP
oCM NU
14 256 2.5 2 hr 0 NP 50, 6 NU
15 8K 5.0 2 hr 170 NP 3 NP
16 4096 5.0 2 hr 240 NU 20 NP
17 4096 5.0 0/N 200 0 2 NP
4b 32K 2.5 0/N 1600 NT 130 NU
Anti-H
21-
Notes,
>1/8 K 10.0 O/N 0
ooo
50, 9, 15 NP
(a) The reciprocal haemagglutination titre was determined on a concentrate
of the column eluate and corrected to be equivalent to the volume loaded.
(b) The titre of the original TCS was determined as detailed on page 103.
<c) The time that MAb was circulated is shown in hours or overnight CO/N). The
MAb codes are referenced in Table 9.
(d> S/N is the unadsorbed material (supernatant). The ammonia concentrations
used for elution are shown. NP means no peak. NT means peak not tested 
NU means that a particular ammonia concentration was not used for 
elution. RA the supernatant was re-adsorbed in a subsequent run and not 
tested.
(e) These MAb were supplied as X 10 concentrates.
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Anti-B
Anti-B (11) was a times ten concentrate (cf MAb 1). MAb (4b) 
was an IgG MAb from Dr 5 Moore, Edinburgh Regional Blood Transfusion 
Service. MAb 11 and 14 were purified on the affinity column; MAb 4b had 
substantial activity remaining in the supernatant although the fraction 
eluting after 0.5 % ammonia had some HAG activity. MAb 12, 15, 16 and 17 
were not purified on the Synsorb B column.
Anti-H
Several peaks were eluted after adsorption of anti-H MAb onto 
an affinity column but only those eluting after 0.5 % ammonia had any 
HAG activity.
SDS-PAGE was carried out on many fractions produced in these 
analyses (data not shown). The results were qualitatively similar to
those obtained above; ie BSA was present in the 0.05 % ammonia eluate 
and both immunoglobulin and BSA (though apparently less BSA than in the 
parent TCS) was present in fractions eluted after 0.5 % ammonia. The 
wash of the column with 2.0. % ammonia did not produce any peaks of
activity.
A 2.5 ml sample of anti-H MAb (21) was loaded onto an affinity 
column. The supernatant was retained. After eluting bound material the 
supernatant was recycled through the column. This sequence was repeated 
three times and some of the fractions analysed for HAG activity and by 
SDS-PAGE. The results indicated that the TCS retained HAG activity after 
the initial adsorption. However the ammonia concentration required to
elute material with any HAG activity, albeit low, was 0.05 % in contrast 
to other findings. The results were generally difficult to interpret.
The reproducibility of the method and a comparison between
overnight and two hour adsorption were compared in a separate test. The 
activity in the supernatants and the eluted fractions varied from run to 
run when 5.0 ml anti-B MAb (coded 12) was loaded for two hours. The
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runs were interrupted by problems with the HPLC pumps stalling during 
the loading of MAb. The only apparent advantage with an overnight 
adsorption stage was the convenience in terms of saved time.
4.2 Conventional Size Exclusion Chromatography
A chromatography column was packed and equilibrated as 
described in the methods section (page 100). A one ml sample of anti-B 
MAb (ST1, No. 12b) was loaded onto a column packed with Ultragel 1.5. 
The eluted 2ml fractions were analysed by HAG and show that the HAG 
activity co-incided with fractions 16-18, ie with the first (excluded) 
peak albeit slightly late. This may have been due to the delay between 
the detector and the fraction tube indicator not having been compensated 
for when the fraction interval was calculated.
A sample of monoclonal anti-H was purified on this column; 1.0 
ml, 2.0 ml, 4.0 ml and 6.0 ml samples were applied in successive 
experiments to determine the capacity of the column. The traces for the 
2.0, 4.0 and 6.0 ml runs are shown in Figure 32 and the analyses in 
Table 37. The excluded peak, which was demonstrated as being IgM in 
later work, and the second eluted peak (BSA) were discriminated even 
with a sample loading of 6.0 ml of a times ten concentrate TCS. The 
spread of HAG activity was wide and ran into the second peak (fractions
20 - 25). As the sample size increased, this was more evident. In later
work analysis of the fractions between the first and second peaks 
showed an increase in the level of detectable BSA. The size of the BSA 
and IgM peaks was greater for the higher sample loadings both in terms 
of height (higher A280) and width (poorer resolution).
4.3 The Combination of HPLAC and Conventional SEC.
The use of either affinity chromatography (batch or HPLAC 
modes) or classical size exclusion chromatography to prepare MAb free of
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TABLE 37
COMPARISON OF SAMPLE LOADING OF MAb ON SIZE EXCLUSION COLUMN 
Reciprocal HaemagglutInatIon Titre
Sample Size; 1.0 ml 2.0 ml 4.0 ml 6.0 ml
Fraction
10 NT NT NT NT
11 NT NT NT 0
12 NT NT 0 0
13 NT NT 0 32
14 NT 0 128 512
15 8 32 IK 2 K
16 256 1 K 2 K > 2 K
17 1 K 1 K IK 2 K
18 128 512 512 512
19 256 128 256 256
20 64 64 128 128
21 NT 32 32 128
22 NT 32 64 64
23 NT 32 32 64
24 NT 16 16 32
25 NT NT 16 16
26 NT NT 16 16
Four separate chromatography runs with sample loadings of 1.0, 2.0, 4.0 
and 6.0 ml of antl-H MAb (code 21) were compared. The two ml fractions 
analysed for HAG activity.
NT = not tested.
A2
80
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Sample Loading:
1.0 n
0.9 
0.8 
0.7 - 
0.6 - 
0.5 - 
0.4 - 
0.3- 
0.2 
0.1
2 ml 4 ml 6 ml
iiiiiiiiimm III *iimnn
0 1 2 3 4 5 6 7 8
L ttirrmmiiTii
0 1 2 3 4  5 6 7 8
unimnn.
T i m e  ( H r s ) Time (Hrs)
0 1 2 3 4 5 6
Time (Hrs)
Figure 32. Analysis and Purification of Monoclonal Antisera.
The effect of sample size on the elution profile of antl-H MAb 
(coded 21) from a size exclusion column. The column details are 
given In the text.
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contaminating BSA from foetal calf serum was not completely successful. 
For both approaches, BSA was still present in some of the eluates or in 
the excluded peak respectively. The combination of both approaches was 
seen as a solution to this problem.
Samples of monoclonal anti-A (MAb 1) were purified on a column 
packed with Sephacryl S-300 as detailed in the methods section, page 
100. The eluted fractions (2 ml) were tested for HAG activity and those 
fractions with HAG activity > 1/128 were pooled and affinity purified in 
a batch mode on Synsorb. The trace obtained in one such purification run 
(on Sephacryl S-300) together with the analyses for HAG activity and on 
SDS-PAGE are shown in Figure 33. The SDS-PAGE analysis for fractions 18 
to 30 is shown in Figure 34.
The excluded 'peak' was small but contained antibody activity as 
demonstrated by the HAG activity. The fractions between the two peaks 
contained BSA as shown by the SDS-PAGE analysis. Fractions 17 to 22 
were pooled, divided into four aliquots (3 ml each) and purified in a 
batch system on Synsorb A, No HAG activity was left in the supernatants 
or in washes of the affinity support. The first eluate (four 1ml 
fractions) had a HAG titre of 1/256 for each fraction; the fractions from 
the second elution had titres of 1/64 each. No BSA was detected in any 
of the fractions of the batch affinity purification run.
Several purification runs were carried out with similar results 
(not shown). The polyacrylamide gel from one such run was stained with a 
commercial silver staining kit instead of Coomassie Blue. The results 
showed that BSA was detected as early as fraction 17 wheras the same 
gel previously stained with Coomassie Blue (data not presented) showed 
BSA from fraction 26.
4.4 High Performance Size Exclusion Chromatography (HPSEC).
HPSEC was used as an analytical tool in conjunction with pur if i-
A2
80
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1.0
.8
0.6
0.4
0.2
0
10 It If ^  ^  /o FRACTION NUMBER
0 30 60 90 120 150 180 210 240
Time (Mins)
ANALYSIS OF FRACTIONS-
Fraction HAG Titre SDS-PAGE Fraction HAG Titre SDS-PAGE
‘ 16 4 ' NT 24 256 BSA
17 64 NT 25 128 BSA
18 128 - 26 128 BSA
19 256 - 27 128 BSA
20 256 - 28 64 BSA
21 256 - 29 64 BSA
22 256 - 31 16 NT
23 256 (BSA) 32 16 NT
Figure 33. Analysis and Purification of Monoclonal Antisera.
SEC of anti-A MAb on Sephacryl S-300. A 2 ml loading of MAb was 
chromatographed at 0.5 ml/min, HAG activity was determined on 
undiluted 2 ml fractions. SDS-PAGE analysis (Figure 34) showed BSA 
in some fractions. NT = not tested, = No visible protein, 
a) Fractions 3 to 15 had no HAG titre and were not tested by SDS-PAGE
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-cation and analysis methods of MAb for conjugation work.
A steel column packed with GPC 100 chromatography medium was 
used for size exclusion work on small samples of crude and affinity 
purified TCS. A linear relationship between the elution volume <VW> of an 
excluded peak and the protein standard was seen (Figure 35).
A typical analytical trace for a TCS is shown in Figure 36 
together with a comparison with conventional SEC. The identity of the 
three major peaks was investigated as follows. The first peak was found 
to be reduced in size when the TCS was purified on homologous Synsorb 
affinity adsorbent in an HPLAC system as previously described. The 
profile for HPLC compares well with a trace obtained with conventional 
size exclusion chromatography (eg Figure 32). Only the excluded peak on 
the latter system had HAG activity. The evidence for the second peak as 
BSA was derived from SDS-PAGE analysis as previously described. The 
elution volume for BSA was found to be equivalent to that for peak 2. 
The nature of the third peak was unclear. A sample of polyethylene 
glycol (PEG), used in hybrldoma fusions, ran co-incident with peak 3 in 
a separate run (not shown). No further work was done to identify it.
A total of fifteen MAb were analysed by HPLC (size exclusion) 
using a GPC 100-packed column as described above. From traces of the 
UV recordings, estimates of the immunoglobulin concentration were made. 
These are shown in Table 38. The TCS sold as concentrates (MAb coded 1, 
11 and 21) had appreciably higher estimated Ig levels. The values were 
in the range expected for TCS [Gooi and Feizi 19823.
4.5 Conjugate Analysis bv Post-Column Reaction Detector.
A system to analyse enzyme-ant ibody conjugates both from 
commercial and ’home-made’ sources was developed as described in the 
methods section, page 115,
Several commercial alkaline phosphatase antibody conjugates were
LO
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)
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Protein KV V.
1. Cytochrome C 12 500 7.3
2. Chymotrypsin 25 000 6.9
3. HR? 43 000 5.7
4. Ovalbumin 45 000 5.6
5. Catalase 60 000 5.4
6. Alkaline phos. 140 000 5.0
200-
1 0  1 1 1 1 ; 1 1  1 1
o.l 0.2 0.3 0.4 0.5 0.6 0.7 0.8
Ratio Ve Protein/Ve Excluded Peak
Figure 35. Analysis and Purification of Monoclonal Antisera.
HPSEC: Standard Curve. Plot of ratio of elution volume (V.) for 
proteins. The elution volume for the excluded peak (IgM) =1.8 ml.
A2
80
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IgM BSA
ULTRAGEL 1.5
PEG
0 1 2 3 4 ^ 5 6  7 8  Time (Hrs)
PEGIgM
BSA
GPC 100
0 1 2 3 4 5 6 Time (Mins)
Figure 36. Analysis and Purification of Monoclonal Antisera. 
Comparison of HPSEC and conventional SEC. A sample of antl-H MAb 
(coded 21) was separated in both systems. Sample size was 1 ml or 
50 pi and flow rates 0.2 ml/min or 0.5 ml/min in conventional SEC 
(Ultragel 1.5) or HPSEC (GPC 100) respectively. Columns were eluted 
with PBS pH 7.4.
RESULTS; CHAPTER 4 Page 225.
TABLE 38
ESTIMATION OF SPECIFIC IMMUNOGLOULIN IN TCS
MAb Code* A260b A280 Total Protein % Ig<= Corrected Igd
(mg/ml) (fig/ml)
Ant i-A
1 1.45 2.11 10.77 15.0 162
2 0.38 0.39 1.56 5.0 7.8
3 0.31 0.27 0.90 5.0 4.5
4 0.23 0.19 0.59 3.2 1.9
5 0.44 0.52 2,34 5.4 12.6
6 0.12 0,14 0.62 17.1 10.6
7 0. 14 0.19 0.93 14.2 13,2
8 0.23 0.24 0.97 19.0- 18.43
8a 0.01 0.02 0.12 19.0 2.2
9 0.20 0.21 0,86 17.1- 14.7
10 0.26 0.27 1.09 14.2- 15.5
10b ND
Anti-B
11 2.68 2.75 11.00 14.1 155,0
12 0.30 0.25 0.78 10.2 8.0
13 0.42 0.50 2.59 11.9 30.9
Anti-B
14 0.83 0.97 4.32 6.6 28.5
15 0.31 0.32 1.29 11.4 14.7
16 0.32 0,33 1,33 9.2 12.2
17 0.31 0.35 1.52 11.5 17.5
18 0.18 0.19 0.78 11.4- 8.9
18a ND
Antl-AB
19 0.42 0,60 3.03 6.0- 18.2
20 0.28 0,29 1.17 15.0- 17.6
Antl-H
21 2.70 2.79 11.23 10.5 117.9
Notes
(a) The MAb codes are listed in Table 9, page 91.
(b) Total protein was calculated from the formula;
Protein (mg/ml)= <1.55 x A280) - (0.77 x A260).
(c) The percentage Ig was estimated from HPSEC analysis of the appropriate 
TCS.
(d) Approximately 10% of the immunoglobulin in TCS is reported as being 
specific CBussard 19843.
<e> These figures are based on HPSEC analysis of previous batches of antisera of 
the same clone.
ND = Not done.
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analysed and traces of the fluorescent intensity recordings are shown in 
Figure 37. While peaks of activity corresponding with the excluded 
material (ie presumably enzyme conjugated to IgG) were seen, appreciable, 
though unquant if lab le amounts of free enzyme were detected in this 
system.
To confirm the identification of the peaks of activity as 
indicated in Figure 37, a sample of Sigma anti-mouse IgG alkaline 
phosphatase conjugate (coded A4656) was analysed. The output from the 
column (post-detector) was ‘fractionated1 manually (Figure 38) and the 
three fractions tested in ELISA (Figure 39). The ELISA method is given 
on page 116. It was clear that fraction 3 contained the conjugated 
material as it was the most effective in the ELISA test.
4.6 Discussion.
Affinity Chromatography.
The affinity chromatography support used in this work (Synsorb) 
is based on a synthetic trisaccharide CLemieux et ai. 19811 linked 
through a spacer arm to crystalline silica. Hence only the terminal 
antigenic determinants are represented and no part of the backbone chain 
is present. Since each monoclonal antibody will recognise only one 
epitope the affinity of binding of antibody to the affinity 
immunoadsorbent and more importantly its elution characteristics will 
vary from antibody to antibody.
The batch approach appeared to work successfully for the MAb 
from Ce 11 tech (anti-A, coded 2, Table 9 page 91) and the Chembiomed 
anti-H (21)(Table 31 and 32). Successive adsorptions of the antisera 
from CNTS produced variable results. The anti-B (coded 15) had virtually 
no affinity for the Synsorb B as determined by residual HAG titre. Only 
in one case (anti-B coded 16) was the HAG titre completely reduced after 
the first 'pass'. No data are available on the immunogens used to raise
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Figure 39. Analysis and Purification of Monoclonal Antisera.
ELISA using fractions of commercial anti-mouse alkaline phosphatase 
conjugates. Group 0 saliva was tested by ELISA as indicated in the 
methods. The A405, corrected for MSB, was determined after a 30 
minute substrate incubation.
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these MAb. The immunogen for the Ce 11 tech antibody (coded 2) was colon 
carcinoma from a group A individual CVoak et al, I960].
This antibody reacts preferentially with group A hepta- 
saccharide compared with pentasaccharide or hexasaccharide but generally 
the inhibition studies used were not able to ascribe differences in the 
reaction of MAb with oligosaccharides to particular immunisation methods 
[Chen and Rabat 19853. Data are not available for the immunogens used to 
elicit the majority of anti-ABH MAb used in these studies (Table 9).
The use of immunoadsorbents as a preparative technique is 
useful only insofar as the limitations are considered. Antibodies which 
are directed to portions of the chain carrying these sugars may well 
have lowered affinity for Synsorbs and might be discarded on that basis. 
Although affinity chromatography will provide some information on the 
specificity of the MAb used in ELISA and conjugate preparation work only 
comprehensive inhibition studies with various oligosaccharides will give 
a complete picture of fine specificity [Chen and Rabat 19853.
The limitations of using HAG titres must be considered when 
comparing the amount of material recovered from these affinity 
purifications. This is referred to in the context of HAG and ELISA 
(Discussion, Chapter 3) and also for conjugate evaluation (Discussion, 
Chapter 5). An interesting parallel can be drawn between the use of HAG 
in screening the material desorbed or otherwise from affinity 
chromatography matrices and its use in initially screening MAbs during 
cloning. In the former, antibody will only be detected if it can 
agglutinate homologous red cells under the conditions used. le the 
antibody binds to and brings about agglutination of the red cells. If the 
antibody fails to do this the serum would be discarded even if it 
contained antibodies which might function perfectly well in ELISA 
recognising different forms of the ABH antigens, If in the latter case 
(monoclonal antibody production) the screening criterion is exclusively
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HAG then perfectly viable EIA MAb might also be passed over. The only 
comforting thought is that most of the IgM MAb used in this study will 
have already been screened by HAG and hence I would not be liable to 
discard any (more!) MAb by chance.
The lack of apparent correlation between the weights of freeze- 
dried eluate and the HAG titre (and estimated Ig in the TCS, Table 38) 
may have been due to the presence of contaminating BSA (of PCS origin) 
as was shown by SDS-PAGE analysis of Synsorb eluates, Figure 30.
Although stepwise elution of MAb from column-packed Synsorb
produced MAb lower in BSA than the native TCS, it was clear that
significant quantities were still present (Figure 30). In the batch
method subsequent elutions reduced contaminating BSA (Figure 30 lanes 9 
and 10). BSA is a very sticky protein and was found to associate non- 
spec if leal ly to the column matrix.
The darker staining of the heavy chain of purified IgM over the 
light chain was thought to reflect the molecular weight differences
between the chain types ie more dye-reactive groups in the H-chain than
the. L-chain. Losses of light chain during affinity chromatography were 
not thought to be responsible.
The usefulness of SDS-PAGE for MW determination has been
proven with high MW proteins such as RNA. The necessity of reducing the 
protein prior to electrophoresis was to establish purity and due to the 
large size of the IgM. The maximum size of protein which can enter a gel 
of this composition (T= 7.5%) was about 100,000 but more permeable gels 
are difficult to handle.
The inferred MW of -the H and L chain of 81,000 and 21,000 to
give an estimated MW of 1.02 x 10s contrasts with published values of
70,000 and 30,000 (for H and L chains respectively) I Jarvis and Voss 
19813. The results for MW determination, however, were fairly consistent 
from run to run.
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The use of a column system to purify MAb by HPLAC (Table 36) 
has the potential advantage of convenience and reproducibility CLarsson 
et al. 19823. It was not expected that the properties of the MAb would 
change after HPLAC with respect to affinity. Higher titres would be 
expected as a result of a concentration effect (removal of PCS) and 
possibly other Ig's CGooi and Feizi 19823. Material from the purification 
of ant i-A coded 2 was used in subsequent conjugation work.
Overall this approach produced material with low titre and was 
complicated by HPLC-type plumbing problems. Protein dénaturation is a 
problem with steel components [ Trumbore et al 19833. Gas build-up 
(from aqueous ammonia used for elution) in the pump heads caused 
aborted runs.
The batch method is more labour intensive and difficult to 
control but is a simple alternative to machine based affinity 
chromatography,
SEC.
The large size of pentameric IgM (MW = 1 x 10*) offers the 
potential for purifying it by SEC to remove or reduce contaminating BSA. 
The material produced by this approach was used in several conjugation 
experiments (Chapter 5) but SDS-PAGE analysis revealed the presence of 
BSA in almost all the antibody fractions. This breakdown in resolution 
may have been in part due to poor column performance (eg see excluded 
peak in Figure 33). Without a clear idea of the weight of BSA still 
remaining, the effects on conjugation strategy are difficult to 
determine. The price of accidentally conjugating BSA to alkaline 
phosphatase is high in terms of high background and reduced sensitivity.
Other Approaches.
Even the combination of SEC and HPLAC failed to produce
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completely BSA-free fractions. It was not demonstrated in later work 
however that contaminating BSA had a detrimental effect on the quality 
of MAb conjugates in ELISA.
Other methods of IgM purification Include ion-exchange 
chromatography, salt precipitation and preparative ultra-centrifugation. 
Specific affinity columns eg Bioger are also available. These methods 
were not attempted since neither time nor resources permitted.
HPSEC proved to be a useful analytical tool for analysing TCS 
rapidly and reproduclbly to enable an estimate of specific Ig content to 
be made (Table 38). The range of values produced was reasonable given 
other reported figures for TCS IGooi and Feizi 19823.
The PCRD system proved to give a good check on the success of 
conjugation attempts (Chapter 5) before ELISA evaluation was carried out. 
The method was reproducible and although it was not able to detect 
active (in the ELISA sense) conjugates it showed graphically the extent 
of active enzyme conjugation. , It was also very useful for comparing 
commercial conjugates and for assessing why these might perform 
differentially in ELISA systems.
CONCLUSIONS
Several IgM MAb were purified using affinity chromatography, 
SEC or a combination of both approaches.
Significant though unquant if led levels of BSA remained in 
purified MAb preparations with methods of purification.
Limited characterisation of MAb in terms of Ig content and some 
indication of specificity was gained using affinity chromatography. 
However only inhibition studies with oligosaccharides would give 
information on the fine specificity of these MAb.
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CHAPTER 5 The Conjugation of MAb to Enzymes for ELISA.
There were four main approaches to the conjugation of MAb for 
ELISA. These were the glutaraldehyde method, the periodate method, the 
SPDP method and the avidin-biotin system. The results obtained with the 
conjugations attempted for each method are detailed below.
5.1 Glutaraldehvde Method.
5.1.1 Experiment I
The material produced (before freeze-drying) did not retain 
enzyme activity as indicated in Figure 40. It was inactive in an ELISA 
test for immobilized liquid saliva dilutions (not shown).
Various fractions of the MAb used in this conjugation (anti-A 
coded 1, Table 9) were retained for HAG analysis to monitor the progress 
of the conjugation experiment. The HAG titres of these fractions are 
shown in Table 39 and indicated that although the Synsorb affinity 
material on which the conjugation was performed adsorbed activity from 
the starting material, no active material was eluted.
In an attempt to demonstrate residual enzyme activity on the 
Synsorb, the sample of Synsorb was washed three times, with each wash 
discarded. A 1.0 ml volume of substrate solution was added to the tube 
containing the Synsorb and a rapid substrate conversion took place. This 
was also the case when the Synsorb was transferred to a second tube and 
the test repeated. An attempt to demonstrate mouse protein on the 
Synsorb sample using a commercial anti-mouse FabL, Ig (S-galactosidase 
conjugate (New England Nuclear, NE1-606 kit) was unsuccessful.
The same sample of Synsorb was tested to determine whether it 
had retained its affinity for homologous MAb, The Synsorb reduced the 
titre of added MAb; material with HAG activity was released from it 
after treatment with ammonia solutions.
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Figure 40. Conjugation of Enzymes to Monoclonal Antibodies. 
Conjugation of alkaline phosphatase to MAb:
Glutaraldehyde Method I. Enzyme activity of fractions taken during 
conjugation. The assay details are given in the text.
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TABLE 39
HAG ACTIVITY OF MAb FRACTIONS USED IN GLUTARALDEHYDE CONJUGATION I
Fraction HAG Titre5*
Anti-A MAb as used in Conjugation 1/2000
Post-Synsorb adsorbed material 1/256
Eluate (Pre-freeze dried 1 conjugate1) 0
Reconstituted 1 conjugate' 0
a) HAG titres were determined as described on page 103 and corrected 
for dilution to be equivalent to the conjugate volume.
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5.1.2 Experiment II.
The fractionation and analyses of the conjugate produced by the 
second conjugation experiment for enzyme and protein are shown 
superimposed in Figure 41.
A small peak of enzyme activity was associated with the HMW 
peak (peak 1) where IgM was found to be fractionated in other 
chromatography runs. The HAG activity of all fractions was 0. Fractions 
25 to 35 (pool 1) and fractions 40 to 50 (pool 2) were tested by ELISA 
after being concentrated using Am icon” concentration units. An effective 
five-fold and ten-fold dilution of the original fraction volumes was 
tested by ELISA as described above, page 114. No activity in ELISA was 
found for either of the fraction pools. Thus although some enzyme had 
become associated with excluded material and multiple enzyme homo­
conjugates cannot be ruled out, no active conjugate was formed. The HAG 
titre of the original antibody (1/2,000) was destroyed by the conjugation 
method.
5.2 Periodate Conjugation of HRP.
5.2.1 Experiment I.
This experiment, using a Molar ratio of HRP: anti-B MAb of 80:1 
resulted in an inactive 'conjugate' as measured by HAG. The material was 
not tested by ELISA. The fractionation of the material is shown in 
Figure 42.
The enzyme activity was localized in three major peaks (1, 2 and 
3). Peak 3 was co-incident with free HRP (MW= 43,000) as shown by other 
analyses. Peak 1 was excluded by Ultragel 1.5 medium and could be IgM 
conjugated to HRP or a mixture of HRP and IgM homo-conjugates.
Peak 2 had a MW estimated between 150,000 to 200,000 and may 
have been a homoconjugate of HRP or an enzyme- labelled breakdown 
product of IgM. The identity of peak 4 was not investigated.
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It was clear that the conjugation process inactivated the IgM 
antibodies to some extent. It also appeared as if the HRP had become 
attached either to or within a high molecular weight complex.
5.2.2 Experiment II. III.
The conjugation of HRP to IgM MAb using initial molar ratios of 
4:1 and 8:1 (experiment II and III respectively) produced material 
analysed as shown in Figures 43 and 44.
The material from experiment II, although retaining at least 25% 
of HAG activity (the original MAb had a titre of 1/2000 in 3.5ml) had 
little enzyme activity associated with it (peak 1, Figure 44). A hump of 
UV absorbing material (A280), in between peaks 1 and 2 had no associated 
enzyme activity and may have been denatured, aggregated HRP or a 
breakdown product of the MAb. Peak 2 corresponded with free HRP and it 
appeared that the majority of the enzyme activity was unconjugated.
The analysis profile of 'conjugate' III showed higher enzyme
activity which was concentrated in three peaks (peaks 1 to 3, Figure 44). 
The HMW peak 1 had associated enzyme and HAG activity present in a more 
discrete peak than 'conjugate' II. Enzyme activity was also associated 
with material of nominal MW of 150,000 to 200,000 as found for the
previous experiment. In fact the protein profile for the fractionation of 
products for both experiments were quite similar.
Fractions 17 to 20, 22 to 27 and 30 to 34 from the third HRP 
conjugation (experiment III) were collected into three pools and tested 
for ELISA activity against immobilized liquid saliva.
None of the pools had ELISA activity suggesting that the enzyme 
was not joined to the Ig or that the conjugation had modified the Ig so
that it was not able to react in a so lid-phase assay. Any conjugated Ig
may have been inactivated by the conjugation process.
The enzyme activity of the material produced in experiment III 
had disappeared after one month at 4*0.
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Figure 43. Conjugation of Enzymes to Monoclonal Antibodies. 
Conjugation of HRP to MAb: Periodate Method I,
The whole conjugate using an initial ratio of HRP:MAb of 4:1 was 
chromatographed on Ultragel 1.5. Fractions <2 ml) were tested for 
HAG activity and enzyme activity.
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Figure 44. Conjugation of Enzymes to Monoclonal Antibodies. 
Conjugation of HRP to MAb: Periodate Method II.
The whole conjugate using an initial ratio of HRP:MAb of 8:1 was 
chromatographed on Ultragel 1.5. Fractions (2 ml) were tested for 
HAG activity and enzyme activity. Three pools were collected.
RESULTS: CHAPTER 5 Page 244.
5.3 SPDP Conjugation of Alkaline Phosphatase to MAb.
5.3.1 Experiment I.
The material produced in this synthesis was tested for HAG
activity along with intermediate fractions. The results are shown below: 
Fraction HAG Titre
Original MAb 1/256
Affinity purified MAb 1/1024
Post Sephadex G-25 fraction 1/128 
Crude 'conjugate* 0
The original material had lost appreciable activity merely by
chromtographing on Sephadex G-25. When tested in an ELISA the crude 
conjugate, diluted 1/100, 1/500 and 1/1000 was inactive, with A405 for 
tests equal to sample blank values. The material produced by the 
conjugation was fractionated on a size exclusion column and fractions 
tested for enzyme activity. The results are shown in Figure 45. The peak 
of enzyme activity corresponded to free alkaline phosphatase. The
analysis of the protein profile (not shown) indicated that very little 
protein was present (A280 < 0.02 AU).
From the above data no conjugation took place or a very 
unstable conjugate was made. The incorporation of 2-pyridyl disulphide 
groups into the alkaline phosphatase was calculated by reducing a .sample 
of pyridyl-thiolated enzyme with DTT -and measuring the release of
pyridine-2-thlone by following the  ^change in absorbance < at 343nm 
<A343nm, = 8.08 x 10® M-'cm-1 ). The calculation is shown in
Figure 46. The low estimated incorporation may have accounted for the 
apparent failure of the conjugation method. Only 0.16 mg of IgM was used 
with low HAG activity. Dilution effects, losses during purification and 
the instability of protein at low concentration may have contributed to 
the failure of the experiment.
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Figure 45. Conjugation of Enzymes to Monoclonal Antibodies. 
Conjugation of Alkaline Phosphatase to MAb: SPDP Method I. 
The whole conjugate was loaded onto an Ultragel 1.5 column. 
Fractions were tested for enzyme activity.
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Figure 46
Calculation of Incorporation of 2-pyridyl Disulphide into Aik. Phos.
SPDP Experiment I
A343 (before reduction) = 0.008 
A343 (after reduction) = 0.026 
A343 = 0.018
The Molar concentration of P-2-T = AAU
e
= 0.018 
8.08 x 10a
In 2ml volume the moles P-2-T = 4.45 nmoles.
Assuming no losses due to Sephadex G-25 chromatography the maximum 
protein concentration of alkaline phosphatase was Img (7 nmoles, 
MW=140,000).
Therefore ratio of pyridyl-2-thione:Aik.Phos.=
4.45/7 = 0.64:1
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5.3.2 Experiment II.
The HAG titre of the 'conjugate' was 1/8 against a theoretical 
titre, allowing for dilution, of 1/260. The crude material, when diluted 
1/250, had no activity when used in an ELISA method for liquid saliva. 
The enzyme activity was assessed in two ways. A 50 pi and 200 pi sample 
of the crude material was analysed on a react ion-column system as
described in the methods. The trace showed no enzyme activity associated 
with the HMW portion (ie IgM) suggesting that only free enzyme was 
present. This was confirmed by fractionating the crude material on a
size exclusion column. The excluded peak, which when tested had no
alkaline phosphatase activity, had an A280 of 0.0025 AU maximum from a 
sample loading of 2.0 ml of crude 'conjugate'.
5.3.3 Experiment III.
The HAG titres of the three anti-H MAb alkaline phosphatase
'conjugates' was well retained as indicated below in Table 40.
TABLE 40
SPDP EXPERIMENT III: HAG TITRE OF PRODUCTS
'Conjugate* Initial SPDP:IgM Ratio HAG Titre Expected Titre 
Ilia 15:1 1/64 1/128
Illb 35:1 1/64 1/128
IIIc 70:1 1/32 1/128
When tested in an ELISA at a dilution of 1/250 all three 
'conjugates' were inactive when compared to an assay using anti-H MAb 
and commercial anti-mouse alkaline phosphatase conjugate against 
immobilized liquid saliva. The material produced by this experiment was 
fractionated by size exclusion chromatography. The protein profile for 
'conjugate' Ilia is shown in Figure 47. The two peaks corresponded to IgM
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Figure 47. Conjugation of Enzymes to Monoclonal Antibodies. 
Conjugation of Alkaline Phosphatase to MAb: SPDP Method III. 
The whole conjugate was loaded onto an Ultragel 1.5 column. 
Fractions were tested for at 280 nm.
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and alkaline phosphatase. No enzyme activity was associated with peak 1. 
The recovery of IgM was estimated to be 23%.
5.3.4 Experiment IV.
The material produced by this experiment was tested using a 
size exclusion column and post-column reaction detector (Methods, page 
115). No enzyme activity was found associated with the excluded (IgM) 
peak (data not shown).
5.3.5 Experiment V.
The conjugates produced by this experiment, labelled Va, Vb and 
Vc are shown analysed in Figures 48, 49 and 50 respectively. An initial 
397 pi of anti-B purified MAb (code 12, Table 9) with a HAG titre of 
1/4,000 was conjugated to alkaline phosphatase as described in the 
methods, page 111. The resulting 10.5 ml for each conjugate was 
concentrated to 1.0ml (Va and Vb) or 2.0ml (Vc). In each case the whole 
concentrate was loaded onto the chroma tography column.
Conjugate Vc had some enzyme activity in fraction 18 (Figure 
50) which correspdonded to the excluded (IgM) peak. For Va and Vb the 
majority of the enzyme activity was found associated with free alkaline 
phosphatase (fractions 22 to 38). The enzyme activity was split into a 
double peak (eg fractions 27 and 28, Figure 50) although the total 
enzyme activity was similar to a single peak (Figure 48).
The three traces (Figures 48 to 50) were very similar. The main 
difference was that Vc had some enzyme activity associated with the 
excluded peak. The proportion of total column and enzyme activity was 
estimated for each of the two pools of column fractions (pool 1, 
fractions 16 to 22; pool 2, fractions 23 to 35) (Table 41). The recovery 
of IgM was also estimated for the three 'conjugates' (Table 42). The 
figures were very similar and thus offer no explanation for the
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Figure 48. Conjugation of Enzymes to Monoclonal Antibodies. 
Conjugation of Alkaline Phosphatase to MAbi SPDP Method Va.
The whole conjugate was loaded onto an Ultragel 1.5 column. 
Fractions were tested at 280 nm and for enzyme and HAG activity,
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Figure 49. Conjugation of Enzymes to Monoclonal Antibodies. 
Conjugation of Alkaline Phosphatase to MAb: SPDP Method Vb.
The whole conjugate was loaded onto an Ultragel 1.5 column. 
Fractions were tested at 280 nm and for enzyme and HAG activity.
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Figure 50. Conjugation of Enzymes to Monoclonal Antibodies. 
Conjugation of Alkaline Phosphatase to MAb: SPDP Method Vc.
The whole conjugate was loaded onto an Ultragel 1.5 column. 
Fractions were tested at 280 nm and for enzyme and HAG activity,
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TABLE 41
ESTIMATION OF ENZYME ACTIVITY IN POOLED FRACTIONS 
SPDP Experiment Vc
Enzyme Assay.
From each 2.0 ml column fraction, 20 pi was added to 250 pi substrate 
solution (total volume 270 pi). The A405 was measured after 4 minutes.
The para-nitropheno1 concentration (Ip-NPl) = AA405 M (in 20 pi)
18.5 x 10=
Assuming a linear AA405 then in one minute,
[p-NP] = AA405 M
18.5 x 10= x 4
Allowing for dilution (20 pi in 270 pi)
[p-NP] = AA405 X 270 M
18.5 x 10= x 4 20
the pmoles of p-NP =
A A405 x 36.49 pmoles. . . ... (A)
The pmoles of o-NP produced by each fraction can be calculated using
(A) above:
Fraction No. A405 6A405 jiioles p-NP % Total
15 0.025 0,0 0,0 t
16 0.024 0,0 0,0 1
17 0,099 0,074 2,70 0,67
18 0,361 0,336 12,26 3,10 1
19 0,309 0,284 10,36 2.60 J POOL 1
20 0,309 0,284 10,36 2,60
21 0,388 . 0,363 13,25 3,30 1
22 0,515 0,490 17,88 4,50
23 0,749 0.724 26.42 6.60
24 1,002 0,977 35,65 8.90 1
25 1,057 1,032 37,66 9,40
26 1,354 1.329 48.50 12,10 1
27 0,771 0,746 27.22 6,80 1
28 0,900 0,875 31.93 7,90
29 1,301 1.276 46,56 11,60 Î POOL 2
30 0,636 0,611 22.30 5,60
31 0,729 0,704 25,69 6.40
32 0,416 0.391 14,27 3,60 1
33 0.219 0.194 7.08 1,76
34 0.111 0,086 3,14 0,80 1
35 0,081 0,056 2,04 0.50 4
36-45 0,155 5,66 0,67
% Total Enzvme Activity; Pool 1 17% of column activity
Pool 2 82%
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TABLE 42
ESTIMATION OF RECOVERY OF IgM:SPDP Experiments Va, Vb and Vc 
Experiment Va.
Area under Peak 1 (fig. 48) = 187 mm2 for 6 x 2.0 ml fractions.
= 15.6 mm2 /ml.
FED = 0.2 AU (= 200mm)
= 0.0156 AU/ml
(e = 1.18 M-1) = 0.0132 mg/ml
% Recovery estimated as 0.159/1.0* = 16 %
Experiment Vb
Area under Peak 1 (fig, 49) = 395 mm2 for 6 x 2.0 ml fractions.
= 32.9 mm2 /ml.
FED =0.1 AU (= 200mm)
= 0.0165 AU/ml 
= 0.0140 mg/ml 
% Recovery estimated as 0.168/1.0* = 17 %
Experiment Vc.
Area under Peak 1 (fig. 50) = 840 mm2 for 8 x 2.0 ml fractions.
= 52.5 mm2 /ml.
FED = 0.05 AU (e  200mm)
= 0.013 AU/ml
= 0.011 mg/ml
% Recovery estimated as 0.176/1.0* = 18 %
a) A 1.0 mg sample of IgM was used in the conjugation.
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differential behaviour of the three conjugates when tested by an ELISA.
The material from this experiment was tested by ELISA as 
described in the methods, page 114 (Table 43). Only conjugate Vc showed 
marginal specific activity in this system.
The conditions used in all five SPDP experiments are summarised 
in Table 44.
5.4 The avid in-bio tin system.
5.4.1 The NHBS Method.
Four separate conjugation experiments were performed using the 
NHSB method (Table 45),
The activity of the resultant conjugates depended on the initial 
ratio of the NHSB reagent to IgM and also on the amount of 
immunoglobulin used in the conjugation attempt. In three out of the four 
experiments, active anti-A biotin conjugates were produced as measured 
by a sequential ELISA technique. The optimal ratio of NHSB:IgM was found 
to be approximately 200:1,It was necessary to use higher ratios of the 
reagent to produce active anti-B biotin conjugates (Experiment IV, 500:1 
ratio). Partially active anti-H conjugates were produced using a ratio of 
around 50:1. It was found that low initial immunoglobulin concentrations 
led to the formation of very weakly reacting conjugates (Experiment III). 
These conjugates were found to be very unstable: although having 
activity when tested in a pre-mix ELISA (data not presented), all 
conjugates produced by Experiment III had lost all ELISA activity after 
one month although still retaining haemagglutinating activity,
The original antibodies had HAG titres of four million, 512K and 
16K for anti-A, anti-B and anti-H respectively. It was clear that all 
the biotin conjugates had lost appreciable biological activity as 
measured by red cell, agglutination.
At low ratios of NHSB to IgM it was possible that the immunogl-
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TABLE 43
ELISA TESTING OF SPDP EXPERIMENT V ANTI-B CONJUGATES 
A405 Corrected for NSB
Experim ent Va
Saliva Type 
A 
B 
0
Conjugate Pool 1 Dilution
1/50
0.026
0.014
0.009
1/100
0.012
0.009
0.012
1/200
0.002
Experiment Vb
Saliva Type 
A 
B 
0
Conjugate Pool 1 Dilution
1/50
0.007
0.006
0.018
1/100
0.005
0.004
0.012
1/200
0.006
Experiment Vc
Saliva Type 
A 
B 
0
Conjugate Pool 1 Dilution
1/50
0.045
0.077
0.042
1/100
0.049
0.083
0.044
1/200
0.009
0.039
0.004
The ELISA vas carried out as detailed in the text, The fraction pools (Pool 1 were fro» fractions 
17-22, Pool 2, fractions 24-32) vere diluted as indicated, The A405 values were read after one hour 
and corrected for antisera blank (NSB), All Pool 2 for each experiment gave A405 less than the NSB 
(denoted - above).
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Table 44
Conjugation of Alkaline Phosphatase with MAb Using the SPDP Method.
Experiment: I II III IV V
MAb (Code*) Anti-A Anti-H As II As II Anti-B
(8) (21) (11)
Class IgM IgM IgM IgM IgM
Purified by HPLAC SEC SEC SEC SEC
Vol. of TCS 18 ml 13 ml As II As II 9 ml
Total Protein*" 0.38 mg 5.45 mg i ii 11.34 mg
Titre 1/1024 1/8000 i ii 1/4000
Mass Usedc 0.16 mg 0.50 mg 3 X 0.5 mg 0.5 mg 3 X 1.0 mg
Ratio SPDP/IgM 0. 18:1 12:1 15, 35, 70:1 ND 12, 50, 100:1
% Incorp.** ND ND ND ND ND
Enzyme Sigma P0405 Alkaline Phosphatase Type VII-NT Bovine Intest.
Mass Used 2.0 mg 2.8 mg 0.68 mg 0.69 mg 1.26 mg
SPDP:E 24:1 24:1 40:1 180: 1 40: 1
% Incorp.^ 0.6:1 0.9: 1 ND 5.2: 1 ND
Conjugate
E:MAb Ratio 3:1 2:1 3:1 10:1 3:1
AE343- ND 0 ND 0 0, 0, 0
Corrected titre 1/50 1/260 1/128 ND ND
Notes
a) The codes refer to Table 9.
b) This is the total antibody produced by the purification from the indicated
volume of TCS. Protein is estimated by A280.
c) The initial mass of antibody is given.
d) The percentage incorporation of pyridyl disulphide groups is given as 
estimated by the AA343 measurement,
e) The change in absorbance at 343 nm is proportional to the number of moles of
2-pyridyl disulphide residues released on conjugation (Pharmacia 1SPDP1)
(£3*3™= 8.08 x 10® M"1 cm-1).
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TABLE 45
ANALYSIS OF CONJUGATES PRODUCED BY NHSB METHOD
ELISA*
A405 Corrected for Blank6*
Antibody Amount(mg) Ratio* Titre Dilution A B o
EXPERIMENT I
Antl-A (1) 1.09 120:1 4 K 1/100 0.796 0.104 0. 110
1/500 0.351 0. Ill 0. 109
Ant i-B (11) 1.92 68:1 2 K 1/100 0. 100 0.103 0.100
1/500 0. Ill 0.107 0. 105
Antl-H (21) 1.93 68:1 32 1/100 0. 106 0.111 0. 115
1/500 0. 104 0.110 0.114
Blank6* 0.098 0.103 0.103
EXPERIMENT II
Antl-A (1) 0.25 20: 1 8 K 1/100 0.435 0.193 0. 198
h 40: 1 5 K ii 0. 555 0.151 0. 157
ii 100:1 5 K h 0.739 0.164 0. 162
ii * 200:1 5 K ii 1.182 0.161 0. 170
Antl-B (11) 0.25 10:1 150 1/100 0. 166 0.154 0.155
ii 20: 1 - II 0. 178 0.166 0,166
h 50:1 - II 0.171 0. 173 0.179
« 100:1 - II 0.170 0.167 0, 173
Antl-H (21) 0.25 10:1 800 1/100 0. 189 0.182 0.215
« 20:1 800 II 0. 186 0.173 0. 177
ii 50:1 256 II 0.209 0.214 0.249
ii 100:1 144 II 0.234 0,206 0.225
Blank6* 0.102 0.099 0.100
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TABLE 45 CCont.)
ANALYSIS OF CONJUGATES PRODUCED BY NHSB METHOD
ELISA-
A405 Corrected for Blank19
Antibodv Amount(mg) Ratio® Titre Dilution A â o
EXPERIMENT III
Anti-A (1) 0.1 200:1 256 1/500 0.024 - -
h 2K: 1 512 ii 0.016 - 0.015
h lOKil — ii
Anti-B (11) 0.1 100:1 128 1/500 - 0.065 -
« IK: 1 644 ii - 0.020 —
ii 5K: 1 - ii ' —
Antl-H (21) 0.1 100:1 128 1/500 0.040 0.020 0.039
n IK: 1 32 ii - — —
h 5K: 1 - h
Blank* 0.095 0. 110 0. 100
EXPERIMENT IV
Anti-A (1) 0,67 500:1 2K 1/50 0.617 0.087 0.030
IK: 1 4K « 0.581 - 0.016
ii 2K: 1 4K « 0.689 — 0.030
Anti-B (11) 0.67 500:1 32 1/50 0.082 0.314 0.008
« IK: 1 64 ii - 0.140 0.011
« 2K: 1 2 ii — 0,079
Antl-H (21) 0.67 500:1 — 1/50 - - -
h IK: 1 - ii - 0.049 —
w 2K: 1 - ii 0.054 0.051 0.029
Blank* 0.234 0.215 0.216
a) The ELISA was carried out as detailed In the Methods section with blotln 
conjugates diluted as Indicated, against group A, B and 0 liquid saliva. 
All absorbances were read at 405nm after 20 minutes incubation of 
substrate (5 minutes for conjugation IV) and corrected for the NSB(b). 
A405 < 0.000 is expressed as 
c) The ratio is the initial molar ratio of NHSB:IgM assuming the MW of IgM 
is 1,000,000.
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obulin had been incompletely labelled by bio tin, which would lower the 
sensitivity of any ELISA method. When the anti-H conjugate, produced in 
Experiment I, was purified on an affinity column the products had
increased ELISA activity (Table 46) compared to the crude preparations. 
Similar results were obtained for an anti-B conjugate (data not shown).
5.4.2 The Biotin Hvdrazide Method.
The biotin hydrazide approach produced active anti-A and anti-H 
conjugates (Table 47). The anti-A conjugate (titre 58K), and the two 
anti-H conjugates were able to discriminate salivary bloodgroup 
substance even when diluted 1/500. The anti-B conjugates were 
effectively inactive. When these conjugates were tested in a pre-mix 
ELISA system, it was found that the anti-H conjugates had no ELISA
activity and the second anti-B conjugate had slight activity (Table 48). 
Additionally the antibody blanks were very high in the pre-mix mode.
5.4.3 Other Investigations.
The stability of the biotin conjugates was investigated. In 
contrast to findings for Experiment III for the NHSB method, the
conjugates from Experiment IV retained their activity in ELISA for at 
least two months when stored at 4'C (data not shown).
The high antibody blank values in many tests was found to be a 
consequence of the avid in-alkaline phosphatase conjugates binding to the 
immobilized saliva in the absence of bio tiny la ted antibody. It was found 
necessary to incubate the avidin-alkaline phosphatase for only five
minutes to obtain the optimal signal to noise ratio; the avidin-alkaline 
phosphatase could be diluted 1/5000 without significant loss of ELISA 
potency (data not shown). In order to explain the high antibody blank 
values, saliva and avidin-alkaline phosphatase were titrated in the 
absence of bio tiny la ted antibody.
At the working dilution of the avidin-alkaline phosphatase 
conjugate (1/1000) there was considerable cross-reaction between the co-
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TABLE 46
PURIFICATION OF BIOTINYLATED ANTI-H ON AVIDIN-AGAROSE COLUMN
ELISA*
A405 Corrected for Blank*
Fraction Description Titre L B. o
Crude anti-H Conjugate* 512 0.067 0.034 0.164
Supernatant from 
affinity column
16 0.053 0.031 0.083
Eluted fraction 1 32 0.012 0.022 0.031
2 64 0.056 0,022 0.098
3 128 0.100 0.069 0.213
4 128 0.035 0.034 0. 106
5 32 0.034 0.008 0.064
6 16 0.008 0.004 0.035
a) The ELISA was carried out as detailed in the methods section using 
aliquots of fractions diluted 1/50 against liquid saliva of groups 
A, B and 0, The A405 was corrected for NSB (b) after a substrate 
incubation of 30 minutes. The titres were determined on group 0 red 
cells only.
c) The sample loading was 500 pi of crude anti-H conjugate.
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TABLE 47
ANALYSIS OF CONJUGATES PRODUCED BY THE BIOTIN HYDRAZIDE METHOD
ELISA*
A405 Corrected for Blank**
CBiotin
Antibodv Hydrazide] Titre Dilution L E o
Antl-A (Al) 10 mM 300 1/100
1/500
0.139
0.022
0.013
0.000
0.021
0.015
Anti-A (A2) 5 mM 58K 1/100
1/500
1.280
0.337
0.023
0.005
0.025
0,011
Anti-B (Bl> 11 mM 0 1/100
1/500
0.011
0.003
0.051
0.015
0.014
0.000
Anti-B (B2) 5 mM 0 1/100
1/500
0,017
0.004
0.030
0.016
0.014
0.005
Anti-H (HI) 10 mM 1.6K 1/100
1/500
0.638
0.223
0.681
0.236
0.988
0.342
Anti-H (H2) 7 mM 1.6K 1/100
1/500
.0.491 
0.189
0.624
0.227
0.838
0.303
Blank** 0.165 0.179 0.173
a) The ELISA was carried out as detailed in the methods section with blot in
conjugates (in parentheses, all made using 0.3 mg IgM) diluted as indicated, 
directed against group A, B and 0 liquid saliva. All absorbances were read 
at 405nm after one hour substrate incubation and corrected for the NSB (b).
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TABLE 48
COMPARISON OF PRE-MIX AND SEQUENTIAL MODES FOR ELISA TESTING OF CONJUGATES
ELISA*
A405 Corrected for sample blank 
Mode : Pre-mix Sequential
Conl ugate Saliva: Â. E Q. 6. E Q.
Al 0.088 - - 0.139 0.013 0.021
A2 1.040 0.227 0.087 1.280 0.023 0.025
B1 - 0.045 - 0.011 0.051 0.014
B2 0.028 0.144 0.038 0.017 0.030 0.014
HI - - - 0.638 0.691 0.988
H2 - 0.003 - 0.491 0.624 0.838
Sample blank 0.434 0.574 0.525 0.165 0.179 0.173
a) ELISA was carried out as detailed in the methods section with 
biotin conjugates produced by the biotin hydrazide method 
diluted 1/100 for the assay and A405 values read after one 
hour substrate incubation. A405 < 0.000 expressed as
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-njugate and the immobilized saliva after a 15 minute incubation of 
substrate solution (Figure 51). The strength of this reaction was 
maximal at a saliva dilution of 1/500-1/1000 and this was found to be 
true for other avidin-alkaline phosphatase dilutions. The pre-incubât ion 
of the avidin-alkaline phosphatase conjugate with free biotin for 30 
minutes prior to addition of this mixture to plates previously coated 
with liquid saliva was found to inhibit the reaction. described above 
(Figure 52). This was true for group A saliva and experiments with other 
saliva samples gave similar results. Conjugates produced by Experiment 
IV were mixed with avidin-alkaline phosphatase in various ratios and 
stored prior to use to see whether these pre-mixtures would ac% as 
complete MAb-enzyme conjugates, through their linkage with avid in-bio tin.
The details of the method are given in the methods section. In 
two experiments, the level of the no-MAb background exceeded that of 
the tests, and no specificity was shown by the. bio tiny la ted MAb for the 
immobilised salivary blood group substance. In -a separate test these 
same MAb retained their activity when used in a sequential assay.
MAb was immobilized onto plates to act as a capture antibody as 
described in the methods section. Biotinylated MAb, produced by 
Experiment IV, was used to detect captured blood group substance, in the 
form of bloodstain extracts. The level of the no-bloods ta in control was 
very high and exceeded that of the tests in the single experiment 
carried out.
5.4.4 Discussion 
Glutaraldehyde Conjugation
The two attempts to conjugate alkaline phosphatase to IgM 
monoclonal anti-A were unsuccessful using the two-step glutaraldehyde 
method (experiment I) or the one-step approach (experiment ID.
In experiment I an estimated 300 pg of specific Ig was loaded 
onto the Synsorb immunoadsorbent. The HAG titre of the TCS was reduced
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Figure 51. Conjugation of Enzymes to Monoclonal Antibodies.
The avidin-biotin system. Titration of avidin-alkaline phosphat 
conjugate with immobilized saliva dilutions in ELISA in the 
absence of biotinylated MAb to determine the cross-reactivity 
pattern.
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Figure 52. Conjugation of Enzymes to Monoclonal Antibodies.
The avidin-biotin system. Inhibition of 'cross-reaction' between 
avidin-alkaline phosphatase conjugates and immobilized saliva in 
ELISA using free biotin concentrations.
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from 1/2000 to 1/256 (le 90%) giving an estimated 270 pg of IgM on the 
affinity matrix. This is equivalent to 0.3 nmoles which was reacted with 
1,2 nmoles alkaline phosphatase using 0.2% (final concentration)
glutaraldehyde.
In experiment II, 1.0 mg of antibody (equivalent to 1.11 nmoles) 
was reacted with 2.22 nmoles alkaline phosphatase using 0.2%
glutaraldehyde in a one-step method.
The one-step glutaraldehyde method of Avrameas 119693 re­
commends 10 mg of alkaline phosphatase (= 71.4 nmoles, MW = 140,000) 
and 5 mg IgG (33.3 nmoles, MW = 150,000) with a final glutaraldehyde 
concentration of 0.025%. The reaction was carried out for two to three 
hours.
The Law of Mass Action states that the rate of formation of
(antibody-enzyme) complexes, assuming 1:1 reaction is proportional to the
concentration of (activated) enzyme and antibody le
CAb-E3 = K. [Ab3CE3 
dt
In experiment I, using the weights of antibody (0.3 nmoles) and
enzyme (1.2 nmoles), to achieve the same level of conjugation and
ignoring differences between the two and one-step methods, a reaction 
time, compared to the published method, of some 6,600-fold would be 
necessary. Similarly for experiment II an increase in reaction time of 
almost 1000-fold would theoretically , be needed.
All the reactions above were carried out at pH 7.4 in PBS
buffer. At this pH glutaraldehyde is not reacting optimally [Molin,
Wygren and Do1onius 19783.
The conjugation of alkaline phosphatase to immunoglobulin bound 
to an affinity matrix (cf experiment I) would be expected to conserve 
the antibody activity especially in situations where the reactive group 
(e-amino group of lysine) may be distributed over the whole molecule 
including the antigen binding sites, Although the antibody was apparently
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bound to the affinity matrix there was no evidence of viable antibody 
conjugates being formed. It appeared as if the enzyme was extensively 
homoconjugated and became attached to the Synsorb as shown by it's 
persistence even after washing.
The use of haemagg lut ina t ion titre as a means of assessing the 
level of viable antibody has limitations as mentioned above. This is more 
relevant when free and conjugated antibody are assessed by the same 
method. The use of . what can be a variable test method (due in part to 
the use of red cells) further comfounds the issue. Every assay must 
introduce some bias* HAG testing was adopted for this work since it 
gives a reasonably quick «  1 hour) result and the results for similar 
samples were (within one doubling dilution) reproducible.
Other methods of measuring antibody activity vary in the 
linearity of their response when compared with 'titre' (using log-log 
plots, Tijssen 1985, page 401). The absence of a suitable reference serum 
makes many other alternatives such as MONA (multiple of.normal activity, 
[Feigner 19781 and ratio-based methods redundant. The use of absorbance 
values in EIA's [De Savigny and Voiler 19803 again rely on standard 
sera and the linearity of absorbance measurements on some equipment is 
in doubt above absorbances greater than 1.5.
It was clear (Figure 41) that the majority of the alkaline
phosphatase activity was present as free enzyme.
In addition to the kinetic considerations some workers have
noted the extensive se If-polymerisation of glutaraldehyde in commercial
preparations (only 3% free glutaraldehyde, Korn et ai. 1972). Care was 
taken in this work to use only purified e lec tron-m icroscopy grade
glutaraldehyde stored at -20'C prior to use (Sigma Grade I 25% aqueous 
solution coded G5882).
The recovery of IgM may be roughly estimated from the trace in 
Figure 41. The protein peak 1 had an absorbance at 280 nm of about 0.03
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AU/ml over an elution volume of 16 ml (peak height = 0.06 AU, base = 8 
x 2 ml fractions) and using e2®0™" for IgM = 1.38 C Jarvis and Voss 
19811 the maximum amount of IgM in peak 1, assuming no enzyme content, 
was 0.35 mg ie = 35% recovery. However some enzyme apparently was 
present in the excluded peak and so the final recovery must be lower. 
This enzyme may have been present as a high molecular weight conjugate 
which was also excluded from the gel filtration medium.
The Periodate Method.
The optimal ratio of reactants for coupling HRP to IgM 
antibodies has not to my knowledge been reported in the literature. The 
basis of the conjugation method is that free amino groups of eg the IgM 
antibody (for which there is little available data, [Metzger 19703 form 
Schiff's bases with aldehyde groups on the HRP produced themselves by 
oxidation of surface carbohydrate residues by meta sodium periodate. The 
product is stabilised by reduction with NaBH*. The original method 
CNakane and Kawoi 19741 relied on prior blocking of amino groups on HRP 
by DNFB (Sanger's reagent). That method involved an initial molar ratio 
of HRP:IgG of 4:1. In later methods ratios of 2:1 and lower have been 
used.
An initial ratio, (experiment I), of 80:1, would tend to favour 
the formation of large conjugates which may not be desirable in EIA 
(size limits diffusion and hence reaction speed). The extent to which the 
enzyme is activated by carbohydrate oxidation is critical when 
determining starting concentrations of reactants. At high pH self- 
polymerization of activated enzyme can occur hence the elution of enzyme 
with 0.001 M sodium acetate buffer pH 4.5. The final periodate level 
during the enzyme activation step was 33 mM (experiment I) although the 
optimum level quoted has been as low as 4 mM [Tijssen 19851 with some 
batches of HRP.
In experiments II and III similar protein elution profiles of
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purified ’conjugate' were found. Only the 8:1 initial molar ratio of 
HRP:IgM produced enzyme activity associated with the HMW peak. Since 
this ratio is suboptimal for other methods the activation of the enzyme 
may have been incomplete or the surface carbohydrate on the IgM 
antibody (as much as 15%) may have reacted with residual NalO* masking 
amine groups on the former.
The 'conjugates’ from experiments II and III were inactive in 
ELISA although there was HAG activity in the material chromatographed. 
This suggests either a mixture of free (viable) IgM and HRP polymers or 
modification of any IgM (linked to HRP) activity, so that whilst it was 
active against red cells it was in a conformation that was not able to 
function in the ELISA.
The periodate method is still much favoured and has been
refined. It is clear however that the reaction conditions have to be 
critically controlled. Additionally IgM molecules may present problems of 
their own in enzyme conjugation.
The SPDP method.
In experiment I it was clear that no conjugate was produced by 
the experiment as a whole. The principal cause of this must have been 
the SPDP concentration which was made 100 times too weak in error.
Additionally the method as used was for an initial 0.05-2 pmoles of 
antibody. By using 0.16 mg of antibody (compared to between 22.5 to 900 
mg in the published method) the 30 minute incubation time for reaction 
with SPDP would have to be increased some 140-fold if the Law of Mass 
Action is considered (cf glutaraldehyde method).
In the second conjugation experiment using anti-H monoclonal
antibody purified by SEC instead of HPLAC (experiment I) 0.5 mg of 
purified Ig was used. However only about 10% of the antibody was
recovered as estimated by the reduction in HAG titre and A280 
measurements which is suprising since Carlsson et al. [ 19781 do not
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make any mention of reduction in activity of proteins following pyridyl 
thiolation. Tijssen [19851 makes the comment, without any apparent 
evidence, that "the titres obtained in EIA with conjugates prepared by 
this theoretically attractive method are disappointing despite the high 
conjugation efficiency". Harr is-Smith and Fletcher [19831 used the SPDP 
method to produce successful anti-H lectin ( Ulex europeaus) alkaline 
phosphatase conjugates for use in ELISA.
Experiment III also apparently failed presumably for similar 
reasons, despite the varied ratio of SPDP : IgM. Some workers have 
suggested that ratios as high as 200:1 can bring about better 
conjugation efficiency (see below).
Experiment IV was an attempt to conjugate alkaline phosphatase
contining pyridyl disulphide groups with any natural thiol groups in IgM 
antibody, IgM contains several types of disulphide groups (page 43) and 
may also contain reactive thiol groups that could theoretically take part 
in a reaction of this type. This approach however was unsuccessful.
In experiment V only conjugate Vc had any activity as shown by 
the small amount of enzyme activity associated with the HMW peak. That 
this conjugate also showed marginal specificity in ELISA (Table 43)
indicated that the higher initial ratio of SPDP:protein (100:1 on a Molar
basis) resulted in a partially successful conjugation. Carlsson e t a l ,
[19781 reported that increased substitution can be obtained by using a 
large excess (up to 200:1) of the SPDP reagent.
The overall performance of the SPDP method was disappointing 
despite its reported success for IgG antibody conjugation. The pyridyl- 
thiolation of alkaline phosphatase appeared to work adequately (as also 
found by other workers eg [ Harr is-Smith and Fletcher 19831 . The
pyridyl-thiolation of the monoclonal IgM preparations was not very
successful. The SPDP method has been used successfully with IgG
monoclonal antibody [Jou, Schepart and Bankert 19821. Scarcity of
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material precluded proper evaluation of antibody substitution efficiency 
or calculation of free amine groups CSatake et al, 19603. The presence 
of contaminating BSA which although markedly reduced from native TCS 
may have reduced the effective SPDP concentration available to the 
antibody.
Biotin Conjugation.
The conjugation of bio tin to monoclonal antibodies was found to
be a simple procedure requiring little technical expertise. The two most
common methods, the NHSB and the bio tin hydrazide methods, were used to 
produce some successful conjugates when assessed in ELISA against liquid 
saliva.
The NHSB method gave good monoclonal anti-A bio tin conjugates 
at an optimal ratio of NHBS : IgM of 200:1. At low ratios of NHBS: IgM,
incomplete labelling of all three antibodies by bio tin was found. These
preparations were purified on an affinity column; the lowered affinity of 
monomeric avid in for biotinylated antibody compared with te tramer ic 
avid in) was exploited to effect the recovery of the antibodies from such 
a column.
The reaction of the NHSB reagent with anti-B and anti-H affinity 
purified monoclonal antibodies was less successful than for anti-A 
though conjugates with low activity were made using ratios of 500:1 and 
50:1 respectively. The lowered titres of the conjugates may have 
reflected the conjugation of biotin to the antigen binding site through 
reaction of NHBS with primary amines or thiol groups.
There appears to be no easy explanation for the variability in 
the preparation of anti-B and anti-H conjugates by this method. Other 
workers L Avrameas 19763 have determined the number of free amine 
groups on antibodies before and after reaction with NHSB to optimise the 
conjugation reaction. The scarcity of the affinity-purified antibody 
precluded that approach.
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Some active bio tin-ant ibody conjugates were produced using 
bio tin hydrazide though this method was not optimised. This method has 
the potential advantage that biotin coupling is through carbohydrate 
residues unlikely to be associated with the antigen binding site on the 
immunoglobulin.
Theoretically IgM is favoured over IgG in this respect since it 
is more highly glycosylated (15 % as against 3 %) I Metzger 19703 . Also 
contaminating albumin from foetal calf serum would not be conjugated 
since it has no associated carbohydrate residues. It was found that 
conjugates produced by this method behaved differently when tested in
either a pre-mix or sequential EL ISA mode. This suprising finding was 
not the case for conjugates produced by the use of NHSB.
The lowering of the NSB (ie no bio tin-ant ibody conjugate) in the
presence of increasing free biotin concentrations suggested that the
high blank reaction may have been in part due to the recognition of 
endogenous bio tin (immobilized with the saliva) by the avidin-alkaline 
phosphatase conjugate. The levels of blot in in whole blood have been 
estimated at 0.25 ng/ml [ Baker 19623; its origin is solely dietary. This 
is a major obstacle in the application of the avidin-biotin system to 
the grouping of saliva and bloodstains in a sequential ELISA system. In 
a pre-mix system the pre-incubation of biotinylated antibody with 
avidin-alkaline phosphatase could be followed by the addition of free 
biotin to block any 'unreacted avid in' preventing its reaction with 
endogenous biotin in immobilized saliva since the avidin-biotin reaction 
is essentially irreversible.
The initial investigations into alternative assay systems to 
exploit bio tin- labelled MAb did not give promising results. The 
pre-mixtures of biotinylated MAb and commercial avidin-alkaline 
phosphatase did not function as ELISA reagents against saliva. 
Additionally, more work is needed on the development of a capture system
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to identify the source of high background reactions.
This study shows the potential of the avidin-biotin system with 
the three antibodies used in a sequential reaction mode. It is simple and 
reproducible and produces stable active conjugates. Its application needs 
the investigation of high background reactions which preclude its use as 
a method to complement other developments in the ABH grouping of 
bloodstains by ELISA. The avidin-biotin system has been used to amplify 
the sensitivity of ELISA I Kendal 1, lonescu-Mat iu and Dreesman 19831 
and in the context of ABH grouping I Lin et a l . 1984, Takatori and
Tsutsubuchi 19863.
General Comments on IgM-Alkaline Phosphatase Conjugation.
A consequence of the production, both commercial and from 
research teams of predominantly IgM monoclonal antibodies (Table 5) for 
use as ABH blood grouping reagents, especially in the form of TCS, is
the need to purify them free from contaminating PCS when conjugation is
contemplated. This purification may be desirable if two or more antibody 
clones need to be mixed to give 'cocktails' which are not deficient for 
rare phenotypes so that the composition of the final sera is accurately 
known. The difficulties experienced with this purification (Chapter 4)
were in part the reason for the scarcity of material available for 
conjugation.
The IgM molecule has several structural attributes which make 
it unsuitable for use in EIA.
Firstly the high MW, although conferring a potential advantage 
(not borne out) for purifying it by SEC means that resultant conjugates 
may be large enough to spontaneously precipitate on storage. Although 
high protein concentrations may be desirable to prevent dénaturation the 
reaction of high MW (antibody enzyme) complexes with immobilized enzymes 
may be limited by diffusion control at the liquid so lid-phase interface.
IgM's have typically, low affinity which in a heterogeneous
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system, especially one in which there are two separate incubations (and 
hence two wash steps), may lead to desorption of bound reactants after 
washing after the equilibrium has been disturbed. Hybridoma IgM 
antibodies have been reported as having two classes of binding sites 
amongst the two Fab arms [Giles, Klapper and Clem 19831 . This will 
tend to moderate the advantage of having 10 binding sites per molecule. 
In this respect IgM fragments, the preparation of which is very difficult 
to control, would have a higher specific activity in EIA if conjugated to 
enzyme. It is likely that IgM increases its avidity by flexing; this may 
be restricted by enzyme conjugation.
The difficulty experienced in purifying IgM's restricted the 
diversity of conjugation approaches attempted. Fragmented IgM would have 
been a more useful raw material for enzyme conjugation especially if the 
'high affinity fragments' were selected by eg affinity chromatography.
Although IgM's are intrinsically very stable, pen tamer ic IgM is 
sensitive to mild reduction by DTT at a level of 10 mM in as little as 
ten minutes [Knight 1978], The levels of DTT used in the SPDP method 
were of this order and may well have destabilised the molecule 
especially at the low levels «  1.0 mg) used in these studies.
CONCLUSIONS
Attempts to conjugate IgM anti-ABH MAb to alkaline phosphatase 
using the glutaraldehyde methods were not successful.
Biotinylation of IgM's for use in an avid in-bio tin system gave 
some success and offer the best route for using whole IgM MAb in ELISA.
The difficulties experienced in this conjugation work were 
attributed to the structural features of the IgM molecule.
General Discussion
General Discussion
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6 General Discussion.
This work presents studies into the application of ELISA to 
some aspects of ABO grouping in the context of forensic science. The 
studies have shown that some facets of the area in which forensic 
science concerns itself have been addressed.
The types of materials that will be encountered in a forensic 
science serology laboratory include liquid saliva (as a control to check 
secretor status), saliva stains (on masks etc.), liquid blood (as a 
control for grouping), bloodstains from potential exhibits, semen stains, 
vaginal fluid stains and mixed stains of any of the above. Occasionally 
tissue and hair are submitted for grouping. In the context of ABO 
grouping sources of soluble and red cell bgs need to be grouped. These 
are represented in this work by liquid saliva (a source of soluble, 
especially type I antigens) and by bloodstains (a source of type 1 and 2 
antigens).
The assay of these two sources provides a model for the other 
types of materials grouped by forensic serolegists. The ELISA developed 
here has certain advantages over the two agglutination methods (A/I and 
A/E) used in parallel in forensic science laboratories. The ELISA is 
objective in result evaluation, it is convenient in reaction format and 
reagent preparation and has comparable or better sensitivity using the 
indirect format.
Although I have not demonstrated that as little as 0.13 pi of 
liquid saliva (1/2000 dilution, 250 pi sample size) or 1.5 pi blood as a 
stain can be detected by ELISA the dilutions used here suggest they can. 
The comparable amounts used at present are of the order of 30 to 90 pi 
liquid saliva (1 to 3 drops from a Pasteur pipette) or a 0.5 cm= stain 
(= to 15 pi liquid blood). The age and condition of submitted material
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always makes such estimates very error prone.
Sensitivity may not be the most important criterion of a good 
ABH grouping system for although using less material in one test leaves 
more for repeat tests (by independent experts for example) or other
grouping systems* detecting very small amounts of fairly ubiquitous 
sugars may lead to problems with bacterial contamination of stains.
The convenience of EL ISA and the data reduction and storage
facilities offered by automatic plate readers are the most tangible 
advantages. Others include the fine specificity offered by using a 
battery of MAb against different epitopes (eg salivary ABH, sweat ABH, 
bacterial ABH etc) in the convenience of the microplate format. The use 
of an extractive method in a heterogeneous system means more rigorous 
agents can be used since the final detection system is not affected by 
them (cf red cells being lysed by detergent on cloth). This is useful 
where stains are old and do not readily give up their secrets.
The use of monoclonal antibodies in ELISA is both an advantage
and disadvantage. As mentioned mixtures of stains can possibly be 
discriminated. However mixtures of MAb might be necessary to cover not 
only the naturally occurring forms of the ABH antigens but also the 
epitopes generated by cell lysis in stains and changes in epitope 
presentation following detergent extraction and solid-phase
immobilization. A caution has been sounded about the use of anti-ABH MAb 
in blood grouping without full characterisation of them [Salmon e t a l . 
19843.
Full characterisation of the MAb used here is impossible without 
synthetic oligosaccharides. These would be useful in developing other 
assay formats including IRMAs and competitive binding systems for ABH 
grouping.
Other reports on the application of ELISA to ABH grouping have 
been published by groups outside the Forensic Science Service
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[Katsumata et a l . 1984, Katsumata et aL 1985 Rukavishnikova e t a l . 
1985, Bol ton and Thorpe 19861.
In one report [ Katsumata e t a l . 19841, group AB secretor 
saliva is detected by using a variant of the IRMA technique using 
alkaline phosphatase conjugated anti-human antibody and human anti-A or 
anti-B. By using capture antibody on wells only the bgs is extracted 
obviating the cross-reaction with anti-human Ig conjugates such as I 
found (results, chapter 1).
Group AB secretor saliva was distinguished from artificial 
mixtures of groups A and B saliva (such mixtures of secretions may be 
present in submitted evidence) by exploiting the presence of both A and 
B structures in true AB saliva. The sensitivity of the test was said to 
be equivalent to existing methods and could discriminate saliva at a 
dilution equivalent to 0.01 pi group A saliva or 1 pi group B saliva (cf 
my findings of = 0.4 pi of group A or B saliva using polyclonal 
reagents).
A refinement of the technique allowed group 0 saliva to be 
detected I Katsumata e t a l . 19851.
An ELISA method based on adsorbing salivary bgs to wells was 
not successful using polyclonal reagents [Rukavishnikova e t a L 19853 , 
Only with monoclonal reagents were the group able to confirm they had 
successfully immobilized bgs on the so lid-phase. When they immobilized 
lectins to wells they were able to detect group A saliva and aqueous 
blood extracts,
Bolton and Thorpe [ 19861 found that routine typing sera were of 
insufficient specificity to discriminate group A and B salivary bgs. Only 
when monoclonal anti-A and anti-B (from the West of Scotland blood 
transfusion service) were used was absolute discrimination observed. The 
sensitivity of the technique was quoted as detecting bgs in the ng/ml 
range.
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7. Conclusions
1. Polyclonal anti-A and anti-B were used to discriminate groups A and B 
secretor saliva. Other saliva was not discriminated using these reagents.
2. Polyclonal reagents in the system used were unable to discriminate 
extracted A and B bgs from red cells.
3. Monoclonal anti-A, B and H gave differential reaction with both 
salivary and erythrocyte bgs depending on the conjugates used to detect 
them and the assay conditions.
4. Studies were made into the development of direct ABH ELISA. The 
avid in-bio tin system offered the most promising route to a complete 
method for blood-grouping for forensic purposes.
8. Future Study.
More antibodies need to be gathered or raised. These could 
either be MAb or affinity purified polyclonal sera.
The investigations here could be applied to other body fluids, 
especially semen.
The fine specificities of existing reagents need to be analysed 
by oligosaccharide inhibition studies.
These methods should be applied to case materials gathered from 
the field. Also the robustness of these methods and the supporting 
equipment should be evaluated in field trials.
Other reaction formats need to be examined and the general 
applicability of these methods to other grouping systems especially 
Rhesus, the MN system and HLA could be examined.
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Chembiomed Ltd, Edmonton, Alberta, CANADA.
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Oxoid Ltd, Basingstoke, HANTS,
Pharmacia, Milton Keynes, BUCKS.
Sarstedt, Leicester, LEICS.
Seraclone, Bicester, OXON.
Shandon Ltd, Astmoor, CHESHIRE.
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Tago Inc., (Tissue Culture Services), Southampton, HANTS. 
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APPENDIX B
APPENDIX B 
Surface Area Calculation (see page 141)
APPENDIX B
Calculation of Wetted Surface Area for Flat and 'U1-bottomed
Wells (see page 141),
The surface area of each well-type in contact with 250 pi reagent 
(the reagent volume) may be calculated as follows:
* U*-bottom (Well diameter= 0. 58cm, the 1U8-bottom well may be 
considered as a hemisphere of height r and cylinder of height 1) 
Volume = 250 pl= (II. r2 . 1 ) + (2/3.II. r3 ) (1 is the cylinder height) 
250 = (3.142 x (3,4)= x 1) + (2/3 x 3.142 x 3.43 )
1 = 4.62 mm.
Substituting this value of I in the formula for the area of a ’ U'- 
bottom well (given by 2. II. r. 1 + 2.0. r2 ) the area wetted by 250 pi of 
reagent can be calculated:
Area = (2 x 3.142 x 3.4 x 4.62) + (2 x 3.142 x (3.4)=
= 171.27 mm2
Flat Bottom
The area wetted by 250 pi reagent was calculated in a similar way 
and found to be 183.29 mm2
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* * *
Practical work on the development of an ABO ELISA grouping 
method utilizing monoclonal antibody reagents began at CRE in 
late 1983. This development has entailed a considerable amount 
of fundamental work on the extraction and immobilization of 
blood group substances, on the characterization of many 
different monoclonal reagents (currently 34), and on the 
evaluation of a wide range of assay conditions. Work on the 
purification of monoclonal IgM by affinity chromatography was 
also carried out as a prerequisite for attempts to synthesize 
monoclonal antibody— enzyme conjugates. The results from this 
program will be issued as a series of CRE Reports under the 
general title "ABO Grouping by ELISA" followed by a more 
specific sub-title. The present report is the first of this 
series, and deals with the characterization of monoclonal 
sera and the conjugates used to detect them.
* * *
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ABSTRACT
Combinations of 10 alkaline phosphatase anti-mouse 
immunoglobulin conjugates with 19 monoclonal (MCA) anti-ABH 
reagents were tested against bloodstains and saliva. An 
indirect ELISA method was used, with MCA and conjugates added 
to the plates simultaneously. Different conjugates gave a 
wide variation in results, with no overall "best conjugate” .
MCA also gave wide differences in reactivity. Most of the 
MCA that reacted did so with ABH substances in both blood 
and saliva. However, five preparations showed a great disparity 
in their reactions with salivary and erythrocytic ABH substances 
and these may prove useful in discriminating the individual 
components of mixed stains.
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INTRODUCTION
Enzyme linked immunosorbent assays (ELISA) have been used 
successfully in many immunological applications for several 
years (Voiler et al., 1979; Blake and Gould, 1984) and more 
recently have been applied to Forensic Serology. Applications 
in this field include the development of ELISA's for the 
spéciation of bloodstains (Fletcher et al., 1984), detection 
of immunoglobulin allotypes (Fletcher et al., 1983; Newall, 1984) 
and ABO typing of saliva stains (Katsumata et a l ., 1984; 
Harris-Smith and Fletcher, 1984).
The use of an ELISA technique in combination with monoclonal 
antibodies (MCA) for the detection of A, B and H blood group 
substances in blood and secretions offers several potential 
advantages over present methods. Most notably it offers increased 
sensitivity and specificity, greater standardization and 
objectivity, and ease of automation (Blake and Gould, 1984).
A number of MCA's have been reported which react with A, B and 
H blood group substances (Voak et a l . , 1980; Edelman et al. ,
1981; Bundle et a l . , 1982; Knowles et al . , 1982; Munro et a l . ,
1982; Barrie et a l . , 1983; Messeter et a l ., 1983; Abe et a l . , 
1984). Many of these are now available commercially. However 
not all the M CA’s raised-against a particular blood group antigen 
react with the two known structural types of ABH blood group 
substance. Most appear to react with both the salivary (type I) 
and erythrocyte (type II) substances, but some are reported to 
detect only type I antigens (Abe et a l . , 1984) while others 
detect only type II antigens (Young et a l . , 1981). Even where 
the specificity is nominally for the same molecule, different 
MCA's can give widely varying results in an ELISA as a result 
of affinity differences (Lehtonen and Eerola, 1982; Lew, 1984).
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The choice of the anti-mouse immunoglobulin conjugate used to 
detect the MCA's is another important factor to consiaer, as 
this can also influence the specificity and sensitivity of 
an ELISA assay (Fletcher et al. , 1984).
A necessary preliminary to the development of ELISA 
grouping methods is the identification of suitable combinations 
of specific MCA's and anti-mouse immunoglobin conjugates for 
extended investigation. We report here the results of a study 
in which 19 MCA clones and 10 alkaline phosphatase labelled 
anti-mouse immunoglobulin conjugates were assessed for specificity 
and sensitivity in an indirect ELISA method using both bloodstain 
extracts and liquid saliva. The MCA's and the saliva or bloodstain 
extracts were used only at one dilution in each assay,which 
was chosen on the basis of results obtained previously. Liquid 
saliva rather than stains was used, on the assumption that 
salivary A, B and H substances are readily soluble in saline, 
and it is anticipated that saliva stain extracts will give 
reactions approaching those of liquid saliva.
MATERIALS AND METHODS 
Monoclonal Antibodies
Commercially available MCA's were obtained from Chembiomed 
Ltd, Edmonton, Alberta, Canada; from Celltech Ltd, Slough, 
Berkshire, UK; from Seraclone, Biotest Folex Ltd, Frankfurt/Main, 
West Germany ; and from the Centre National de Transfusion 
Sanguine (CNTS), Paris, France. The remaining eleven were 
supplied by Dr S Moore, S.E. Scotland Regional Blood Transfusion 
Service, Royal Infirmary, Edinburgh, Scotland, by Dr K Gelsthorpe, 
Regional Blood Transfusion Service, Sheffield, UK, and by 
Dr H Lee of CNTS, Paris, France. All MCA's, with the exception 
of that from Dr S Moore, were of the IgM class. Details of 
MCA are given in Table 1.
TABLE 1
DETAILS OF MCA’s USED
No. SOURCE CODE SPECIFICITY TITRE**
1 Chembiomed AH8-123A Anti-A 1 2000
2 Celltech A1005X 6D4 Apti-A 1 1000
3 Celltech 3D3 Anti-A 1 512
4* Moore E516 Anti-A 1 256
5 Biotest 132054 Anti-A 1 1000
6 CNTS Al. 83 Anti-A 1 2000
6a CNTS Al. 84 Ant i-A 1 1000
7 CNTS A2.84 Anti-A 1 512
8 CNTS A3. 83 Anti-A 1 2000
8a CNTS A3.84 Anti-A 1 512
9 Chembiomed AH8-123B Anti-B 1 2000
10 Celltech NB1.83 Anti-B 1 32
10a Celltech NB1.84 Anti-B 1 32
11 Biotest 12 2024 Anti-B 1 32
12 CNTS B1.83 Anti-B 1 512
12a CNTS B1.84 Anti-B 1 256
13 CNTS B2.83 Anti-B 1 128
14 CNTS B3.83 Anti-B 1 64
15 CNTS 836 36 Anti-B 1 512
16 CNTS 836 38 Anti-A,B 1 1000(A)
1 64(B)
17 Biotest 11 1084 Anti-A+B 1 128(A)
1 64(B)
18 Chembiomed A07-149H Anti-H 1 128
19 Gelsthorpe 43.3.5 Anti-H None
* IgG. All other are IgM.
Using 1% red cell suspension; 2% BSA-saline; read by 
spin and streak method.
TABLE 2
ANTI-MOUSE IMMUNOGLOBULIN-ALKALINE PHOSPHATASE CONJUGATES USED
CONJUGATE SOURCE CODE SPECIFICITY
A Miles-Yeda S148 Rabbit anti-mouse IgG
B Miles-Yeda E003 Rabbit anti-mouse IgG
C Serotec AAC07A Sheep anti-mouse IgM
D Serotec AAC01A Sheep anti-mouse IgG (Heavy chain)
E Sigma 22F-8855 Goat anti-mouse IgG (Adsorbed)*
F Sigma 42F-S900 Rabbit anti-mouse IgG
G Sigma 123F-8868 Goat anti-mouse IgG
H Tago 510501 Goat anti-mouse IgM
I Tago 530102 Goat(Fab’)^  anti-mouse IgG+IgM
J Tago 530704 Goat anti-mouse IgG+IgM
*
With human serum protein.
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A total of 23 MCA preparations from 19 different clones 
were used in this study of which MCA Nos. 6, 10, and 12 were 
present as two different batches. Some preparations were 
mixtures of more than one MCA; No. 15 was made up of three 
anti-B MCA's, No. 16 contained two different anti-A,B's and 
No. 17 was a mixture of anti-A and anti-B.
Conjugates
The conjugates used were all commercially available alkaline 
phosphatase labelled anti-mouse immunoglobulins. Two of these 
were purchased from Miles-Yeda Ltd, Rehovot, Israel ; two from 
Serotec Ltd, Bicester, UK; three from Sigma Chemical Co., Poole, 
Dorset, UK, and three from Tago Inc., Burlingame, C A , USA.
Details of the conjugates are given in Table 2.
Saliva
Fresh saliva was collected from laboratory staff of known 
group and secretor status. It was then heated in a boiling water 
bath for 15 minutes, divided into 200yl aliquots and stored at 
-20°C prior to use.
Bloodstains
Samples of blood were collected from laboratory volunteers 
into heparinized tubes (Microvette CB1000, Sarstedt, W. Germany). 
Stains were made using 30yl of fresh blood on clean, boiled, 
cotton cloth and left at room temperature for at least 72 hours 
before use. Extracts were made by cutting out the whole stain 
and placing it in a plastic tube containing 0.4ml of 1% octyl 
glucose and 5% 0.880 ammonia, dissolved in phosphate-buffered 
saline (PBS) pH7.4 (Dulbecco 'A' tablets; Oxoid Ltd, Basingstoke, 
Hants). Extractions were carried out for 30 minutes at room 
temperature on a Luckham VR/4 vibrator (Luckham Ltd., Burgess 
Hill, West Sussex).
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ELISA
Assays were carried out in Dynatech 96 well microELISA 
plates (M129B, Dynatech Ltd, Billingshurst, Sussex). Diluent 
buffer for antigen was 0.1M phosphate buffer, pHS.O (13.18g 
NagHPO^ and 0.99g NaH^PO^ in 11 distilled water). Diluent 
for antibody and conjugate was PBS containing 0.05% Tween 20.
Wash buffer was PBS containing 0.05% Tween 20 and 0.1% bovine 
serum albumin (Ortho Diagnostic Ltd, High Wycombe, Bucks, UK). 
Substrate solution was lmg/ml p-nitrophenyl phosphate (Sigma 
Chemical Co, Poole, Dorset) in diethanolamine buffer (1M 
containing ImM MgClg and 0.02% sodium azide, adjusted to pH9.8 
with 5N HC1).
Bloodstain extracts (100yl at 1:50 dilution) or saliva 
dilutions (lOOpl at 1:5000 dilution) were dispensed into microtitre 
plate wells using a Titertek Autodrop (Flow Laboratories Ltd, 
Rickmansworth, Herts, UK). After 2 hours incubation at 37°C, 
the plates were washed using a Titertek Microplate Washer 120 
(Flow Laboratories Ltd, Rickmansworth, Herts). The wash 
sequence was: rinse - soak for 15 minutes - rinse. MCA and 
conjugate, were then added to the plate simultaneously, in a 
total volume of lOOyl per well, giving a final dilution of 1:1000 
for the conjugate. The MCA's were used at final dilutions of 
1:100 for the bloodstain assays and 1:500 for the saliva assays.
The plates were then incubated for a further 2 hours at 37°C 
and washed as before. Finally, 100yl of enzyme substrate 
solution was added to each well.
Plates were read 1 hour after the addition of substrate 
using a MR580 Micro-ELISA Autoreader (Dynatech Ltd, Billingshurst, 
Sussex, UK) in dual absorbance mode with the reference filter 
set at 630nm and the test filter set at 405nm.
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The following control wells were included on each plate:-
1. Antibody blank (bloodstain extract, antibody diluent, 
anti-mouse conjugate, substrate solution).
2. Antigen blank (antigen diluent, MCA, anti-mouse 
conjugate, substrate solution).
3. Substrate blank (substrate only).
Results are expressed as mean sample absorbance (A405nm- 
A630nm) minus the mean absorbance of the antibody blank wells.
For clarity, only results above an absorbance level of 0.05 are 
reported in the tables ; the significance of values below this 
level is uncertain.
RESULTS
Saliva
The results obtained with saliva (Table 3) demonstrate a 
considerable variation in the binding of conjugates to the 
MCA’s used in this study. Most conjugates reacted well with the 
anti-A MCA but only three reacted appreciably with the anti-B, 
anti-H, and anti-A,B MCA’s . Some of the conjugates failed to 
react with any of the monoclonals.
The conjugates used 'were directed against different 
immunoglobulin classes but their reactivity did not, in many 
cases, reflect their published specificity. Conjugates A, B,
D, E, F and G, though specific for murine IgG, reacted with IgM 
MCA's. The reason for this is unclear, but might be due to the 
presence of contaminating antibody or to reactivity with structures 
involving light chains. Of the four conjugates with IgM specificity, 
one was ineffective, but the other three gave the strongest 
reactions with most MCA's.
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No evidence of reaction was given by five of the 23 MCA’s 
preparations tested. All 10 anti-A MCA’s reacted to some extent, 
five quite strongly. Five of the 9 anti-B MCA’s reacted, but only 
one (No. 9) gave a strong reaction. One of the two anti-H MCA's 
gave no reactions while the other, No. 18, reacted moderately 
well with group 0 and A salivas. The pattern of reactions of 
the anti-A, MCA's was unexpected. One reacted weakly with 
group B saliva, and the other reacted weakly with group A 
saliva when used with three of the conjugates and with group B 
saliva also with one of these conjugates (conjugate H).
In all cases cross reactivity with heterologous blood group 
substances was minimal and background levels of enzyme activity 
in control wells were very low.
Blood
The results obtained for bloodstain extracts are given in 
Table 4. The pattern of results was similar to that for saliva 
but generally the absorbance levels were not as high. The 
bloodstain extracts and MCA’s required higher concentrations 
than saliva to obtain reactions of comparable strength.
Variations between the binding abilities of different conjugates 
were again evident, with the Tago conjugates (i.e. H, I, J) 
giving the best results. As before, conjugates specific for 
IgG gave good reactions with IgM M C A ’s and, in contrast to the 
finding with saliva, the IgM specific conjugate, H, showed some 
reactivity with the IgG MCA No. 4.
All the anti-A MCA's gave moderate or strong reactions, with 
the exception of No. 2, which gave a weak reaction with only one 
conjugate. The best were Nos. 1 , 4 , 5  and 6. Despite the fact 
that more anti-B reactions were observed here, the individual 
reactions were uniformly weak. Neither of the anti-H MCA gave 
any indication of reaction. The anti-A,B which had given a
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single weak reaction against group B saliva reacted weakly 
with group A blood. In contrast, the other anti-A,B gave very 
strong reactions with group A blood. MCA reactions with 
heterologous blood substances were again low, although some 
cross reactivity was observed for MCA No. 4 with conjugates 
A, B, and E , and MCA No. 5 with conjugate A.
DISCUSSION
The results obtained in this study underline the importance 
of testing a MCA with a number of anti-mouse Ig-enzyme conjugates 
in assessing its reaction with antigen. Additionally, the 
published specificity of the conjugate may not be entirely 
accurate for all uses. This variation of conjugate binding 
means that it may not be possible to identify the MCA’s which 
bind to antigen to the greatest extent since the reactions 
observed are composite of MCA-antigen binding and MCA-conjugate 
binding. It is therefore conceivable that some of the MCA’s 
which failed to react at all in this work might bind more avidly 
than those which did react. There was, in fact, no overall best 
anti-A MCA, with Nos. 1, 4, and 5 each showing the strongest 
reactions for bloodstains depending on the conjugate used.
The differences in MCA reactivity with blood and saliva 
are of considerable interest from a casework viewpoint. The 
use of MCA’s which are specific for a single chain type determinant 
presents the possibility of developing ELISA methods capable of 
discriminating the individual groups of blood and saliva/semen 
in mixed stains, or of a bloodstain on heavily sweat- or saliva- 
stained cloth. For most of the MCA's used in this study the 
chain type specificity - type I or type II - is unpublished or 
untested, but from these results most appear to recognise both 
chain types.
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However, five of the MCA’s showed significant differences 
in their reactions against blood and saliva. Two, Nos. 2 
and 18, reacted strongly against saliva, but weakly or not 
at all with blood. It is unlikely that this reflects an 
absolute specificity for type I chains as all the MCA's tested 
here were identified and characterised by haemagglutination 
methods. However, it is possible that these MCA’s bind more 
avidly to type I than to type II chain structures.
A second explanation could be that the detergent extraction 
method, or the subsequent immobilization process, alters the 
presentation of the immunodeterminant in such a way as to 
discriminate selectively against some MCA's. There is., in fact, 
good evidence that some detergents, e.g. sodium dodecyl sulphate, 
bind strongly to glycoproteins and glycolipids, inducing 
conformational changes (Reynolds and Tanford, 1970). Additionally, 
alkaline extraction conditions have been shown to destroy the 
normal immunoreactivity of H substance but not of A or B 
substance (Rutter, 1984). With the anti-H M CA’s, for example, 
it might be that the lower degree of glycosylation, compared 
with A or B glycolipid, leads to a closer association of the 
determinant with the detergent monolayer on the polystyrene 
surface. However, complete destruction, or occlusion, does 
not occur. Previous work in this laboratory (Harris—Smith and 
Fletcher, 1983), in which group 0 bloodstains were extracted 
and immobilized under the same conditions used here detected 
H substance quite strongly with a Vlex europaeus lectin-enyzme 
conjugate. This indicates that H substance is extracted and 
immobilized in a form which retains the ability to bind the 
lectin.
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Further work is in progress on the use of different 
detergents for extraction and on immobilization conditions 
to clarify the critical factors in this area. Whatever the 
explanation for this lack of reactivity with bloodstain extract, 
providing it holds over a sufficiently wide range of sample 
conditions, it could provide the basis for the detection of 
contaminating salivary A and H activity in a bloodstain.
Anti-A M C A ’s 6, 6a, 7, 8, and 3a all reacted better 
with blood than with saliva. With some conjugates they reacted 
only with blood, albeit weakly. The two anti-B MCA's 12 and 
14, which reacted with blood alone may indeed be specific for 
type II chain B determinant. Both, however, reacted weakly, 
and it is unlikely that these MCA's, used under the conditions 
described, would give enough sensitivity for the projected use. 
Nevertheless, they are the only "blood-specific" MCA's revealed 
by this study and the use of a different conjugate, or a change 
of detergent, might dramatically improve their potential.
The anti-A,B preparation, No. 16, also showed much greater 
reactivity with blood than with saliva, albeit with group A 
only. Discrimination was absolute with several conjugates.
Type II chain specificity is strongly indicated, and the 
restriction of reaction to group A alone makes the use of this 
reagent as an anti-A feasible, provided the specificity holds 
over a more extended range of sample conditions. The reason 
for the restricted specificity is unclear but it is possible 
that detergent could adversely affect the presentation of one 
antigen and not the other.
The strength of reaction in ELISA did not correlate 
particularly well with the saline agglutination titre of the 
MCA's. This may reflect the differing effects of antibody binding
14
affinity in different immunoassay systems. For example,
Nimmon et a l . (1984) have suggested that low affinity anti­
bodies may dissociate from the antibody during the microplate 
washing steps, and Lehtonen and Eerola (1984) found that the 
affinity of MCA used in an ELISA could affect the direct 
absorbance measurement rather than endpoint titre.
In conclusion, suitable MCA's, conjugates, and extraction 
and immobilization conditions have been identified which permit 
the detection of A, B, and H substances in saliva, and of A 
and B substances in bloodstains. Under the conditions used, 
one anti-A,B and 2 anti-B MCA's react only with bloodstain 
substance, and one anti—A and one anti—H MCA react only with 
saliva substance. This last group of MCA's holds out some 
promise for the development of mixed stain grouping ELISA 
methods.
15
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Abstract.
Extracts of 100 bloodstains were grouped in an indirect ELISA 
method using monoclonal sera. Group A, and B stains were grouped 
reliably, with good reproducibility and with little cross-react ion with 
heterlogous sera. Group A= and A=B stains reacted weakly. The monoclonal 
anti-H serum gave weak reactions with all groups and only 80% of group 
0 stains.
Introduction
A considerable number of monoclonal antisera to blood group 
antigens have been tested in an indirect ELISA against liquid saliva and 
bloodstain extracts [13. The results of that study, and others C2, 33 
indicate that bloodstain grouping by ELISA is a practical possibility. 
These studies, however, have been conducted using samples from a few 
individuals only, and it was considered necessary to evaluate the 
technique with a much larger number of samples before further 
development. We therefore chose three monoclonal sera * (MCA), one each 
for group A, B and H which had given strong reactions in previous work, 
and investigated their reactions with extracts from 100 bloodstains. This 
report presents the results obtained.
Materials and Methods
Cotton cloth was purchased from R Adams (Burnley, England). 
MicroELISA plates (Type 129B) were purchased from Dynatech Labs. Ltd. 
(Billingshurst, Sussex, England). These have found to be the most 
suitable for the immobilisation of extracted blood group substances [43. 
Bovine serum albumin (BSA) was obtained from Ortho Diagnostic Systems 
Ltd. (High Wycombe, England). Tween 20, sodium azide, diethanolamine,
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octyl glucose and p-nitrophenyl phosphate (5 mg tablets) were obtained 
from Sigma Chemical Co. (Poole, Dorset, England).
Bloodstains were prepared on boiled cotton cloth, using 30 pi of 
freshly drawn whole blood from laboratory volounteers. The stains were 
then dried at room temperature for at least 24 hours before use. All 
stains were subsequently coded and the bloodgroup of the donors not 
revealed until after the analysis. A,/Az sub typing was carried out using 
a lectin technique by the Aldermaston Forensic Science Laboratory.
Whole bloodstains (approximately 1 cm square) were extracted 
using 400 pi of extractant (PBS containing 5% 0.880 ammonia solution and 
1% octyl glucose) for 30 minutes at room temperature on a laboratory 
vibrator. Extracted cloth was removed and extracts were diluted in 0.1M 
phosphate buffer pH 8.0 (13.18 g/L Na2HP0* plus 0.99 g/1 NaH2P0*).
Phosphate-buffered saline (PBS tablets from Oxoid Ltd, 
Basingstoke, England) containing 0.05% Tween 20 and 0.1% BSA, was used 
to wash the plates. Diluent buffer for antibody and conjugate was PBS 
with 0.05% Tween 20. Substrate solution was p-nitrophenyl phosphate (1 
mg/ml) in 10% diethano lamine buffer containing ImM MgCl=, pH 9.8.
Monoclonal blood grouping reagents (anti-A, B and H) were 
purchased from Chembiomed Ltd. (University of Alberta, Edmonton, Alberta, 
Canada). These antibodies were produced by immunisation with synthetic 
haptens [53. Goat anti-mouse IgM-alkaline phosphatase conjugate was from 
Tago Inc. (Burlingame, California, USA). Reagents were dispensed using a 
Titertek Autodrop and microELISA plates were washed in a Tltertek 
Microplate Washer 120, both from Flow Labs. (Irvine, Scotland).
ELISA
Bloodstain extract dilutions and controls (both 100 pi) were 
incubated in micro titre plate wells for 2 hours at 37*C. Plates were then
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washed with PBS using two rinse stages, a 15 minute soak stage and two 
further rinses, leaving the wells empty. Monoclonal antibody was diluted 
1/25 (anti-A, anti-B) or 1/10 (anti-H) and pre-incubated with an equal 
volume of anti-mouse IgM alkaline phosphatase conjugate (diluted 1/500
in diluent buffer) for 30 minutes at room temperature. After this pre­
mix stage, 100 pi aliquots of antibody-conjugate mixtures were dispensed
into plate wells.
The plates were covered, incubated at 37#C for 2 hours, and then 
washed as described above. Substrate solution (100 pi) was dispensed 
into the wells and the plates were left covered at room temperature. 
They were read after one hour and again after an overnight incubation 
at 4'C,
The following blanks were included on each plate:
Stain Extract Monoclonal Anti-Mouse Substrate 
Antibody Conjugate Solution
1 Antibody Blank + - + +
2 Sample Blank - + + +
In addition a positive control for extracts of group A,, B and 0 
was prepared. Large stains were extracted and extracts aliquotted and 
frozen for use in subsequent assays. They were used within two weeks of 
preparation, at a dilution of 1/50. Each plate contained a sample of each 
control. The addition of reagents to plates was carefully synchronised to 
minimise drift.
Plate wells were read spectrophotometrica 1 ly at 405nm using a 
model M580 dual beam reader (Dynatech Laboratories, Billingshurst, 
Sussex) with the reference filter set at 630nm. Any absorbance at the 
reference wavelength is subtracted automatically from the sample reading 
at 405nm to compensate for marks or scratches on plate wells. The plate 
reader, interfaced to an Apple lie micro, was controlled under software 
developed in-house.
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Absorbance readings were printed out and saved on floppy disc 
for further analysis by a commercial spreadsheet package (Flashcalc, 
Visicorp, San Jose, California, USA). The absorbance values for each test 
were corrected by subtracting the Antibody Blank.
Results
A summary of the results for all the stains, at an extract 
dilution of 1/50 is given in Table 1. The results of homologous reaction 
of individual bloodstains, at all three dilutions, is given in Appendix 
1.
The monoclonal anti-A reagent (at a dilution of 1/50) reacted 
strongly with A, bloodstain extracts diluted from 1/20 to 1/100, but 
only weakly with A2 (donors 18 and 19) and A=B (donors 25 and 26) 
bloodstain extracts. The anti-B monoclonal antibody at the same dilution 
(1/50) reacted well with group B bloodstain extracts but not as strongly 
as the anti-A in homologous reactions. However, duplicate or
quadruplicate extracts from the same donor processed separately were in 
better agreement in homologous B reactions than in homologous A 
reactions. The anti-B also reacted well with the A=B bloodstain extracts. 
The anti-H monoclonal antibody (diluted 1/10) reacted weakly with all 
group 0 bloodstain extracts even at an extract dilution of 1/20. The 
degree of cross-reaction of all A, and B bloodstain extracts with 
heterologous antisera was very low.
In the majority of cases, increasing the dilution of bloodstain 
extract gave a lower A405 reading (corrected for blank). This decrease 
in absorbance values from a bloodstain extract dilution of 1/20 to one 
of 1/100 was greatest for anti-B homologous reactions (approximately 
50%). However, even at the highest dilution (equivalent to 0,08 pi of
- 5 -
TABLE 1
BLOODSTAIN TYPING BY ELISA: SUMMARY OF RESULTS
Corrected A405*
Antibody Stain Type Mean SD Range %CV Sampl
Anti-A A, 0.984 0.373 0,09041.387 37.9 40
A2 0.106 0.031 0.06240.148 29.2 4
B 0.038 0.024 0.00740,109 63.1 12
A,B 0.702 0.028 0.67440.730 4.0 2
A=B 0.070 0,028 0.02840.099 40.0 4
0 0.034 0.021 0.00340.080 61.8 38
Anti-B A, 0.009 0.011 0.00040.039 - 40
a2 0.000 0.001 0.00040.003 - 4
B 0.432 0, 152 0.19840.674 35.2 12
A,B 0.206 0.001 0.20540.206 0. 5 2
ASB 0.348 0. 161 0.14040.571 46,3 4
0 0. 007 0.009 0.00040.042 - 37
0b 0.019 0.073 0.00040.462 — 38
Anti-H A, 0.031 0.015 0.00040.078 48,4 40
A= 0.041 0.018 0.02140.069 43.9 4
B 0.041 0.016 0.00840.070 39.0 12
A,B 0.020 0.001 0.01940.020 5.0 2
A2B 0.057 0.016 0.04640.085 28.0 4
0 0.083 0.039 0.02140,162 47.0 38
a) A405nm corrected by subtraction for Antibody Blank for extracts diluted 1/50,
indicates a %CV not calculated.
b) An outlier (0.462) is included in the data summary.
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original liquid blood) the discrimination between positives and negatives 
was good.
Table 3 summarises the control bloodstain extract data (shown 
in full in Appendix 2). The data shows that for A and B bloodstains 
there is no overlap between the range of absorbance values for 
homologous and heterologous reactions. For group 0 bloodstains, however, 
there is no clear difference in the reactions of the homologous antisera 
and the heterologous antisera.
Discussion
The ELISA method for ABO grouping of bloodstain extracts used 
in this trial was simple to perform. The results were obtained using an 
automated reader, and were processed by computer, eliminating the 
subjective component of results assessment normally associated with 
blood grouping.
The reproducibility of the method was generally good. Replicates 
agreed well, with only three exceptions (donors 12, 15 and 17). Mean 
plate to plate variation for the controls of 28.6% was roughly 
equivalent to plus or minus one doubling dilution in haemagglutination 
terms.
The stain results indicate that at the current stage of 
development good discrimination of A, and B bloodstains can be made, but 
that grouping of 0, A2 or A2B stains is unsatisfactory. These results 
indicate a quantitative difference between the H levels in A, and A2 
stains but the significance of this is difficult to assess on such few 
data. However it raises the possibility of sub typing A stains using an 
A:H ratio.
The weak reaction of the monoclonal anti-H with bloodstain 
extracts was unexpected. The monoclonal anti-H used in this study perfo-
- 7 -
TABLE 2
SUMMARY OF POSITIVE CONTROL RESULTS
Corrected A405-
Group Antibody Mean SD Range %CV
Anti-A
Anti-B
Anti-H
0.560
0.059
0.076
0.123
0.021
0.013
0.35040.915
0.03040.119
0.05340.104
22.0
35.6
52.7
Anti-A
Anti-B
Anti-H
0.083 0.022
0.304 0.072
0.099 0.016
0.05040.138
0.19040.530
0.06440.136
26.5
23.7
16.2
Anti-A
Anti-B
Anti-H
0.074
0.064
0.130
0.020
0.027
0.015
0.02640.029
0,03040.149
0.09140.157
27.0
42.2
11.5
a) A405 corrected for Antibody Blank.
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-rms well In ELISA [13 against saliva and in saline agglutination testing 
of erythrocytes. Its failure to react adequately in this study may have 
been due to a loss of H substance activity following ammoniacal 
extraction of bloodstains as previously demonstrated [6, 73. Alternatively 
detergent extraction may result in an unfavourable presentation of the H 
substance for so lid-phase immobilisation or monoclonal antibody binding 
or both. Other anti-H binders (Ulex europeaus lectin 1 conjugated to 
alkaline phosphatase [23) detected ammoniacal detergent extracted H 
substance strongly.
Some discussion of the setting of threshold limits as criteria 
for positive reactions is appropriate. The need for acceptance levels 
normally only occurs when the ranges of values for true positives and 
negatives overlap. In the results reported here, overlap occurs in two 
areas: between heterologous and homologous reactions of the anti-H; and 
between the reaction of anti-A with A2 and 0 stains (and, marginally, B 
stains). Setting the threshold at 0.05 absorbance units (corrected) for 
all three specificities produces the situation shown in Table 3, an 80% 
success rate. Of the 20 mis-typed or "no-result" stains, 18 were group 0 
stains and inspection of the data reproduced in the Appendix suggests 
that the majority of these unsatisfactory results can be attributed to 
the poor performance of the anti-H monoclonal antibody. Other than these 
one group B stain was typed as AB and one AB stain typed as B. In both 
cases repeats gave the correct results.
In addition for group A stains the low reactions of Az subtypes 
is a potential problem, particularly in the AZB combination. The use of 
more avid monoclonal antibodies and a better understanding of the 
extraction and assay conditions should help overcome the problems 
revealed by this study.
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TABLE 3
GROUPING RESULTS INTERPRETED BY ABSORBANCE VALUE THRESHOLD
Result of Grouping
Incorrect No Result
0 
0 
1 
9 
1
11 9
—  10 —
Group Number of Samples Correct
A, 40 40
A= 4 4
B 12 11
0 38 20
AB 6 5
TOTAL 100 80
O 
O 
O 
CD 
O
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APPENDIX 1
Assessment trial of MAb with 100 Bloodstain Extracts.
Corrected A405*
Extract Dilution: 1/20 1/50 1/100
A,
Anti-A
Stains
Anti-B Anti-H Anti-A Anti-B Anti-H Anti-A Anti-B Anti-1
1 1.312 - 0.025 1.144 0.005 0.029 0.959 0.029 0.074
1.359 — 0.027 1.269 0.030 0.034 0.978 0.001 0.050
2 1.330 0.003 0.028 1.088 0.008 0.034 0.934 0.007 0.071
1.328 — — 1.387 0.008 0.036 1.270 0.010 0.054
3 0.834 0.005 0.024 0.661 0.004 0.027 0.429 0.008 0,018
1.366 0.018 0. 024 1.058 0.015 0.037 0.816 0.014 0.051
4 1. 374 0.014 0.041 1.373 0.017 0.039 1.051 0.011 0.056
1. 166 0.000 0.034 0.972 - 0.043 0.739 0.000 0.053
5 1.071 0.002 0.023 0.937 0.005 0.028 0.611 0.008 0.037
0.776 0.006 0.023 0.487 0.018 0.043 0.303 0.021 0.044
6 1.184 - 0.024 0.909 — 0.078 0.733 - 0.027
0. 588 - 0.008 0,445 0.000 0.027 0.357 0.018 0.044
1.085 0.004 0.030 0.855 0.021 0.026 0.863 0.034 0.041
1.237 0.035 0.017 1. 102 0.001 0.026 0.910 0.007 0.034
7 0.944 0.021 0.053 0.591 — 0.002 0.465 0.009 0.042
1.393 0.006 0.019 1.368 0.039 0.009 1.360 0.005 0.028
8 1. 129 0.008 0.031 0.677 0.011 0.040 0.555 0.003 0.048
0. 988 0.016 0.035 0.795 0.007 0.033 0.584 0.007 0.067
9 1.249 - - 1.308 — 0.003 0.861 — 0.044
1.393 0.025 0.045 1.939 0.009 0.027 1.262 0.012 0.059
10 1.325 - - 1.069 — 0.035 0.890 — 0.029
1.366 0.018 0.024 1.058 0.015 0.037 0.816 0.014 0.051
1,225 — 0.064 0.996 — 0.019 0. 589 0.010 0.054
11 1.343 - - 1.340 0.008 0.025 1.176 0.004 0.025
1.362 0.046 0,037 1.360 0.009 0.045 1.107 - 0.061
12 1.301 — - 1.255 0.010 0.025 1.068 0.004 0,041
0, 555 0.008 0.070 0.473 0.017 0.038 0.355 0,015 0.053
13 1.014 0.003 0. 178 0.834 0.015 0.039 0.714 0.014 0.052
1.391 0.004 0.010 1.383 0.000 0.011 1. 129 0.006 0.028
14 1.204 0,065 0.017 0.654 0.011 0.033 0.710 0.001 0.033
1,375 0.030 0.060 1,353 0,006 0.062 1.313 0.023 0. 109
1.375 0.013 0.080 1.266 - - 1.307 0.021 0. 104
1.345 - 0.062 1.083 0.017 0.036 0.704 - 0.036
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APPENDIX 1 (Cont.)
Corrected A405
Extract Dilution: 1/20 1/50 1/100
MAb: Anti-A Anti-B Anti-H Anti-A Anti-B Anti-H Anti-A Anti-B Anti-H
Group A, Stains
15 1.253 
0.162
0.019
0.013
0.057
0.036
0.913
0,239
0.015 0.055
0.017
0.905 
0. 193
0.016 0.037
0.027
16 1.392
1.376
0.024 0.030
0.055
1.379
1.352
0.011
0.001
0.039
0.033
1.351
1.140
0.012
0.011
0.054
0.066
17 1.292
1.387
0.097
0.015
0.014
0.014
0.036
0.027
1,033
1.387
0.090
0.030
0.011
0.017
0.038
0.022
0.679
1.361
0.088
0.002
0.008
0.032
0.029
0.033
Group Az Stains
18 0.143 
0.061 0.006
0.036
0.029
0. 148 
0.062 0.003
0.069
0.021
0. 155 
0.034
0.011
0.004
0. 117 
0.045
19 0. 142 
0. 113
0.016
0.016
0.043
0.045
0,113
0.099
- 0.029
0.046
0.084
0.060
0.006 0.057
0.045
Group B Stains
20 0.010
0.021
0.487
0.438
0.586
0.570
0.061
0.023
0.027
0.043
0.038
0.031
0.022
0.459
0.301
0.479
0.434
0.022
0.070
0.048
0.008
0.022
0.022
0.041
0.023
0.264
0.262
0.328
0.240
0.035
0.045
0.045
0.051
21 0.022
0.010
0.287
0.350
0.028
0.052
0.025
0.050
0. 198 
0.242
0.031
0.042
0.016
0,034
0. 134 
0. 134
0.033
0.061
22 0.002
0.008
0.467
0.500
0.020
0.021
0.026
0.007
0.238
0.420
0.046
0.029
0.028 0.202
0.274
0,037
23
-
0.576
0.660
0.034
0.035
0.025 
0.034
0.547
0.537
0.040
0.041
0,046
0.029
0.340
0.343
0.078
0.065
24 0.011
0.031
0.833
0.876
0.054
0.082
0. 109 
0.048
0.650
0.674
0.062
0.045
0. 127 
0.059
0.384
0.385
0. 106 
0. 102
Group AB Stains
25
0.032
0.277
0.881 0.056
0.028
0.099
0. 140 
0.571
0.046
0.085
0.012
0.095
0. 154 
0.421
0,042
0.084
26 0.022
0.066
0.304
0.506
0.036
0,091
0.062
0.092
0,270
0.411
0.046
0.052
0. 109 
0.048
0.208
0.241
0.044
0.077
27fa 0.767
0.751
0.235
0.267
0.020
0.064
0.730
0.674
0.206
0.205
0.019
0.020
0.568
0.500
0. 165 
0. 169
0.051 
0. 110
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Corrected A405*
Extract Dilution: 1/20 1/50 1/100
MAb: Anti-A Anti-B Anti-H Anti-A Anti-B Anti-H Anti-A Anti-B Anti-1
Group 0 Stains
28
-
0,022 0.097 
0.167
0.048
0.028
0.005
0.462
0.096 
0.128
0.069
0.044
0.000
0.020
0.087
0.087
29 0.012
0,006
0.017
0.006
0.077
0.093
0.029
0.008
0.003
0.010
0.062
0.050
0.028 0.003 0.072
0,054
30
0.026 0.017
0.050 
0. 196
0.011
0.035
0.005
0.007
0.038
0.118
0.012
0.023
0.007
0.010
0.037 
0. 132
31 0.011
0.019 0.017
0. 151 
0.202
0.024
0.011
0.004
0.013
0.132 
0. 161
0.031
0.014
0.004
0.008
0. 143 
0. 130
32
0.003 0.010
0,027
0.024
0.003
0.010
0.000
0.003
0.021
0.066 0.007
0.005
0.021
0.011
0.022
33
0.004
0.006
0.014
0.119
0.064
0.039
0.015
0.015
0.002
0.090
0.069
0.016
0.001
0.017
0.015
0.063
0.042
34
0.027 0.002
0.044
0,086
0.022
0.011
0.001 0.041
0.022
0.009
0.003
0.002 0.058
0.055
35 0.030
0.011
0.060
0.076
0.012
0.009 0.000
0.. 042 
0.037
0.005
0,060 0.010
0.056
0.098
36 0.016
0.021
0.009
0.029
0.222
0.270
0.054
0.041
0.006 0. 118 
0. 136
0.062
0.017
0.012
0.005
0, 156 
0, 113
37 0.002
0.062
0.017 0. 167 
0. 199
0.017
0.049 0,003
0. 113 
0. 150
0.019
0.060
0.009
0.021
0.112 
0, 129
38 0.013
0.015
0.015
0.009
0.089
0.093
0.041
0.052
0.001
0.010
0.066
0.065
0.021
0.002
0.011
0.007
0.065
0.061
39
0.018
0.007
0.011
0.075 
0. 118
0.070
0.055
0.026
0.016
0. 103 
0.088
0.002 
0.023
0.002
0.001
0.040 
0. 110
40 - - 0. 159 
0.070
0,037
0.039
0.013
0.010
0. 129 
0.058
0.030
0.023
0.014
0.015
0. 124 
0.067
41 0.027 0.021
0.007
0,098
0.074
0.020
0.056
0.006 0.077
0.075
0.035
0.059
0.002 0.067
0.217
42 0.001
0.000
0.000
0.046
0. 177 
0. 120
0.076
0.059 0.042
0.062
0.082
0.073
0.844
0.016
0.007
0. 124 
0.085
43 0.006
0.017 0.015
0.083 
0. 114
0.042
0.025
0.028
0.007
0.072
0.116
0.005
0.079 0.028
0.052 
0.097
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Corrected A405*
Extract Dilution: 1/20 1/50 1/100
MAb: Anti-A Anti-B Anti-H
Group 0 Stains
44 - 0.007 0. 129
— 0.010 0.119
45 0.001 0.014 0.087
0.003 0.006 0.082
46 0.026 0. 055 0.056
0.020 0.012 0.141
Notes
Anti-A Anti-B Anti-H Anti-A Anti-B Anti-;
0.059
0.008
0.004 0.065
0.064 0.010 0.009
0.053
0.064
0.050
0.033
0.000 0.034
0.048
0.008
0.026 0.008
0.057
0.062
0.014
0.080
0.015
0.008
0.041 
0. 107
0.013
0.077 0.004
0.035 
0. 121
a) A405 corrected for ASB. A405 < 0.000 are denoted by * .
b) This stain was an equal mixture of group A and B blood.
APPENDIX 2
Control Bloodstain Data for MAb ELISA Assessment Trial.
Corrected A405*
Control Blood Group A
MAb: Anti-A Anti-B Anti-H Anti-A
Plate*
1 0.647 0. 105 0. 103 0. 103
2 0.587 0.057 0.083 0.090
3 0.588 0.083 0.075 0.075
4 0.559 0.068 0.091 0. 107
5 0.745 0.062 0.063 0. 112
6 0.408 0.048 0.057 0.092
7 0.479 0.069 0.067 0. 100
8 0.591 0. 065 0.090 0,091
9 0.442 0.051 0,081 0.084
10 0.522 0,091 0,089 0. 106
11 0.440 0.049 0.071 0.066
12 0.764 0.053 0.091 0.072
13 0.485 0.039 0.072 0.072
14 0.408 0.038 0.071 0.072
15 0.350 0.080 0. 104 0.101
16 0.426 0.046 0.064 0.083
17 0.576 0, 119 0,060 0.071
18 0 . 443 0.060 0,078 0.079
19 0.527 0.047 0.077 0.075
20 0.422 0.044 0.086 0.090
21 0.708 0.030 0.062 0.059
22 0.915 0.071 0.058 0.080
B
Anti-B Anti-H Anti-A
H
Anti-B Anti-H
0.307 0. 112 0.103 0.081 0.145
0.326 0.112 0.086 0.050 0. 128
0.294 0.093 0.088 0.085 0. 145
0.318 0.098 0. 108 0.069 0. 154
0.365 0. 100 0. 129 0.094 0. 150
0.255 0.096 0.026 0.035 0.091
0.257 0. 121 0.093 0.077 0. 137
0.299 0. 125 0.101 0.093 0. 132
0.237 0.099 0.065 0.053 0. 112
0.245 0. 136 0.092 0. 142 0. 147
0.206 0.087 0.068 0.056 0. 157
0.442 0.076 0.054 0.041 0. 123
0.235 0. 126 0.062 0.046 0. 128
0.269 0.088 0.064 0.038 0. 128
0.197 0. 109 0.099 0.087 0. 139
0.263 0.090 0.076 0.056 0. 124
0.404 0.093 0.076 0.072 0. 150
0. 190 0. 108 0,077 0.075 0. 131
0.362 0. 115 0.067 0.049 0. 138
0.261 0. 106 0.071 0.053 0. 124
0.451 0,089 0. 056 0.041 0. 123
0.530 0.064 0,050 0.030 0. 126
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Control Blood Group
Corrected A405* 
B
MAb: Anti-A Anti-B Anti-H Anti-A Anti-B Anti-H Anti-A Anti-B Anti-H
Plate*»
23 0.687 0.036 0.073 0.064 0.281 0.081 0.053 0.039 0. 113
24 0.382 0.038 0.076 0.106 0.327 0.093 0.075 0.055 0. 130
25 0.585 0.040 0.070 0.098 0.301 0.104 0.066 0.073 0. 131
26 0.342 0.096 0.088 0.138 0.298 0.094 0.075 0.051 0. 135
27 0,714 0.074 0.062 0.082 0.347 0.105 0.074 0.063 0. 121
28 0.588 0.048 0.084 0.080 0.335 0.089 0.081 0.051 0. 149
29 0.498 0.043 0.069 0.084 0.270 0. 110 0.077 0.077 0. 118
30 0.402 0.056 0.063 0.088 0.228 0.094 0.065 0.040 0. 115
31 0.561 0.079 0.092 0.090 0.314 0. 104 0,080 0.149 0. 143
32 0.591 0.039 0.053 0. 050 0.296 0. 066 0.045 0.041 0.097
33 0.524 0.051 0.079 0.069 0.278 0.092 0.066 0.061 0.124
34 0.638 0.036 0.073 0.079 0.248 0.080 0.063 0.058 0. 112
Notes
a) A405 corrected for Antibody Blank.
b) Each of 34 microtitre plates contained the controls Indicated.
[RS1TY OF m
- 17 -
